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ABSTRACT.
The physiology of a murine hybridoma has been investigated during stirred batch 
culture. Use of cubic spline interpolation and differentiation of the experimental data 
has revealed a three-phase culture physiology which characterises growth and antibody 
synthesis. During this triphasic sequence, antibody synthesis was found to be non­
growth associated, and data was obtained indicating that the energy charge of the cell 
is involved in the regulation of antibody synthesis. Firm evidence of ammonia 
assimilation was obtained, indicating that it was utilised by incorporation into alanine 
by glutamate dehydrogenase and subsequent transamination.
Glutamine was identified as a key metabolite required for proliferation by the 
hybridoma, and the cell-line found to be incapable of adaptation to growth in the 
absence of glutamine. Levels of glutamine synthetase (GS)-mRNA and the 
accompanying enzyme activity were found to vary throughout the duration of batch 
culture in a manner consistent with the three phases. Levels of GS expressed by the 
hybridoma, however, were insufficient to enable the synthesis of adequate amounts of 
endogenous glutamine for its metabolic requirements, even after amplification of the 
GS gene copy number.
The hybridoma was transformed to glutamine independence with a gene coding for 
glutamine synthetase. Southern hybridization studies showed that the gene was 
incorporated into the genomic DNA. Levels of GS-mRNA and the associated 
production of active enzyme were found to be elevated. The effect of modifying 
glutamine metabolism on cellular physiology was assessed, and compared to that of the 
untransformed hybridoma. In the GS transformed cell-line it was observed that; cell 
yields were increased, the specific growth rate had decreased, there was a greater 
overall percentage of glucose utilised, and a lower ratio of lactate-produced to glucose- 
consumed occurred. Neither glutamine or ammonia were detected in the growth 
medium. However, lower antibody titres were obtained than in the parent hybridoma.
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CHAPTER 1.
INTRODUCTION.
1. ANIMAL CELL CULTURE.
1.1. AN OVERVIEW.
Cells are the structural and functional units which make up all living organisms. 
Consequently they have diverse characteristics which reflect their evolutionary 
adaptation to different enviroments, and distinct functions both as unicellular 
"organisms" and within a multicellular organism. The potential of all cells to maintain 
an independent existence has led to the development of mammalian cell culture 
techniques. This technology has facilitated the study of various aspects of cellular 
biology, physiology and genetics, which were previously hampered by the multiplicity 
of the whole organism. Much interest in mammalian cell culture has stemmed from 
the therapeutic or prophylactic nature of certain molecules produced by the cell during 
growth and development, and in the use of cells as a "vehicle" to produce further 
biologicals through genetic engineering. Commercially, the market value of products 
from animal cells in culture is high, and it has been estimated that it will reach $25 
billion per annum by the mid to late 1990s (Spier, 1990). A number of 
comprehensive reviews on animal cell culture technology, including the current and 
potential applications, have been made (Lubiniecki et al, 1989; Spier and Griffiths, 
1990; Spier and Horaud, 1985). Some examples of the current uses of animal cells are 
summarised in Table 1.1.
TABLE 1.1.
CURRENT AND POTENTIAL PRODUCTS FROM CULTURED ANIMAL CELLS.
Viral vaccines
Recombinant viral vaccines:
- hepatitis B surface antigen
- herpes simplex glycoprotein D
Immunoregulatory proteins:
- interferons
- interleukins 
Monoclonal antibodies
Polypeptide growth factors
Enzymes:
- tPA
- factor Vm
- factorIX
Hormones:
- erythropoietin
Viral insecticides:
- baculoviruses
Tumor specific antibodies:
- carcinoembryonic antigen
Animal cells as products:
- reconstitution of skin
Spier 1983
Spier and Horaud 1985 
Mizrahi 1988
Crowley et al., 1983 
Berman and Laskey 1985
Phillips et al., 1985 
Shoham 1983 
Klein et al., 1983
Sadowski 1982 
James and Bell 1987 
Spier 1990
Kris et al., 1985
Kadouri and Bohak 1985 
Kaufman et al., 1985 
Toole et al., 1984 
Wood et al., 1984 
Anson et al., 1985
Jacobs et al., 1985 
Katinger and Bliem 1983
Miltenburga* and Krieg 1984
Kim et al., 1985 
Reuveny et al., 1987
Green et al., 1979 
Bell et al., 1983
1.2. THE HISTORY.
Reports of the cultivation of mammalian cells in vitro date back to the late 19th 
centuary when Wilhelm Roux (1885) maintained chick embryo tissue for several days 
in warm saline. Two years later, Arnold (1887) studied the behaviour of isolated frog 
leukocytes over a duration of 4 to 5 days, by sustaining them in lymph-soaked elder 
pitch. It was not though, until the turn of this century that animal cell culture really 
became established, stimulated by Harrison (1907) when he performed his classical 
study on the growth of nerve cells in lymph clots. This led on to investigations of 
the cell culture milieu, and to the refinement of the amino acid and salt composition 
in media containing either clotted lymph, or plasma, to promote growth (Burrows, 
1912; Carrel and Burrows, 1911; Lewis and Lewis, 1912). Subsequently, Rous and 
Jones (1916) demonstrated that it was possible to propagate cells serially. This they 
achieved by cultivating disaggregated chick embryo cells in a plasma clot, and later 
redispersing the cells using trypsin, after which which re-growth was observed.
The next decade saw the launch of investigations into cellular metabolism, with the 
establishment that the cell’s energy requirements were supplied by both glucose (Lewis, 
1922), and by the deamination of amino acids (Holmes and Watchom, 1927; Warburg 
and Kubowitz, 1927). These studies were reinforced by the identification of the 
essential amino acids, vitamins and minerals contained in plasma, serum or lymph, 
which were the principle tissue culture milieu at that time. Studies carried out to 
define the media components led to the identification by Eagle (1955) of the basic 
components required for tissue culture, except for the factors which were provided by 
the added serum. Based on these findings he produced a defined medium, referred to 
as "Eagles minimum essential medium" (MEM), modifications of which are still used 
today.
A major step forward in animal cell culture came in 1949 when Enders demonstrated 
that poliomyelitis virus could be grown in primary cell cultures, which led to the 
establishment of large scale cell culture for the production of viruses and viral vaccines 
(Holmstrom, 1968; Van Hemert and Van Wezel et al., 1970). Further developments 
stemmed from the discovery of the first interferons in mammalian cells in the 1960’s, 
and their promise in both anticancer and antiviral therapy (reviewed by Cantell, 1979). 
The identification of cell-lines which could be used to synthesize interferons revealed
the potential of the use of animal cell cultures for the production of therapeutic 
products. Later, the establishment of continuous cell-lines which constitutively 
expressed therapeutic proteins, resulted in the development of large scale culture 
processes for the production of a number of therapeutic agents, including tissue 
plasminogen activator (tPA) from human melanoma cells (Kluft et al., 1983), and 
û//?/zû-interferon from Namalva cells (Philips et al., 1985). A main concern of using 
continuous cell-lines came from the perceived risk of the transfer of tumorigenic 
material to the recipient. Activated oncogenes and transforming viral genes can 
transform cells in vitro (Bishop, 1983; Diderholm et al., 1965) and cause tumours in 
vivo (Fung et al., 1983; Israel et al., 1979). Consequently, a lot of effort was 
channelled into increasing the sensitivity of techniques for the detection of residual 
nucleic acids (Van Wezel et al., 1982), and assessing the real risks involved in using 
products derived from continuous (transformed) cell-lines for human therapy (Petricianni, 
1987; Ramabhadran, 1987). Regulatory agency approval for the use of alpha- 
lymphoblastoid interferon, derived from an overt cancer cell-line, for use in humans 
has now been obtained by the Wellcome Foundation (Finter, 1990). This has given 
hope for the licensing of further products.
A significant advance in mammalian cell technology came from the introduction of cell 
fusion techniques (Sinkovirs et al., 1970), which led to the advent of hybridoma 
technology in the 1970’s (Kohler and Milstein, 1975). The potential of hybridomas 
to produce monoclonal antibodies, and their value as therapeutic and diagnostic agents, 
was quickly recognised. The requirement to produce high yields of monoclonal 
antibodies stimulated extensive research concerned with the cell’s culture environment, 
growth kinetics, and production processes. More recently, the ability to express foreign 
genes in mammalian cells, and the development of recombinant DNA technology, has 
had a major impact on the potential use of the animal cell as a vehicle for the 
synthesis of biologically important proteins. Considerable resources have been spent 
developing this technology to enable the commercial production of therapeutic and 
prophylactic agents, including human growth hormones (Pavlakis and Hamer, 1983), 
virus subunit vaccines (Hsiung et al, 1984), tissue plasminogen activator and interferons 
(Bimbaum et al., 1987; Kaufman et al, 1985,). Progress is also being made, through 
genetic engineering techniques, to further the understanding of gene expression and 
regulation, the processing of proteins, and protein secretion (reviewed by Rigby, 1984; 
Sanders, 1990).
1.3. THE BIOLOGY OF THE CULTURED CELL.
Mammalian cells exhibit a range of properties, many of which reflect the tissue or 
organ from which they originate. An appreciation, therefore, of the biology of the 
cell is fundamental for the successful cultivation of any cell-type.
CELL-TYPES.
A cell culture is derived either by the outgrowth of migrating cells from a fragment 
of tissue, or by enzymatic or mechanical dispersal of the tissue. Freshley isolated 
cultures are referred to as primary cultures until they are passaged or subcultured, 
following which they are known of as a cell-line. Transformed cell-lines are those 
which exhibit some or all of the properties typical of tumor cells (e.g. immortality, 
loss of "contact inhibition"). Transformation may occur "spontaneously" after the 
repeated subculturing of a tissue culture, or may be induced by certain viruses (e.g. 
SV40, Rous sarcoma virus).
A broad division used to categorise most mammalian cells is whether they are "normal" 
or "continuous" cell-lines (Hayflick and Moorhead, 1961). "Normal" refers to cell- 
types that have originated from non-pathological tissue and have a finite lifespan. In 
culture these cell-lines tend to maintain their characteristic morphology, karyotype and 
function, examples include BHK cells, CHO cells, and human embryonic lung cells.
Continuous cell-types are derived from pathological tissue, especially tumours, for 
example Bowes melanoma, a human tumour cell-line. However, continuous cells can 
stem from the transformation of normal cell-lines, which may either occur 
spontaneously, or be chemically or virally induced. Steinitz and colleagues (1977) used 
the Epstein-Barr virus to transform human B-lymphocytes, to obtain a human 
lymphoblastoid continuous cell-line for the production of human monoclonal antibodies. 
Interest in this area has been stimulated by the discovery that many continuous cell- 
lines derived following transformation by retroviruses, can grow in the absence of 
certain growth factors which they were previously dependent upon (Doolittle et al., 
1983; Marquardt et al, 1983; Niman, 1984). A key feature of all continuous cell- 
lines is that they are immortal. In addition (as mentioned above) they tend to be less 
nutritionally fastidious, they are usually aneuploid, and they show considerable 
heteroploidy.
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Plate 1.1. THE POXBl/2 HYBRIDOMA rXlOOOl
THE HYBRIDOMA.
A further cell-type, the "hybridoma", is the result of a fusion between a lymphocyte 
(a "normal" cell ) which secretes antibody, and a myeloma cell (a "continuous" cell- 
line which confers immortality to the resulting fusion product). A hybridoma cell 
culture is shown in Plate 1.1. In accordance with Burnet’s clonal selection theory for 
antibody production by lymphocytes (Burnet, 1957), it is possible to select a single 
hybridoma clone producing antibodies of uniform specificity. Hybridomas were first 
produced when lymphocytes, obtained from the spleen of a virally infected mouse, were 
fused together with tumour cells, to produce a "hybrid" cell-line which secreted virus 
specific antibodies (Sinkovirs et al., 1970). The full potential of hybridoma technology 
to enable the production of monoclonal antibodies, was developed by Kohler and 
Milstein (1975). Detailed descriptions of the technique of hybridoma production are 
available in several texts (Campbell, 1984; Coding, 1983; Milstein, 1980). The basic 
principles are shown in Figure 1.1, and outlined below.
To produce a hybridoma secreting an antibody of the desired specificity, an animal, 
for convenience usually a mouse, is immunised with the antigen of interest (a number 
of workers, however, have reported the successful employment of in vitro immunisation 
techniques (Borrebaeck, 1986; James and Bell, 1987)). The spleen is then excised 
from the animal, the lymphocytes harvested and subsequently fused with a cultured 
myeloma cell-line. Originally Kohler and Milstein used Sendai virus to promote the 
fusion of cells, but this has been largely superseded by the use of polyethylene glycol 
(PEG) (Davidson et al., 1976), or electrofusion (Zimmerman et al., 1985).
In PEG promoted fusion, the myeloma cell employed as the fusion partner is a 
continuous cell-line deficient in the enzyme hypoxanthine (guanine) phosphoribosyl 
transferase (HGPRT). This enzyme is part of a salvage pathway which can utilise 
hypoxanthine for purine biosynthesis in the absence of the de novo pathway (refer to 
Figure 1.2). Cells deficient in HGPRT are unable to synthesize purines from 
hypoxanthine, and will, therefore, die in the presence of aminopterin (a folate 
antagonist) which blocks the de novo synthesis of purines and pyrimidines. 
Lymphocytes cells, however, possess HGPRT and thymidine kinase, and can use these 
two enzymes to synthesise purines from hypoxanthine, and pyrimidines from thymidine, 
but, as mentioned earlier, they are unable to proliferate in vitro.
FIGURE 1.1. THE PRINCIPLES OF HYBRIDOMA PRODUCTION.
Mouse immunised 
with antigen
Cultured myeloma 
HPRT"
v
B-lymphocytes harvested 
from spleen
Cell fusion 
(promoted by PEG)
o o o o o  'o 0 0 0 0  'n o o o o
Hybridomas selected 
with HAT medium
V
Screen for cells producing 
desired antibody
V
Select by cloning
(Hayter, P.M., PhD Thesis, Surrey University)
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Thus, successful lymphocyte-myeloma cell fusions may be selected by their ability to 
proliferate indefinately in "HAT medium", which contains hypoxanthine, aminopterin and 
thymidine (Littlefield, 1964). The resulting "hybridomas" can then be screened for 
secretion of the desired antibody by immunoassay. The subsequent selection and 
cloning of a secreting cell-line will achieve a single hybridoma clone which produces 
a specific monoclonal antibody.
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Figure 1 .2  An outline o f the de tiovo and salvage pathways of nucleotide biosynthesis. *, 
XGPRT is not found in mammals. The salvage pathways are indicated by thick 
open arrows. The important enzymes are boxed, these are HGPRT =  hypoxanthine- 
guanine phosphoribosyl transferase; XGPRT -  xanthine-guanine phosphoribosyl 
transferase; APRT =  adenine phosphoribosyl transferase; TK  = thymidine kinase; 
DHFR =  dihydrofolate reductase; TS = thymidine synthase. Inhibitors o f the 
pathways are shown in dark boxes; these are: MTX =  methotrexate; APT — 
aminopterin; AZASER =  azaserine; MPA = mycophenolic acid. THE =  
tetrahydrofolate; D H F =  dihydrofolate. IMP, AMP, XMP, GMP, UMP are 
inosine, adenosine, xanthine, guanosine, uridine monophosphates respectively.
1.4. SYSTEMS FOR THE CULTIVATION OF MAMMALIAN CELLS.
MODES OF GROWTH.
Mammalian cells propagated in culture exhibit different modes of growth, which are 
catergorised as either "anchorage-dependent" or "suspension". Anchorage-dependent 
cells require a solid substratum to attach to in order to proliferate, and is the style 
of growth exhibited by most cell-types derived from solid tissues. Suspension cells, 
as their name implies, grow in free suspension and is the manner of cultivation of 
cells derived from haemopoietic tissue, and certain transformed cell-lines. However, 
the distinction between anchorage-dependent and suspension cell-lines is not always 
clear-cut. Capstick and colleagues (1962) isolated a baby hamster kidney cell variant, 
BHK21, normally an anchorage-dependent line, which grows in suspension. The 
Chinese hamster ovary cell-line, CHO-Kl, has also been found to proliferate both 
attached or in suspension. Conversely, most suspension cells can be adapted to grow 
on a suitably charged matrix, and a number of appropriate substrata have been 
developed to enable this (reviewed by Griffiths, 1990).
CULTURE VESSELS.
The system employed for the cultivation of mammalian cells is primarily determined 
by the cell-type and the purpose for which the culture is required. For the small- 
sczde culture of cells, vessels are used which range in size from multiwell plates 
j (capacity per well: 0.317ml) ; , through a range of tissue culture
dishes and flasks, to 180cm  ^ capacity. For the large-scale cultivation of cells there 
exists a diverse range of bioreactor designs, which have emerged in response to the 
demand for increasingly efficient production systems - a continuing activity. Dependent 
on the cell-type, cells may be cultivated in either; (i) homogeneous suspension, (ii) 
immobilized to a substratum in "quasi-homogeneous" suspension, or (iii) in hollow- 
fibre or membrane bioreactors. A number of detailed reviews on this area are 
available (Hopkinson, 1985; Spier and Griffiths, 1985; Tolbert and Feder, 1983).
Homogeneous suspension cultures are generally operated for the cultivation of mono­
dispersed cell-lines. The stirred-tank reactor is customarily the system adopted, which 
may also be operated as an air-lift. The stirred-tank reactor has been successfully 
used for the cultivation of animal cells at capacities of up to 8000 litres (Philips et 
al., 1985), and air-lifts up to 2000 litre unit capacity (Rhodes and Birch, 1988).
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Suspension cultures may be operated in either batch (Phillips et d ,  1985), fed-
batch (Miller et al, 1989a and 1989b), or continuous modes (Miller et al, 1987).
Immobilized cell systems are primarily used to enable bulk cultivation of anchorage- 
dependent cells on a matrix in quasi-homogeneous suspension. A number of techniques 
have been developed for the immobilization of cells, such as porous microcarriers (Van 
Wezel, 1967), entrapment in microbeads (Lim and Sun, 1980), or on solid particles 
(Whiteside and Spier, 1985). These matrices provide a large surface area of suitable 
charge distribution, on which cells can be retained while permitting the nutrients and
products to freely diffuse. Specific substrata have also been developed for the
immobilization of suspension cells, including hybridomas (Lyderson et al., 1985), which 
can facilitate the establishment of perfusion culture systems (Butler et al., 1983). 
Karkare and co-workers (1985) have reported that they have achieved hybridoma cell 
densities approaching 10* cells/cm^ by cultivating them in fibrous collagen beads.
Hollow-fibre bioreactors have been used to grow both anchorage-dependent and 
suspension cells. The basis of these reactors is analogous to a simple dialysis culture 
(Adamson et al., 1983). They consist of loose bundles of semipermeable capillary 
fibres enclosed within a vessel of varying configurations (Ku et al., 1981). The cells 
are grown within the extracapillary space of the culture chamber, and the culture 
medium is circulated through the capillaries. Membrane-bioreactors are an elaboration 
of the hollow-fibre reactor (Klement et al., 1987).
1.5. THE CHARACTERISATION OF CELL GROWTH.
The standard format of a culture cycle, beginning with a lag phase, proceeding through 
the logarithmic phase, to a stationary phase, and finally to the decline phase and death 
of the cells is well documented in microbial studies (see section 3.2). However, the 
relationship of cell growth to its cellular enviroment, product synthesis, and cellular 
physiology is poorly understood. Techniques are now available to facilitate the 
monitoring and control of the nutrient and physio-chemical enviroment. Parameters 
such as pH, temperature, the partial pressures of dissolved oxygen and carbon dioxide 
can be readily determined and adjusted automatically. Biomass concentration can be
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measured either directly by cell counting or by dry weight, or it can be estimated 
indirectly from turbidimetry determinations or oxygen utilization rates. Many medium 
components and catabolites can be quantified either by specific enzyme probes, or by 
automatic sampling and off-line analysis.
To transform the data obtained from measured parameters into a more useful form, the
variable is often differentiated; for example, to calculate specific growth rates and
specific production rates, in order to help devise efficient and effective culture 
processes. Differentiation of experimental data, however, has been found to magnify 
error. Consequently, unless the data are completely free of "noise", a method of 
"smoothing" has to be employed to minimize this (Reinsch, 1967). Polynomials and
cubic splines are two mathematical expressions used to fit curves to experimental data,
the generated curve may then be differentiated to yield volumetric rates of change.
A polynomial is an expression with two or more terms, the number of terms being 
the order of the polynomial. A polynomial will construct the "curve of best fit" 
through all the data points. Splines as originally used by draughtsmen were strips of 
flexible material used to provide a smooth curve between set points. Since then spline 
functions have been used in mathematics to fit curves to specified points, and were 
later adapted to "smooth" fermentation data for the estimation of specific growth and 
production rates (Oner et al., 1986). A cubic spline is a parametric model which is 
fitted to measured data, and may be defined as "piece-wise" polynomials of degree 3 
(Wold, 1973). A "piece" is the polynomial equation found between two data points 
(illustrated in Figure 1.3).
In a cubic spline the "pieces" join in so called "knots", which are discontinuous ie. 
they are determined only by the behaviour of the region defined by the "pieces", and 
not by the data elsewhere. A spline Junction will, therefore, go through all of the 
"knots". To utilize spline functions for experimental data an adjustable smoothing 
function is used which is based on "Chi-Squared goodness-of-fit" (Thornhill, 
pers.conun.). This enables the smoothness of the function to be traded against the 
accuracy of the fit - ie. how near the "knots" are forced to match the data points. 
Such a procedure is known as a partial cubic spline fit.
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Figure 1.3 An illustration of curv e fitting 
using "cubic splines”
Y
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1.6. NUTRITIONAL REQUIREMENTS OF MAMMALIAN CELLS IN CULTURE.
When a cell is removed from its original tissue or organ and placed in culture it must 
be provided with an external envlroment analogous to its enviroment in vivo, in order 
for it to survive and to proliferate. To satisfy these requirements cell culture media 
have been developed (reviewd by Ham and McKeehan, 1979; Sato et al., 1982; 
Way mouth, 1981). The functions of cell growth media may be defined as; (i) 
maintenance of suitable physio-chemical conditions (e.g. osmolarity and pH), and (ii), 
provision of nutrients for synthesis of cell biomass and products. A nutrient may be 
considered as a substance that enters cells and is utilised as a metabolic substrate or 
co-factor. The known essential nutrients include amino acids, vitamins, dissolved gases, 
inorganic ions, and energy sources.
CELL CULTURE MEDIA.
Cell culture media can generally be regarded as being composed of two constituents;
- basal medium - which is composed of all the cells’ essential 
nutrient requirements.
- serum - which is an undefined "cocktail" of supplements necessary 
for cell growth.
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THE BASAL MEDIUM.
The constituents included in basal media were originally derived from a knowledge of 
the composition of blood plasma. In the 1950’s Eagle identified the basic components 
of "tissue-culture medium" except for the factors which were provided by added serum. 
Based on this work he produced a defined basal medium, refered to as "Eagle’s 
minimum essential medium" (MEM) (Eagle, 1959). This contained all the amino acids, 
carbohydrate energy substates, vitamins, inorganic salts, trace elements (and suitable 
buffering system to maintain the pH around neutrality) required to sustain cells. A 
range of defined media, varying in complexity from Eagles MEM, have since been 
developed to meet specific cell requirements, for example RPMI-1640, Ham’s F12 and 
Dulbecco’s minimal essential medium (DMEM).
SERUM.
In order for cells to proliferate the basal medium requires supplementing with a 
complex "cocktail" of growth stimulating factors. Traditionally, these are provided by 
animal sera (Freshney, 1983; Willmer, 1958). Serum is a mixture of hormones,
growth factors, carrier proteins, attachment and spreading factors and nutrients 
(especially trace elements), and has a number of functions in cell culture (Table 1.2). 
The sera most commonly used are foetal calf serum, calf serum and horse serum.
The inherent properties of serum, however, make its presence in cell culture media not 
always desirable; since (i) it is undefined, (ii) of variable quality, (iii) expensive, (iv) 
a potential source of microbial contamination (especially from mycoplasmas), and (v), 
it can be antagonistic to growth. In addition, the various proteins in serum can 
complicate the identification or fractionation of products from mammalian cells. This 
is especially of concern in the production of antibodies, where in order to mimimise 
contamination from serum-derived immunoglobulins, expensive foetal serum is required. 
The need to grow cells in the absence, or in very low concentrations of serum, may 
also be essential in order to; maintain the optimal activity of some products, to 
facilitate downstream processing, and for the licensing of biological materials. 
Consequently, a number of serum-free media have been developed that still enable the 
growth and proliferation of specific cell-lines.
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TABLE 1.2. SERUM COMPONENTS ESSENTIAL FOR CELL SURVIVAL & GROWTH.
COMPONENT
Proteins:
Albumin
Fibronectin
û/p/wZj-Macroglobin
Fetuin
Transferrin
MAIN FUNCTIONS
Carries lipids, hormones, minerals 
Provides osmotic pressure 
Buffering capacity 
Promotes cell attachment 
Inhibits trysin 
Enhances cell attachment 
Binds Fe^^
Polypeptide & growth factors: 
Insulin
Insulin-like growth factor 
I and n  (IGF)
Somatomedin A 
* Multiplication stimulating 
activity (MSA)
Platelet-derived growth
factor (PDGF)
Epidermal growth factor (EGF) 
Fibroblast growth factor (FGF) 
Endothelial growth factor (ECGF) 
Eye-derived growth factor
Peptides:
Glutathione
Promotes uptake of glucose and amino 
acids by cells , ,
Mitogens
Mitogens
Mitogen
Mitogen for fibroblasts, smooth muscle 
cells, and others.
Mitogen
Mitogen
Mitogen
Mitogen
Redox reactions
Other hormones:
Cortisol (hydrocortisone)
Oestrogens, androgens 
Thyroid hormones (T3, T J
Promotes cell attachment 
Induces cell differentiation 
Mitogen
Oxygen consumption, energy metabolism, 
promotes growth and differentiation of 
various cells
Lipids:
Linoleic acid
Prostaglandins
Cholesterol
Membrane biosynthesis 
Membrane biosynthesis
Metabolites:
Amino acids
alpha-YiQio acids (pyruvate) 
Polyamines
Minerals:
Fe"+, Zn"+, Cu"+, M n '\ SeO '^ 
Co"% VO3 , Mo^ O '^"
Cell proliferation
Enzyme activation and others
* now known to be IGF II 15
SERUM-FREE MEDIA.
In serum-ffee media the serum component is ideally replaced by a minimal supplement 
of chemically defined components, designed to stimulate cell growth. These serum 
substitutes include hormones, lipids, trace elements, growth factors, transport proteins, 
cell attachment factors, and proteins. A substantial number of detailed studies on the 
role of the various constituents found in serum-free media are available in the 
literature, and have been comprehensively reviewed (Barnes and Sato, 1980; Maurer, 
1986). A number of serum-ffee media are now commercially available; either in the 
form of a defined "serum supplement" which replaces serum in the basal medium, for 
example Ultroser-G (LKB, Sweden), an undefined "serum supplement", for example Nu- 
serum (Gibco BRL, UK), or as a complete serum-ffee medium, for example HBlOl 
(NEN research Products, USA). There are also a number of "serum additives" on the 
market which are used to supplement cells growing in basal media containing a 
relatively low percentage of serum, for example GF (Gibco BRL, UK).
Due to the diverse nutritional requirements of different cell types, the majority of 
serum-ffee media formulations are appropriate to only a limited number of cell-lines. 
For example, human diploid fibroblasts are nutritionally fastidious and require 
supplementing with a complexed formulation of serum substitutes, including epidermal 
growth factors, prostaglandin and dexamethasone (Bettger et al., 1981). In comparison, 
mouse LS cells will grow in a relatively simple chemically defined medium lacking 
in peptide growth hormones (Birch and Pirt, 1970).
ENERGY SUBSTRATES.
Traditionally cell-culture media have been suplemented with glucose at relatively high 
concentrations (5 to 20mM), reflecting the composition of blood plasma ffom which 
media were originally derived. A comprehensive review on glucose metabolism has 
been made by Morgan and Faik (1986).
Glucose is metabolised by the cell by both glycolysis and the citric acid cycle, to yield 
lactate and carbon dioxide respectively (see supplementary Figures A and B). 
Originally, it was assumed that these two catabolites of energy metabolism were entirely 
derived from glucose metabolism. The molar ratio of lactate accumulation to glucose 
utilization was consequently taken as an indication of whether cellular energy
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metabolism was aerobic or anaerobic (reviewed by Paul, 1965). However, it was 
found that cells could produce lactate concentrations in excess of the glucose consumed 
(Cristofalo and Kritchevsky, 1966). This enigma prompted more detailed investigations 
concerning the contribution of other potential carbon sources to energy metabolism and 
its regulation, which revealed that glutamine was also an important source of energy 
in most media (reviewed by McKeehan, 1986). Zielke and co-workers (1978) found 
that 30% of the energy requirements of human diploid fibroblasts could be provided 
by glutamine in conventional medium containing serum. In analogous studies the 
cellular energy derived from glutamine oxidation in cells was reported to be 40% in 
CHO cells (Donnelly and Scheffler, 1976), and 35% in proliferating rat thymocytes 
(Brand, 1985). Due to the importance of glutamine metabolism to the ensuing work 
described in this study, the role of glutamine metabolism in mammalian cells is 
discussed in detail in the subsequent section.
A third important "substrate" involved in cell growth is oxygen. Oxygen is specifically 
involved in the oxidative metabolism of Krebs cycle intermediates. The oxygen uptake 
rate has been reported to be related to cell growth rate (Katinger, 1987). Optimum 
oxygen concentrations required for cell growth vary with cell type but have generally 
been reported to be in the range of 40 to 50% air saturation (Radlett et al., 1985; 
Reuveny et al., 1986). However, a study by Boraston and co-workers (1984) found 
that the growth rate of hybridomas was only marginally affected by oxygen 
concentrations ranging ffom 8 to 100% air saturation. Oxygen concentrations higher 
than those of atmospheric air have been reported to be toxic to mammalian cells 
(Cooper et al., 1958; Mizrahi et al., 1972).
1.7. THE ROLE OF GLUTAMINE IN MAMMALIAN CELL CULTURE.
The importance of glutamine for the growth of animal cells in culture has long been 
recognised (Eagle et al., 1955; Kitos et al., 1962), and its role in cell metabolism has 
been reviewed (Krebs, 1980; McKeehan, 1986). Glutamine is required in cell growth 
media in far greater quantity than any other amino acid (added at 2 to 4mM), which 
reflects its vital position in cell metabolism. This requirement for glutamine is due 
in part to the central role that glutamine plays in many biosynthetic pathways as the
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amino donor in the synthesis of purines and pyrimidines, amino sugars, and asparagine 
in mammalian cells (refer to Figures A and B). The availability of glutamine has been 
found to regulate the rate of synthesis of purines and pyrimidines, and thus cell growth 
(Ley and Toby, 1970; Zetterberg and Engstrom, 1981). Glutamine is also an 
important energy source for mammalian cells (section 1.6). The rapid appearance of 
large amounts of glutamine carbon as carbon dioxide in cell cultures portrays the high 
rate of glutamine oxidation. The possible fates of glutamine in hybridomas is shown 
in Figure 1.4.
GLUTAMINE CATABOLISM.
The pathway of glutamine catabolism, or "glutaminolysis", in mammalian cells has been 
reported to vary with respect to the cell-type. Ardawi and Newsholme (1982) 
demonstrated that in lymphocytes the activity of glutamate dehydrogenase (GDH) was 
low compared to that of the transaminases, with aspartate aminotransaminase being more 
prominent than alanine aminotransferase, resulting in aspartate accumulating as the major 
end product of glutamine metabolism. Conversely, Miller and collègues (1987) found 
in hybridoma cells that the primary amino acid produced as a result of glutamine 
catabolism was alanine, and not aspartate, which indicated that glutamine was being 
processed via an alternative route. Glutaminolysis has also been found to be influenced 
by the culture enviroment, especially the relative availability of glucose in the media 
(Glacken, 1988).
Recently, the value of exploiting cellular energy pathways to improve bioreactor 
performance has been recognised. For example, the use of glutamine-free media to 
minimize the production of ammonia has been established for human diploid cell-lines, 
HeLa, and MDCK cells, by replacing glutamine with glutamic acid (Griffiths, 1973; 
Hassell and Butler, 1989). This approach is discussed in more detail during chapter
4. It has also been speculated that glutamine can be more efficiently utilised by 
directing the pathway through which it is catabolised, through manipulating the levels 
of key enzymes (Glacken, 1988), this theory is explored further in chapter 5. To 
enable this an understanding of glutamine metabolism and its regulation in mammalian 
cells required.
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FIGURE 1.4. THE FATE OF GLUTAMINE IN HYBRIDOMAS.
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REGULATION.
The first level of regulation of glutamine metabolism occurs at the uptake stage 
(Kilberg et al.^ 1980). Cellular uptake of glutamine is mediated by specific transport 
mechanisms, and depends upon the concentration of the extracellular substrate, the 
affinity of the transport enzymes, and their abundance at the cell membrane. These 
may all vary according to the cell-type, physiological status of the cells (Brand, 1985; 
Weber et û/., 1984), and also the presence of transforming viruses (Weber et a/., 
1984).
Subsequent levels of regulation are thought to occur at the point of entry into, and 
passage through, metabolic pathways (refer to Figure 1.4). Glutamine has to undergo 
two sucessive deaminations before it can enter into Krebs cycle as o^Aa-ketoglutarate 
(Figure B). This can occur by either, or both, of the following separate pathways. 
In the first of these glutamine, is deaminated to glutamic acid by glutaminases, and 
then undergoes a further deamination to aZpAa-ketoglutarate, a step mediated either by 
glutamate dehydrogenase (GDH), or, by glutamate-oxaloacetate transaminase. In the 
second pathway glutamine is deaminated first to o/p/ia-ketoglutaramate, a reaction 
catalysed by keto acid transaminase, and then to û//?/w-ketoglutarate by vv-amidase 
activity. These deaminations are regulated by the concentrations of glutamine and 
glutamic acid, the various products of the transamination and deamination reactions, the 
concentrations of nucleoside phosphates, and by hormones such as testosterone and 
cortisone. Reaction rates within Krebs cycle are regulated by concentrations of the 
intermediates citrate and oxaloacetate, concentrations of ATP, ADP AMP, cyclic AMP, 
NADH, and by adreno-corticotrophic hormone (Lehninger, 1982).
GLUTAMINE SYNTHESIS.
The enzyme responsible for mediating the synthesis of glutamine in the cell is 
glutamine synthetase (GS; L-glutamate:ammonia ligase (ADP), EC6.3.1.2), which has 
been found in all cells so far examined (Meister, 1985). The enzyme catalyses the 
ATP-dependent condensation of glutamic acid (Glu) and ammonia (NH^^) to form 
glutamine (Gin)
GS
GLU + NhJ  + ATP GLN + ADP + Pi
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The function of this enzyme remains an enigma in cell culture, since its presence 
confers the ability to cells to synthesise glutamine, and, therefore, contradicts the 
essential requirement expressed by cells for the presence of high levels of glutamine 
in the culture media (section 1.6). It can be inferred ffom this that certain mammalian 
cells in culture have insufficient levels of GS to enable the biosynthesis of adequate 
glutamine to support cell growth, or a poorly expressed GS-gene. Levels of GS have 
been found to vary between cell-types, ocurring at low levels (0.1 to 0.01% soluble 
protein) in the majority of cells examined, with higher levels occurring in adipocytes, 
hepatocytes and glial cells (Hayward et al. y 1986). GS has also been found to be 
heterogeneously distributed in liver cells, the enzyme being restricted to small rings of 
hepatocytes encircling the terminal hepatic venules (Gebhardt and Mecke, 1984).
In addition to its central role in cellular metabolism (section 1.7), the enzyme also 
serves a critical ftmction in the nervous tissue of higher organisms, where it is 
involved in the metabolism of the neurotransmitter glutamic acid. Due to its key role 
in cellular metabolism (reviewed by Meister, 1974), a considerable amount of research 
has been directed towards understanding how expression of the GS gene is regulated. 
In E.coli the regulation of GS has been extensively studied and a complex control 
system has emerged, which includes repression/derepression of enzyme synthesis (Mecke 
and Holzer, 1966), cumulative feedback inhibition by metabolic effectors, and metabolite 
controlled chemical interconversion of the enzyme (Mecke and Holzer, 1966; Stadtman 
and Ginsburg, 1974). This highly sophisticated multi-level regulation permits substrate- 
dependent alterations of both energy and nitrogn metabolism (Schutt and Holzer, 1972).
In mammalian cells GS has also been demonstrated to be regulated at multiple levels, 
although the mechanisms differ to those which occur in E.coli and other procaryotes 
(Gebhardt and Mecke, 1984; Meister, 1984; Sandrasagra et al. y 1988), and information 
is far more fragmentary. Glucocorticoid steroids, notably dexamethasone, have been 
demonstrated to increase the levels of GS in various cells and tissues (Barnes et al.y 
1971; Kulka and Cohen, 1973). More recently, regulation by glucocorticoids have been 
shown to result ffom a change in the translational effeciency of GS mRNA (Bhandari 
et al.y 1986; Max et al.y 1988). External glutamine can also regulate GS, with the 
removal of glutamine ffom the cell culture medium been found to cause a discernable 
increase in GS activity (Arad et al.y 1976; Milman et al. y 1975; Smith et al.y 1984). 
It has been suggested that glutamine depletion causes the enzyme to assume a more
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stable configuration, which results in increased enzyme activity (Arad et al. y 1976; 
Tiemeier and Milman, 1972). ADP-ribosylation has also been demonstrated to regulate 
mammalian GS - a consequence of the post-translational covalent modification of the 
enzyme. NADiarginine ADP-ribosy 1 ;transferase specifically modifies an arginine residue 
involved in the catalytic site of GS (Moss at el., 1984). More recently, Kimura and 
co-workers (1988) have demonstrated that GS activity is regulated by the 
phosphorylation of the tyrosol residue of the enzyme subunits, suggesting covalent 
modification of GS. Insulin and cAMP have also been found to decrease the GS 
biosynthetic rate in mouse 3T3-L1 adipocytes (Bhandari et al. y 1988), but the 
mechanism is not yet understood.
To facilitate studies concerning the mechanism of GS regulation, Bhandari and 
colleagues (1988) have isolated the GS-gene from mouse 3T3-L1 cells, and analysed 
the nucleotide sequence of the first exon and over 1,000 base pairs of the 5’flanking 
sequences (Figure 1.5). The 5’flanking region of the gene was found to encompass 
several potential regulatory elements, including TATA and CAAT sequences, and a 
40bp poly(dT-dG).poly(dC-dA) putative enhancer element. Potential hormone and fat 
specific regulatory elements, including glucocorticoid and cAMP response elements were 
also identified. It was speculated that these regulatory elements may account for 
observed differentiation-associated changes, and hormone mediated changes, in GS-gene 
transcription and mRNA abundance.
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FIGURE 1.5.
Nucleotide sequence upstream from the first glutamine synthetase codon. Putative 
regulatory elements are designated above the nucleotide sequences as follows: ORE, 
gre% ->; CRE, cre-%->; FSE-1 (fat-specific element 1), fse-1 = = % = = = > ;  FSE- 
2 (fat-specific element 2) =  = % = = = > . %, Percentage identity with the sequence
indicated in text. The arrowhead designates the 5* > 3* orientation. TR-1, TR-2 
and TR-3 indicate the location of three pairs of lObp tandem repeats. The vertical 
double asterisks at nt 1030 indicate the probable transcription start site. Single 
underlined sequences are the potential TATA and CAAT sequences. Double underlined 
sequences are those for which synthetic oligonucleotide primers were prq>ared (direct 
for nt 225, 505, and 890; inverted for nt 1069 and 1252). (Figure adapted ffom 
Bhandari et al., 1988)
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2. GENETIC ENGINEERING OF MAMMALIAN CELLS.
2.1. AN OVERVIEW.
The ability to isolate individual genes or cDNA’s ffom complex genomes, and their 
subsequent manipulation into "expression vectors" which can be effectively transferred 
back into living cells, has led to exciting developments in the field of mammalian cell- 
culture. The cell can be engineered to produce one (or more) recombinant proteins, 
to provide transactivating proteins for vector amplifications and gene expression, to 
analyse cellular biochemistry, or to modify its physiology.
Interest in the genetic manipulation of mammalian cells has principally stemmed ffom 
the requirement for the effective post-translational modification of eukaryotic proteins 
in order for their biological properties to be maintained. Post-translational modification 
may not be performed accurately, if at all, by either procaryotic or non-mammalian 
cells, but is performed by mammalian cells (Brially, 1987; Johnson, 1983), as outlined 
in Table 1.3. The establishment of the technology of gene expression has opened up 
potential new avenues, including "designing" improved host cells which have enhanced 
growth characteristics in bioreactor systems, the use of mammalian cells as model 
systems for developing gene therapy techniques, and their use as production "vehicles" 
for further cellular products.
The aim of this review is to outline the principles involved in the expression of 
recombinant proteins in mammalian cell-lines necessary to provide a background for the 
ensuing experimental work. A substantial number of more detailed texts on this subject 
area are available (Bebbington and Hentschel, 1985a; Colbere-Garapin and Garapin, 
1985; Kaufmann, 1987; Kingsman and Kingsman, 1988; Sanders, 1990; Weymouth and 
Barsoum, 1986).
2.2. VECTORS FOR GENE EXPRESSION.
In order to express foreign genes in mammalian cells grown in vitro a vector which 
is capable of replicating in both procaryotic and eucaryotic hosts is required. Such
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vectors, referred to as "expression vectors" or "shuttle vectors", normally contain 
procaryotic plasmid sequences, combined with controlling elements derived from either 
eucaryotic, procaryotic, or viral genomes (reviewed by Miller and Calos, 1987; Pouwels 
et al., 1985; Rigby, 1984). The components of these hybrid DNA vectors are shown 
in below in Figure 1.6.
FIGURE 1.6. A BASIC EXPRESSION VECTOR.
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A pre-requisite of all plasmid vectors is that they contain procaryotic sequences 
encoding an origin of replication (ORI) and a drug resistance marker, both of which 
are normally derived fron a plasmid such as pBR322. This enables large quantities 
of the vector to be rapidly propagated in E.coli, where it can be more easily 
manipulated and characterised than in the mammalian cell.
The general outline of a protein-coding gene is shown in Figure 1.7. For the 
expression of inserted gene sequences within the vector in animal cells, eucaryotic 
elements, which control the initiation of transcription, are required. These include an 
AUG translational start site (if not already present on the cDNA encoding the gene), 
a promoter, and if necessary enhancer sequences.
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FIGURE 1.7. GENERAL PLAN OF A PROTEIN CODING GENE.
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Translation is initiated by the small (40S) ribosomal subunit moving along the 5* leader 
sequence flanking the gene until the nucleotide sequence AUG is encountered. The 
80S ribosome is then assembled and translation of the gene begins (Kozak, 1983). It 
has been found that there can be more than one AUG codon in the 5’ untranslated 
sequence, and that initiation does not always occur at the first of these. The site of 
initiation has been reported to be influenced by the nucleotide sequences around the 
AUG codon. In higher eukaryotes the optimum initiation sequence appears to be 
'ACCATGG' (Kozak, 1986).
mRNA
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"Promoter" is a loose term used to refer to a combination of signals that control 
transcription, which for RNA polymerase II transcribed genes are located in the 5* 
untranslated region flanking the gene. These sequences include signals that specify the 
mRNA start site, signals that fix the rate of transcription initiation, and signals that 
regulate transcription. Some of these signals are gene specific, such as hormone 
receptor binding sites, whereas others are found more generally, for example the TATA 
box and the CCAAT box, both of which are involved in determining efficient 
transcription initiation. The transcribed region may also contain sequences, referred to 
as "promoter elements", which affect transcription (Theisen et û/., 1986). Regulation 
of gene transcription may also be influenced by sequences termed "enhancers" (Serfling 
et al.y 1985), which are usually found located in the 5’ flanking region, several 
kilobases ffom the mRNA start site, although they have also been found in the 
transcribed region and the 3’ flanking region.
Also required for efficient gene expression in mammalian cells are sequences involved
in the processing of the transcripts. Many genes are far longer than is needed to code 
for the protein product due to the presence of "non coding" regions called introns. 
The introns are initially present in the pre-mRNA transcript, and during processing of 
the transcripts the introns are removed by an enzymatic process, and the exons are 
ligated together to produce the mature mRNA. The process is called "splicing", and 
there are signals present at the exon/intron boundaries that direct correct splicing. The 
signal at the 5’ end of the exon is referred to as the "splice acceptor site" (SA), and 
at the 3’ end of the exon the "splice donor site" (SD). These signals are largely 
conserved between different genes in a range of eukaryotes (Padgett et al., 1986; Reed 
and Maniatis, 1985).
The 3’ flanking region contains signals for the termination of transcription and for 
post-transcriptional processing of the 3* end of the mRNA. In most transcripts, except 
some of the histone mRNAs, a tract of polyadenosine residues is added to this end, 
which is referred to as the "poly(A) tail" (Jackson and Standart, 1990; Wickens, 1990). 
The poly(A) tail is usually about 200 residues long. In addition to splicing and 
polyadenylation there is usually a third post-transcriptional modification of the mRNA 
at the 5’ end. A guanosine nucleotide methylated at position 7 in the base is added, 
via a guanyl transferase, to the first nucleotide of the mRNA to be copied from the
DNA template, creating an unusual 5’-p-p-p-3’ linkage. This modification is called the
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"cap" and the transcription initiation site in the 5’ flanking DNA is often called the 
"cap site". The cap influences the efficiency of translation and mRNA stability 
(Shatkin, 1984).
The 5* and 3’ flanking sequences that are required for expression are often referred 
to as an "expression cassette". A variety of constitutive or inducible promoters are 
available to regulate the control of the cloned genes, and strong termination signals are 
required to prevent read through and interference with the expression of other genes.
Lastly, the expression vector contains the particular gene of interest, which is typically 
a cloned cDNA sequence. This is usually inserted in the expression vector at a unique 
restriction endonuclease site located downstream of the 5* flanking control region, and 
upstream of the 3’ flanking region (i.e. within the expression cassette). A eucaryotic 
selection system involving a drug resistance marker may also be required (section 2.2), 
and if the vector is required to function as an episomal, self replicating unit, it must 
contain a eucaryotic origin of replication. The regulatory sequences required for the 
expression of genes, such as promoters, polyadenylation sites and splice junctions, have 
been found to share common features between species amoung mammalian cells and 
viruses, permitting their interchange within expression vectors. For example, the 
polyadenylation site of the rat insulin gene functions in monkey cells (Gruss and 
Khoury, 1981), and the beta-^ohm gene from mouse is correctly spliced in monkey 
cells (Hamer et aL, 1979). This interchangability has enabled prototype shuttle vectors 
to be constructed that can be used to express genes from different species in various 
host cells, and allowed vectors to be "tailored" to meet specific requirements.
The most extensively used prototype vectors are the pSV series of plasmids which 
contain regulatory sequences obtained from the DNA tumor virus SV40, outlined in 
Figure 1.8 (Mulligan and Berg, 1980). In the plasmid pSV2, the Pvu 2 (Pv) - Hind 
3 (H) fragment, which contains all the promoter signals for early transcription and the 
mRNA initiation site, but no translation initiation codon, is used to initiate transcription 
of any coding sequence placed downstream. This is followed by a fragment which 
contains a 66bp intron from the transcript for the viral small t protein to provide a 
splice donor and acceptor site for the heterologous transcript. There is then a 
fragment containing the transcription termination region and polyadenylation site (pA). 
All of these fragments are linked to a pBR322 fragment which contains a procaryotic
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All of these fragments are linked to a pBR322 fragment which contains a procaryotic 
replication origin (ORI) and ampicillin selectable marker (AMP*^ ). The selectable 
markers Eco-gpt, neo and mouse dhfr have been inserted as Hind 3 (H) - Bgl 2 (Bg 
I) fragments into pSV2 to produce the expression vectors pSV2.gpt (Mulligan and Berg,
1980), pSV2.neo (Southern and Berg, 1982) and pSV2.dhfr (Subramani et al., 1981) 
respectively.
FIGURE 1.8, The construction of pSV2 plasmids. The promoter (P), intron (I), and 
termination region (pA site) from the early region are combined to produce the SV2 
expression cassette.
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2.3. SELECTABLE MARKER SYSTEMS FOR TRANSFECTED CELLS.
When foreign DNA is introduced into mammalian cells a selection system is required 
to identify those cells which have taken up the heterologous DNA. This is especially 
pertinent since gene transfer is far less than 100% efficient, requiring the selection of 
the recipient cells from a background of untransformed cells, of which not all will 
stably express the gene. A number of strategies have been devised to allow selection 
of transformed cells. These either involve identifying morphological transformants, or 
using a toxic metabolite, against which the vector inparts resistance, enabling the 
transformed cells expressing the gene providing resistance to survive in conditions 
which kill any untransformed cells. Mammalian cell selection strategies have been 
reviewed by Kingsman and Kingsman, 1988, Rigby, 1984 and Sanders, 1990.
Two selectable marker genes employed extensively in the expression of foreign proteins 
in mammalian cells, (and used during this project), are the "gpt" and "neo" genes. 
These genes are used to biochemically transform cells to express resistance to the 
potent drugs my cophenol ic acid and geneticin (G418) respectively, allowing transfected 
cells to be selected ffom untransformed cells. The nucleotide sequence encoding the 
respective gene is inserted within an expression vector, under the transcriptional control 
of the appropriate regulatory elements. The most widely used "gpt" and "neo" vectors 
are pSV2.gpt (Mulligan and Berg, 1980) and pSV2.neo (Southern and Berg, 1982), 
which are derived ffom the "pSV2" family of vectors (Figure 1.8).
Selection for eukaryotic cells transformed with the vector containing the E.coli "neo" 
gene is based on antibiotic resistance to geneticin. The aminoglycoside antibiotic 
geneticin (G418), is structurally related to the antibacterial antibiotics kanamycin and 
neomycin, and inhibits the function of 80S ribosomes, therefore, blocking protein 
synthesis in eukaryotic cells. All aminoglycosides can be inactivated by aminoglycoside 
3’ phosphotransferases, which are encoded by the bacterial transposons, Tn601 and Tn5 
(Davies and Smith, 1978). These genes, referred to as neo genes, thus confer 
resistance to aminoglycoside antibiotics, and mammalian cells treated with 
aminoglycosides (eg G418) will stop replicating and eventually die. However, if the 
cells have been transformed with the "neo" gene under the control of appropriate 
expression signals the recipient cells become resistant to geneticin, and can thus be 
selected against a background of dying, untransformed cells (Southern and Berg, 1982).
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The use of the E.coli xanthine-guanine phosphoribosyltransferase gene (XGPRT), 
denoted "Eco-gpt" as a selection system is based on resistance to my cophenol ic acid 
(refer to Figure 1.2). The bacterial XGPRT enzyme can convert xanthine into xanthine 
monophosphate, a precursor of guanosine monophosphate, as well as converting 
hypoxanthine to inosine monophosphate, and guanine to guanosine monophosphate. The 
mammalian analogue, hypoxanthine-guanine phosphoribosyl-transferase (HGPRT), 
however, will only utilize hypoxanthine and guanine to synthesise guanosine 
monophosphate. Guanosine monophosphate is an essential mononucleotide in purine 
metabolism. The addition of aminopterin and mycophenolic acid to the media will 
consequently block the synthesis of inosine monophophate and xanthine monophosphate 
respectively, leading to cell death. The Eco-gpt gene (gpt) has been cloned, and when 
transformed into mammalian cells has been found to confer resistance to mycophenolic 
acid when cells are grown in the presence of xanthine, since the recipient cell can then 
use XGRPT to convert xanthine into xanthine monophosphate, the precursor of 
guanosine monophosphate (Mulligan and Berg, 1980).
2.4. GENE TRANSFER METHODS INTO ANIMAL CELLS.
Mammalian cells are surrounded by a plasma membrane which is impermeable to large 
molecules such as DNA. Consequently, to enable DNA to be inserted through this 
barrier into the cell, a number of techniques have been developed. These have been 
reviewed by Rigby (1984), and a number are outlined in Figure 1.9. The method 
employed depends upon a number of factors including, whether permenent or transient 
expression of the DNA in the cell is required, the cell-type, and the facilities and 
technology available.
DNA mediated transfection (or transformation) techniques use various ways of 
transiently opening the plasma membrane to enable the DNA to move into the 
cytoplasm. The initial methods developed used various chemical treatments to 
reversibly permeate the plasma membrane, such as high molecular weight polymers, 
including DEAE-dextran or polyethylene glycol (McCutchan and Pagano, 1968). DNA, 
when mixed with these is taken up into the cell, and high levels of transient gene
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FIGURE 1 . 9 .  INTRODUCING DNA INTO CELLS.
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expression can be attained (Whittle et aî.y 1987). DNA can also be precipitated with 
calcium phosphate to form aggregates which "permeablise" the cell membrane, thus 
enabling the DNA to enter into the cytoplasm. Calcium phosphate precipitation has 
been used extensively to transform a number of cell-types (Graham and van der Eb, 
1973). These procedures have been found to be enhanced if the cells are first exposed 
to a physiological shock with either glycerol (Parker and Stark, 1979) or DMSO (Stow 
and Wilkie, 1976). Treatment of cells with sodium butyrate, at, or shortly after, 
transfection, has also been r^orted to increase the uptake of DNA. It is postulated 
that sodium butyrate facilitates the assembly of the heterologous nucleotide sequences 
into an active form of chromatin structure (Reeves et al., 1985). A number of cell 
lines though, including most lymphoid cells, will not survive the chemical procedures 
described above. This led to the development of electroporation as an alternative 
technique of permeating the plasma membrane (Potter et al., 1984). Electroporation 
uses brief, high-voltage electric pulses to induce the uptake of DNA from the 
surrounding medium. This technique has been successfully used to transfect suspension 
cell cultures, and is discussed in more detail during chapter 5 and in appendix 6. A 
major problem, however, with all DNA-mediated transfection techniques is that they are 
inefficient, since many of the cells are permently damaged, and, of the cells that do 
survive, relatively few contain any transferred DNA, and even fewer express the 
transfected gene(s) of interest.
An alternative approach is protoplast fusion, whereby the procaryotic vector containing 
the gene of interest is inserted into the mammalian cell’s cytoplasm, together with the 
entire contents of the bacterium (Sandri-Goldin et al.y 1981; Schaffher, 1980). This 
is achieved by using lysozyme to degrade the bacterial cell wall, and then fusing the 
released protoplast with the recipient mammalian cells, using an agent that enhances 
membrane fusion, for example PEG. The method is more efficient than DNA mediated 
transfections but the introduction of extraneous bacterial DNA is often undesirable, 
and hence the technique is rarely used. A more sophisticated version of protoplast 
fusion involves the use of liposomes to encapsulate the DNA. Liposomes are made 
from positively charged lipid, for example DOTMA (N[l-(2,3-dioley-loxypropyl]-N,N,N 
- trimethylammonium chloride) which interact spontaneously with DNA or RNA to form 
liposome-polynucleotide complexes (Kawai and Nishizawa, 1984). These can then be 
used to diffuse with the cell membrane to deliver purified DNA, mRNA and dsRNA 
into the cytoplasm of mammalian cells (Feigner et al.y 1987 and 1989). The technique
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provides a number of advantages and may also enable the targetting of encapsulated 
DNA to specific cells, but further development is required (Fraley et al.y 1983).
The efficiencies of the transformation techniques described above are limited by the 
degradation of foreign DNA in the cytoplasm before it reaches the nucleus. To 
prevent this a method of injecting DNA directly into the nucleus of the cell 
("microinjection") has been developed (Capecchi, 1980). Microin)ection ensures that 
the foreign DNA reaches the nucleus, but it is a time consuming process. Lasers have 
also been used to make transient holes in cells which allow DNA to pass in, however, 
the efficiency of transformation attained has been found to be poor (Kurata et al. y 
1986). Recently, studies on the migration of nuclear proteins into the nucleus have 
led to the discovery that nuclear proteins can facilitate the transport of foriegn DNA 
into the nucleus, and consequently enhance its transcription and translation (Kaneda et 
al. y 1989). To carry out these investigations Kaneda and co-workers devised a system 
whereby they could simultaneously transfer plasmid DNA and nuclear proteins into 
cultured cells by means of vesicle complexes. They speculate that the DNA-nuclear 
protein complex is more resistant to nucleases, or has conformational properties that 
allow it to pass through nuclear pores more easily than DNA alone.
The ability of certain viruses to infect and replicate in mammalian cells can be 
exploited to produce gene transfer and gene expression vectors. Potentially any virus 
can be genetically manipulated to contain foreign DNA sequences provided there is 
some background information about the infectious cycle and the genome organisation. 
The most widely used viral systems are based on papovaviruses (SV40, polyoma, 
papillomavirus) and retroviruses. SV40 and polyoma viruses have been used to derive 
two types of vectors. The first type is a recombinant virus vector y where foriegn 
DNA is inserted directly into a defective viral genome and this is propagated as a 
virus in mammalian cells (Gething and Sambrook, 1981; Gruss and Khoury, 1981). 
The second type is a viral mini-replicon where only the parts of the viral genome 
that are required for replication in mammalian cells are used (Deans et al.y 1984).
Retroviral vectors have been primarily been developed to exploit the broad host range 
of these viruses to introduce DNA into any cell via viral particles, and to increase the 
frequency of obtaining stable transformants by their ability to integrate into the genome. 
Retroviral vectors have subsequently been used for a range of different experiments
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from cloning genes to acting as markers for stem cell differentiation. Extensive 
reviews of retroviruses and retrovirus vectors have been made (Brown and Scott, 1987; 
Temin, 1986; Weiss et al., 1985). Other mammalian virus vectors have been 
developed using; Epstein-Barr virus (Kioussis et al., 1987), vaccinia viruses (Mackett 
et al., 1985), adenoviruses (Davis et al, 1985) and papillomaviruses (Chen et al., 1982; 
Sarver et al., 1982) .
2.5. THE EXPRESSION OF FOREIGN GENES.
Over the last decade two types of mammalian cell expression systems have emerged, 
namely "transient" expression systems and "stable" expression systems. In the former 
the DNA introduced into the cells is expressed almost immediately and generally 
continues for up to 90 hours. The foreign DNA is nuclear, but does not normally 
integrate into the host cell chromatin. Transient expression systems include COS cells 
(Glacken, 1981) and vaccinia virus based vector systems (Mackett et al., 1985), and 
are primarily used for the rapid production of large amounts of heterologous proteins 
for analytical characterisation, and to test vector construct for effective gene expression.
As the name implies, stable expression systems involve the foreign DNA being 
permanently acquired by the cell and being maintained and passed on through subsequent 
cell generations. This situation can arise if the vector stably persists in the nucleus 
of the host cell in an extrachromosomal state, which may either be due to an 
excision/integration equilibrium, or to the autonomous conservation of the plasmid as 
a self-replicating unit (i.e. an "episome") (Anderson et al., 1980; Huttner et al., 1979). 
Some viral vectors, such as bovine papillomavirus and Epstein-Barr virus, are known 
to exist as stable episomes (reviewed by Mecsas and Sugden, 1987; Stephens and 
Hentschel, 1987). Stable gene expression may also occur if the heterologous DNA 
integrates into the chromatin of the host cell, which, when it replicates then maintains 
the new genotype. This form of gene expression is generally employed to create cell- 
lines for long term expression of heterologous gene products. The fate of the foreign 
DNA in the nucleus, its integration into the host cell chromatin, and the subsequent 
levels of gene expression and genetic stability is still poorly understood, and has aptly 
been described as a "black-box".
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Studies have shown that immediately after transport of foreign DNA into the nucleus 
a high percentage of cells transiently express the DNA for up to 24 to 72 hours 
(Cappechi, 1980; Chu and Sharp, 1981; Yamaizumi et al., 1983, ). At this stage the 
DNA is nuclear but has not integrated into the chromatin. After continued growth in 
selective medium the number of cells that continue to express the genes is much lower 
(typically 10  ^ to 10^), with notable exceptions such as microinjection. These are 
"stable transformants". At this stage the exogenous DNA exists as multiple copies 
organised in head-to-tail arrays ("concatamers"), generated by homologous recombination 
at any site throughout the vector. Concatamers act as high molecular weight DNA, 
although they are not integrated into the host cell chromosome. A cell may contain 
several concatamers, and providing selective pressure is maintained, the cell will express 
the new transferred phenotype for many generations. However, if the selective pressure 
is released the cells become unstable and lose the transferred genotype. Pellicer and 
co-workers (1980) reported that this can occur at a rate of 0.1-30% per generation. 
This was subsequently found to involve loss of the entire concatamer, rather than the 
DNA sequence only (Scangos et al., 1981).
Stable cell-lines can be generated if, during the continued growth of cells in selective 
media, a concatamer integrates into the host cells DNA, and this does not result in 
supression of gene expression. The transferred DNA has been demonstrated by Wurum 
and colleagues (1990), using fluorescent in-situ hybridization techniques (FISH) to 
integrate at a single, random, site in a chromosome as head-to-tail tandem repeats. 
This has been postulated to involve the incorporation of the endogenous gene during 
breakage of the chromosome and subsequent repair mechanisms. Prior to integration 
into the chromosome heterologous DNA undergoes extensive recombination and 
mutation, which includes deletion of plasmid DNA and point mutations (Folger et al., 
1985; Kucherlapati et al., 1984; Razzaque et al., 1984). Consequently, the entire gene 
coding or regulatory regions may not be retained. The DNA, therefore, that is stably 
integrated into the mammalian cell has a high probability of being different ffom that 
originally introduced. In addition, changes such as méthylation, deletion and 
amplification may also occur in the transfected gene during propagation of a cell-line, 
which can lead to gene inactivation (Gebara et al., 1987).
A major disadvantage of using vectors which randomly integrate into the host cell 
genome is that the introduced gene may become inserted into an inert region of a
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chromosome, or into a region of low activity, and thus expression of that gene will 
be suppressed. This necessitates the screening of a large number of transformed clones 
in order to select a cell-line in which the gene of interest resides in a particularly 
favourable location for expression. One way to overcome these "position effects" is 
to direct introduced genes to desired sites, by creating conditions which favour 
homologous recombination between an incoming DNA sequence and a transcriptionally 
active chromosomal site (Capecchi, 1989; Smithies et a/., 1985). An exciting
development which has the potential to resolve the problems posed by the dependence 
on the position of integration has come from Grosveld’s laboratory, where they have 
identified human Wa-globin gene sequences which appear to be dominant for gene 
expression in erythroid cells - irrespective of the site of integration (Grosveld et al. y 
1982 and 1987; Talbot et aZ., 1989). When the nature of these nucleotide sequences 
have been determined it has been postulated that they may enable the expression of 
genes in any cell-line.
3. AIMS OF THIS INVESTIGATION.
The use of cultured animal cells for the production of proteins, and as hosts for the 
expression of recombinant DNA products, has become an established technology. 
Exploitation of this technology requires that the cells are grown on a large-scale, 
economically and reproducibly. To achieve this the identification of parameters which 
influence cell growth and protein synthesis, in both "generic" and "engineered" cell- 
lines, is a prerequisite for the optimisation of processes. An understanding of these 
parameters may then enable the use of genetic manipulation, to analyse and modify 
cellular metabolic pathways, which affect protein synthesis and/or secretion. Such 
alterations would potentially facilitate the improvement of the host cell, the media, and 
the design of production processes.
The overall objective of this study was to investigate the effects of genetically 
modifying glutamine metabolism on the physiology of a hybridoma cell-line. Glutamine 
is known to be a key substrate for the growth of cultured animal cells, required both
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as an energy source and for a plethora of biosynthetic reactions. The cell-line 
employed as a "model" in this study was the PQXBl/2 hybridoma, a murine hybridoma 
which secretes a monoclonal antibody against paraquat.
To achieve this objective a number of specific aims were identified;
1. To establish the physiological characteristics defining cell growth, metabolism, and 
antibody synthesis during stirred batch culture of the PQXBl/2 hybridoma.
2. To ascertain the requirement for glutamine by the hybridoma for growth and
product synthesis, and to assess the ability of the cell to adapt and grow in the 
absence of glutamine.
3. To investigate the levels of active glutamine synthetase (GS) enzyme occuring 
during growth of the cell, and to determine the resulting effect of cell adaptation to 
growth in glutamine-limited media, on the levels of the enzyme.
4. To devise a strategy for transforming the PQXBl/2 hybridoma with vector(s) 
containing GS cDNA, under the regulatory control of a viral promoter, and to select 
glutamine-independent variant cell-lines containing the exogenous GS gene.
5. To assess the effect on glutamine metabolism of transforming the hybridoma, and
to compare the resulting cellular physiology, with observations made in the
untransformed PQXBl/2 hybridoma.
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CHAPTER 2.
1. MATERIALS.
1.1. MAMMALIAN CELI^LINES.
POXBl/2 HYBRIDOMA.
A murine hybridoma, derived by polyethylene glycol (PEG) fusion of X63.Ag8.653 
mouse myeloma cells with spleen cells from a mouse which had been hyperimmunised 
against paraquat herbicide. The antibody synthesised and secreted by this cell line is 
an IgG and has agglutinating activity against paraquat. The cell line was obtained 
from ICI (Alderley Edge, UK).
POXB1/2-EX2.
PQXBl/2 hybridoma cells adapted to grow in media supplemented with O.SmM
glutamine.
POXB1/2-EX3.
PQXBl/2 hybridoma cells adapted to grow in media supplemented with O.SmM
glutamine and 4mM glutamic acid.
SPG2.
The SPG2 cell-line was isolated as a clone of SP2/0 cells which grew in glutamine- 
free media (Celltech). SP2/0 cells are a hybrid between a BALB/c spleen cell which 
produces heavy and light IgG chains with anti-sheep red blood cell activity, and the
myeloma cell-line X63.Ag8 (Shulman et al., 1978).
CHO KGSB.
Chinese hamster ovary (CHO) cells with amplified levels of the glutamine synthetase 
gene. Derived from CHO K1 cells following adaptation to glutamine-ffee media 
(Surrey University, UK).
COS-1.
Monkey CV-1 cells transformed with SV40 DNA containing a 6bp deletion in the 
origin of replication (OKI) which prevents replication of the viral DNA (Gluzman,
1981). Obtained from Celltech Ltd. (Slough, UK).
1.2. BACTERIAL CELL STRAINS.
ESCHERICHIA COLI strain HBlOl: F , proA2, recA, hsdR', hsdM' (Boyer and 
Roulland-Dusoix, 1969). Obtained from MGL, University of Surrey, UK.
ESCHERICHIA COLI strain JM109: RecAl, hsdRlT, endAl, supE44, relAl, F ,
traD36, lacIQZ M15. Obtained from Pharmacia Ltd. (Uppsala, Sweden).
ESCHERICHIA COLI strain LM1035: F , proA2, recA, hsdR', hsdM'. Derivative 
of strain HBlOl obtained from Celltech Ltd (Slough, UK).
1.3 VECTORS. 
pSV2.GS.
A pSV2 derived vector containing the CHO GS cDNA (Nae 1 to Pvu 2 nucleotide 
sequence), under the control of a SV40 early region promoter. The CHO GS-gene 
nucleotide sequence is shown in appendix 2. Obtained from Celltech Ltd. (Slough, 
UK).
pSV2.neo.
A pSV2 derived vector containing the "neo" gene from Tn5 encoding an enzyme 
(ADHII) which confers resistance to aminoglycoside antibiotics. In the vector, the 
expression of the neo gene is controlled by regulatory signals (promoter, splice signal 
and polyadenylation signal) from the SV40 early region. Obtained from Dr A.Easton 
(Warwick University, UK). (Southern and Berg, 1982).
pEE6.gpt.
Plasmid pEE6.gpt contains pBR322 fragments together with; the Xmn 1 to Bel 1 
fragment of plasmid pCT54, a polylinker from pSP64 (Mulligan and Berg, 1981) with 
the Bam HI and SAl 1 sites deleted, a SV40 early region polyadenylation signal, and 
the transcription unit encoding xanthine-guanine phosphoribosyl transferase (gpt) from 
pSV2.gpt. Obtained from Celltech Ltd. (Slough, UK).
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pCMGS.
pSV2.GS containing; the major immediate early gene promoter, enhancer, and complete 
5’-untranslated sequence from human cytomegalovirus (hCMV-MIE), inserted between 
the Neo 1 sites such that it directs expression of the GS coding sequence (refer to 
appendix 3  for a restriction map). Obtained from Celltech Ltd. (Slough, UK).
pCMGS.gpt.
A derivative of pCMGS containing the transcription cassette for the xanthine-guanine 
phosphoribosyl transferase (gpt) gene from pEE6.gpt. Obtained from Celltech Ltd. 
(Slough, UK).
dKSVIO.
A pK B lll derived vector containing; a SV40 early region promoter, and the SV40 
large T antigen splice signal and early polyadenylation site (Beckingham, 1980) (refer 
to appendix 3  for a restriction map). Supplied by Pharmacia Ltd. (Uppsala, Sweden).
p41.
A pBR322 vector containing the mouse beta-actin cDNA. Obtained from 
M.Buckingham (Institute Pasteur, France).
1.4 MEDIA.
1.4.1 CELL CULTURE MEDIA.
All tissue culture reagents were obtained from Gibco BRL (Paisley, Scotland). Full 
details of the commercial media composition are given in apppendix 1.
RPMI-1640.
RPMI-1640 basal medium containing 2mM glutamine, 18mM sodium bicarbonate, and 
5 to 10% (v/v) heat inactivated horse serum (Imperial Laboratories Ltd., UK). For
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routine cell culture RPMI-1640 basal medium was obtained as a lOX concentrate and 
diluted with sterile distilled deionised water as required. Bulk medium for large scale 
work was made up using RPMI-1640 powder. The powder was dissolved high grade 
MilliQ water (1:100 w/v). To facilitate the dissolution of the powder a magnetic 
stirrer was employed and the pH of the liquid was reduced to below pH5 by the 
addition of concentrated HCl. When mixing was complete the pH was adjusted to 7.1, 
and the medium was sterilized by filtration through a 0.2u filter (Flow Laboratories 
Ltd., UK). Samples of the filtrate were taken halfway through, and at the end of the 
filtration process, to check for sterility.
SERUM-FREE MEDIA.
The serum-free media formulation contained:
Component
RPMI-1640 (Gibco)
Glutamine (Gibco)
Sodium bicarbonate (Gibco) 
Bovine albumin (BSA) (Sigma) 
Pyruvic acid (Gibco)
Ascorbic acid (Gibco)
Bovine insulin (Sigma)
Human transferrin (Sigma) 
Progesterone (Sigma) 
Hydrocortisone (Sigma) 
Ethanolamine (Sigma)
Putrescine (Sigma)
Linoleic acid (Sigma)
Copper (II) sulphate (BDH)
Iron (II) sulphate (BDH) 
Manganese ^ )  chloride (BDH) 
Zinc (II) sulphate (BDH) 
Ammonium molydate (BDH) 
Nickel chloride (BDH)
Tin (II) chloride (BDH) 
Ammonium metavanadate (BDH) 
Sodium selenite (Sigma) 
Phosphate buffer
Concentration fg/D
10.12
0.14
1.50
0.70
0.11
3.0E-3
0.01
5.0E-3
3.0E-6
2.0E-6
1.2E-3
1.6E-4
8.4E-5
2.5E-6
8.3E-4
3.0E-7
8.6E-4
1.2E-5
7.0E-7
7.0E-7
1.2E-6
8.0E-7
5mM
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Medium was pr^ared using a concentrated "composite" mixture consisting of pyruvic 
acid, ascorbic acid, progesterone, hydrocortisone, ethanolamine, putrescine, linoleic acid, 
copper, iron, manganese, zinc, molybden, nickel, tin, vanadium and selenite, which 
when added to medium supplied all of those components at their appropriate 
concentration. The composite was stored in aliquots at -20°C. Insulin and transferrin 
were stored concentrated in aliquots at -2(PC.
Phosphate buffer (50mM) was prepared from the following solutions:
- Solution A: 11.H g  potassium di-hydrogen phosphate (BDri) in
11 distilled deionised water.
- Solution B: 34.84g di-potassium hydrogen phosphate (BDH) in
11 distilled deionised water.
Solution A and B were mixed in the ratios 2 parts B to 1 part A, and the pH was 
adjusted to pH7.1 if necessary using IM sodium hydroxide.
DMEM.
Dulbecco’s modified Eagle’s basal medium (DMEM) containing 2mM glutamine, 18mM 
sodium bicarbonate and 10% (v/v) heat inactivated foetal calf serum (PCS).
G-DMEM.
DMEM containing 500uM each of glutamic acid and asparagine, 30uM each of 
adenosine, guanosine, cytidine and uridine, lOuM thymidine, lOOuM non-essential amino 
acids (see below) and 10% (v/v) dialysed foetal calf serum (dPCS).
- Non-essential amino adds (NEAA): a sterile stock solution (Gibco BRL Ltd.)
containing; 890 mg/1 L-alanine, 150mg/l L-asparagine, 1330mg/l L-glutamic acid, 
1150mg/l L-proline, 750mg/l glycine and 1050mg/l L-serine.
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GPT MEDIA aX I.
DMEM containing 10% (v/v) foetal calf serum, lOOuM non-essential amino acids, 
3ug/ml my cophenol ic acid (MPA), 250ug/ml xanthine, and 15ug/ml hypoxanthine.
1.4.2 MICROBIAL GROWTH MEDIA.
LB-Agar.
lOg tryptone, 5g yeast extract, lOg sodium chloride and 15g Bacto-agar. Made up to 
1 litre with distilled water and autoclaved'
LB-Broth.
lOg tryptone, 5g yeast extract and lOg sodium chloride. Made up to 1 litre with 
distilled water and autoclaved.
Sabouraud Dextrose Agar (SDAL
65g Sabouraud dextrose agar powder medium containing; lOg mycological peptone, 40g 
dextrose and 15g agar no.l, - dissolved in 1 litre of distilled water and autoclaved.
Thioglvcollate Broth (TGBL
20g thioglycollate powder medium containing; Ig "Lab-Lemco" powder, 2g yeast 
extract, 5g peptone, 5g dextrose, 5g sodium chloride, l .lg  sodium thioglycollate and 
0.002g methylene blue, - dissolved in 1 litre of distilled water and autoclaved.
Tryptone Sova Broth (TSB).
30g tryptone soya broth powder medium containing; 17g pancreatic digest of casein, 
3g papaic digest of soyabean meal, 5g sodium chloride, 2.5g dibasic potassium 
phosphate and 2.5g dextrose, - dissolved in 1 litre of distilled water and autoclaved.
X-GAL/IPTG Agar.
LB-agar containing; lOOul ampicillin (lOOug/ml), lOOul XGal (20mg/ml) and 50ul IPTG 
(lOOmM), - dissolved in 100ml molten agar.
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1.5 SUPPLIERS.
Materials were obtained from the following sources unless otherwise specified in the 
text.
BACTERIAL GROWTH MEDIA.
Oxoid Ltd. (Baisingstoke, UK).
CHEMICALS.
BDH Ltd. (Poole, ÜK), May and Baker Ltd. (UK) and Boehringer Mannheim Ltd. 
(BCL) (Lewes, UK).
ENZYMES AND FINE CHEMICALS.
Gibco BRL Ltd. (Paisley, Scotland) and Sigma Ltd. (Poole, UK).
PLASTICS.
Flow Laboratories Ltd. (Rickmansworth, UK), Imperial Laboratories Ltd. (Andover, 
UK), Nunc, Gibco BRL Ltd. (Paisley, Scotland) and Sterilin Ltd. (UK).
RADIOCEMICALS AND MATERIALS.
Amersham International Ltd. (Amersham, UK).
TISSUE CULTURE MEDIA AND REAGENTS.
Gibco BRL Ltd. (Paisley, Scotland).
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Z METHODS.
2.1. ANIMAL CELL CULTURE TECHNIQUES.
2.1.1 CELL CULTURE - SUSPENSION CELLS.
Reagents.
1. RPMI-1640 and DMEM media (Gibco BRL Ltd.).
2. Horse serum (Imperial Laboratories Ltd.).
3. Foetal calf serum (Gibco, BRL Ltd.).
4. Phosphate buffered saline (PBS): 170mM sodium chloride, 3.4mM potassium 
chloride, ImM sodium hydrogen phosphate and 2mM potassium hydrogen phosphate; 
made up in distilled water and the pH adjusted to 7.2.
5. Trypsin EDTA (T/V): 0.05% (w/v) trypsin (Gibco, BRL Ltd.) in PBS and ImM 
EDTA.
Suspension cells.
Suspension cells were routinely grown in tissue culture flasks in RPMI-1640 medium 
with heat inactivated horse serum (HS) at 5 or 10% (v/v), unless otherwise specified. 
Serum was heat inactivated at 56"C for 60 minutes. The cells were subcultured 
regularly to maintain a population density of between 2 to 10x10  ^ cells per ml. Flasks 
were incubated at 36.5°C and the pH was controlled at between 7.0 and 7.2 using an 
overlay gas atmosphere of 5% (v/v) carbon dioxide in air.
Small-scale experimental work was performed using either 10 to 70 ml cultures in 
tissue culture flasks, or 50 to 500 ml cultures in stirrer flasks.
Large-scale cell culture was conducted in a "LH 2000" series stirred tank reactor with 
a working volume of 10 litres (LH Fermentation, UK). Temperature was maintained
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at 37°C. Dissolved oxygen tension (DOT) was controlled at 40% by a mass-flow 
meter. The pH was monitored and maintained at pH7.1 by buffering the medium and 
addition of H^/OH as necesary (using IM HCl and IM NaOH respectively). Agitation 
was kept at 200 rpm. Cells to be used for the fermenter inoculum were expanded to 
2 litres in stirred flasks and inoculated at a density of 1.5 to 2 x 10^  cells/ml.
Anchorage dependent cells.
Anchorage dependant cell lines were grown as monolayers in tissue culture flasks in 
DMEM with heat inactivated foetal calf serum (PCS) at 5 or 10% (v/v). Cells were 
subcultured when the growth was confluent by (i) rinsing the cell monolayer with PBS,
(ii) incubating in trypsin/EDTA solution until the cells detached, (iii) sedimenting the 
cells by centrifugation (80g/5 minutes), and (iv), diluting the cells 1/5 in fresh medium.
2.1.2 FROZEN CELL STOCKS.
Freezing medium: Sterile solution of basal growth medium with 20% PCS
(v/v) and 10% DMSO.
Stocks were made of each cell line. The cells were sedimented by centrifugation 
(80g/5 minutes) and resuspended in freezing medium at 5 to 10 x 10^  cells/ml, 1ml 
aliquots of this suspension were pipetted into ampoules, placed inside a polystyrene box 
and frozen at -70°C for 4 to 24 hours. The ampoules were then stored at -196°C 
under liquid nitrogen.
To recover cells from liquid nitrogen storage, an ampoule was thawed rapidly and the 
cell suspension diluted with 10ml growth medium. Cells were sedimented by 
centrifugation (80g/5 minutes), and the supernatant discarded. The cell pellet was 
resuspended in 10ml of fresh growth medium (containing 10% (v/v) PCS), transferred 
to a tissue culture flask, and incubated at 37°C with an overlay atmosphere of 5% 
carbon dioxide in air.
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2.1.3 CELL COUNTING AND VIABILITY.
Cell counts were determined by diluting aliquots of cells in erythrocin-B dye (0.04% 
w/v in 0.85% w/v NaCl) and counting using a Fuchs-Rosenthal Hemocytometer. 
Exclusion of the dye was taken as an indication of cell viability. Cells with an intact 
cell membrane were impermeable to the dye and were considered to be viable. Cells, 
however, with a ’leaky* cell membrane incorporated the dye and were considered to 
be non-viable. The cell viability was calculated from the following equation;
% VIABILITY = (V/T) x 100
where; V = viable cells/ml
T = total cells/ml
2.1.4 CELL STERILITY.
Cell cultures were examined every 2 weeks for the presence of contamination by 
bacteria, yeasts or fungi. An aliquot of spent culture was removed and centrifuged 
to pellet the cells (200g/5 minutes). 0.2ml aliquots of the supernatant were used to 
inoculate duplicates of the following media; NA, SDA, TGB and TSB, and incubated 
at 37°C and 25°C for 10 to 14 days. Media composition is given in chapter 2. Any 
suspicious cultures were examined by Gram’s stain and phase-contrast microscopy.
Cell stocks were tested for the presence of my coplasmas using the Hoescht stain and 
culturing in mycoplasma media. This was carried out by ECACC, Porton Down, 
Salisbury, UK. All of the cells were found to be negative.
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2.1.5 RECLONING CELLS.
Recloning of cells was performed by the limiting dilution method. Cloning medium 
was the same as normal growth medium containing 10% PCS (v/v). Prior to making 
dilutions, cells to be recloned were agitated vigorously and examined microscopically 
to ensure that they were in suspension as single cells. Counts were made in order 
to determine the dilution steps required and also to subsequently assess the plating 
efficiency.
Cells were resuspended at 30 cells/ml, 10 cells/ml, and 3 cells/ml, and plated out in
0.1ml volumes in 96-well Costar plates with or without feeder cells. Feeder cells were 
only used if neccessary. Incubation was at 36.5°C in an atmosphere of 5% (v/v) 
carbon dioxide in air. After 3 to 4 days incubation, plates were examined with an 
inverted microscope and wells containing more than one colony were excluded from 
further investigations. Wells containing single clones received a further 0.1ml of fresh 
medium 7 days post inoculation. At 8 to 10 days post inoculation, cells were 
sufficiently well grown to be screened for antibody synthesis and to be transferred to 
24-well culture plates if further investigation was required. Frozen stocks were made 
of the clones as soon as possible.
Feeder cells were prepared from the spleen of 8 to 12 week old BALB/c mice 
(supplied by the Animal Unit, Surrey University, UK). The mouse was killed and 
washed in 70% EtOH. The spleen was removed asceptically in a laminar flow cabinet 
reserved for the purpose and placed into a sterile universal containing RPMI-1640 
supplemented with penicillin/streptomycin (50 lU/ml). The spleen was transferred to 
a cell culture cabinet and placed in a 6cm petri dish containing 3ml RPMI-1640. 
Spleen cells were gently teased apart using sterile forceps and washed by transferring 
the suspension into a universal containing 10ml medium and sedimented (80g/5 
minutes). Cells were resuspended in 5ml growth medium (without antibiotics) and 
diluted into aliquots of 10* cells/ml. Cells were plated out in 0.1ml volumes in 96-
well Costar plates (lO’cells/well), incubated at 36.5°C for 2 days, and checked 
microscopically for contamination. The plates containing the feeder cells were then 
used for recloning as above.
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2.1.6 DEAE-DEXTRAN MEDIATED TRANSFECTION OF COS-1 CELLS.
COS-1 cells were transformed with plasmid DNA using DEAE dextran. In this 
method a DEAE dextran/DNA co-precipitate is formed, which is then taken up into 
the cell.
Reagents.
Sterile solutions of:
1. DNA dissolved in lOOmM sodium chloride, lOmM Tris-HCl (pH7.5) (500ng/35nun 
plate.
2. PBS.
3. DEAE-dextran (MW 500,000) (Sigma Ltd.) lOmg/ml in PBS.
4. 80mM chloroquine (Sigma Ltd.).
5. DMSO (Gibco BRL Ltd.).
Protocol.
Cells were seeded in 35mm well Costar plates at 3 x 10^  cells per plate. The cells 
were incubated for 1 day until the cell monolayer was subconfluent. The transfection 
mixture was prepared in a sterile eppendorf tube by resuspending sterile supercoiled 
plasmid DNA in PBS (190ul final volume) using a vortex mixer, and then adding lOul 
DEAE-dextran solution.
Culture medium was aspirated from the COS-1 cells and the cell sheet rinsed with PBS 
pre-warmed to 37®C. The PBS was aspirated and the transformation mixture distributed 
evenly over the cell monolayer. The plate was incubated at 37°C for 30 minutes with 
gentle shaking to prevent drying. 2ml of growth medium supplemented with 80uM 
chloroquine was added and the plate re-incubated for 3 hours. The medium was then 
aspirated and replaced with 1ml of medium containing 10% DMSO (v/v) for 2.5 
minutes. This was removed and 4 ml of culture medium added. The cells were 
incubated at 36.5°C in an atmosphere of 5% carbon dioxide (v/v) in air and analysed 
48 to 72 hours post-transfection.
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2.1.7. ELECTROPORATION TRANSFECTION.
Transfection of DNA into hybridoma cells was carried out by electroporation using a 
"Gene Puiser" apparatus (Biorad).
Reagents.
Sterile solutions of:
1. DNA dissolved in PBS (40ug/transfection).
2. PBS.
3. Cell culture medium.
Protocol.
Cells were centriftiged to remove the spent culture medium (80g/5 minutes), washed 
twice in PBS, and then resuspended in 0.5ml of PBS in a bijou at 10^  cells/ml. 40ug 
of linear plasmid DNA was asceptically prepared by ethanol precipitation (section 
3.3.3a) and air drying in a laminar flow hood. This was resuspended in 200ul sterile 
PBS, added to the cells, mixed by swirling and the mixture held in ice for 5 minutes. 
The cell/DNA sample was transferred to 0.8ml unit capacity cuvettes and given 2 
pulses (2kV, 3uFD capacitance), with a second interval inbetween pulses, in the "gene 
puiser". The cells were held at room temperature for 5 minutes before diluting with
11.5ml of the appropriate growth medium.
Cells were plated out in 24-well Costar plates at 0.5ml/well and incubated for 24 to 
48 hours at 36.5°C in an atmosphere of 5% carbon dioxide (v/v) in air. Selective 
medium was added and the cells re-incubated for 1 to 2 weeks until clones became 
visible. Clones were expanded in the presence of selective media, initially in 6-well 
Costar plates, and later in tissue culture flasks. The control cell sample was performed 
without the addition of plasmid DNA.
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2.2 BIOCHEMICAL ASSAYS.
2.2.1 AMMONIA DETERMINATION.
The ammonia content of the culture medium was determined using an "EIL" ammonia 
probe, model 8002-8 (Kent Instruments). In the assay 0.1ml IM sodium hydroxide 
was added to 1ml sample. Free ammonia was liberated and detected with the ammonia 
probe. A calibration curve for the probe was constructed using aqueous ammonium 
chloride standards in the range of 10' to 10 ^ M and samples were read against this 
curve.
2.2.2 GLUTAMINE DETERMINATION.
The glutamine concentration was determined enzymatically by monitoring the liberation 
of ammonia during the deamination of glutamine by glutaminase.
Reagents.
1. O.IM sodium acetate buffer (pH4.9).
2. Glutaminase: Grade V from Escherichia coli (5U/ml in sodium acetate buffer) 
(Sigma Ltd.).
Protocol.
450ul sodium acetate buffer and 50ul glutaminase were added to 500ul of sample. 
Controls were set up without glutaminase for each sample using 500ul sample and 
500ul sodium acetate buffer. Samples and controls were incubated at 37°C for 30 
minutes. The ammonia liberated was measured using an "EIL" ammonia probe, as 
described above in section 2.2.1. Ammonia liberated due to the action of glutaminase 
on glutamine was evaluated by subtracting the ammonia present in the controls from
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the ammonia present in the glutaminase treated samples. Glutamine is converted into 
ammonia in a stoichiometric reaction. Consequently, 1 mole of ammonia can be 
assumed to be liberated from the complete breakdown of 1 mole of glutamine. By, 
therefore, measuring the concentration of ammonia the glutamine concentration can be 
quantified.
2 .23  LACTATE DETERMINATION.
Lactate concentrations in cell culture media were determined enzymatically by 
monitoring the reduction of NAD during the conversion of lactate to pyruvate by 
lactate dehydrogenase.
Reagents.
1. NAD Grade m  from yeast (30mg/ml) (Sigma Ltd.).
2. Glycine-hydrazine buffer (pH9.0): 2ml hydrazine hydrate + 3.7g glycine made up 
to 100ml with distilled water.
3. Lactate dehydrogenase (LDH): From bovine muscle (550U/ml) (Sigma Ltd.).
4. Perchloric acid 8% (w/v) (BDH Ltd.).
5. L-lactate standard (0.4mg/ml) (Sigma Ltd.).
Protocol.
Samples for lactate determination were centrifuged to sediment the cells (200g/5 
minutes). 0.5ml of supernatant was deproteinised by the addition of 1ml ice cold 
perchloric acid. Samples were kept on ice for 20 minutes then centrifuged (12,000g/10 
minutes) to remove the precipitated protein. Deproteinised samples were stored at 
4°C until required.
For the assay 200ul of deproteinised sample was added to 2.5ml glycine buffer. A 
blank containing 200ul perchloric acid and a standard containing 200ul of a 0.4mg/ml 
(4.44 mmoles/1) lactate standard diluted 1 in 3 in perchloric acid, were also included.
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200ul NAD was added to each tube and the initial absorbance at 340nm of each 
sample, including the blank and standard, was measured against glycine-hydrazine
buffer. To 1ml of each sample 25ul LDH was then added and all samples were
incubated at 37°C for 30 minutes. The final absorbance at 340nm for each sample was 
then measured. The lactate concentration was proportional to the increase in 
absorbance due to the reduction of NAD during the conversion of lactate to pyruvate 
and was calculated as follows:
Lactate mmol/1 = (ds-dB) x 7.11
where; ds = difference between the initial and final absorbance of the sample. 
dB = difference between the initial and final absorbance of the blank.
7.11 = a conversion factor based on an absorbance change of 22/mmole NADH
and a dilution factor of 44.2.
Assay results were considered valid if the value for the standard was within 5% of 
the expected value.
2.2.4 GLUCOSE DETERMINATION.
Glucose concentrations were determined by an enzymatic assay using hexokinase (Bondar 
and Mead., 1974). Reagents were supplied in a commercial kit "UNI-KIT HI" 
(Roche), and used according to the manufacturer’s recommended instructions. The 
assay is based on the principle that glucose is converted by hexokinase (HK) into D- 
glucose-6-phosphate, which is then converted into D-gluconate-6-phosphate by glucose- 
6-phosphate dehydrogenase (G6PDH). In the reaction NADH is produced, and the 
concentration of the NADH formed is directly proportional to the glucose concentration.
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HK
D-GLUCOSE + ATP — ^  D-GLUCOSE-6-PHOSPHATE + ADP
G6PDH
D-GLUCOSE-6-PHOSPHATE + NAD+ —^
D-GLUCONATE-6-PHOSPHATE + NADH + H+
During the assay NADH released from samples is determined by measuring the 
absorbance at 340nm using a "Cobas Bioanalyser" (Roche). Glucose standard solutions 
(100 to 500mg/dl) were used to construct a calibration curve. The glucose 
concentrations of the samples were calculated from the curve.
2.2.5 ANTIBODY DETERMINATION.
Antibody concentration in the medium was determined by sandwich enzyme-linked
immunosorbent assay (ELISA). Samples for the assay were centrifuged at 200g for
5 minutes to remove cells and debris then stored at -20°C until required.
Reagents.
1. Wash buffer: PBS (pH7.4) containing 0.1% Tween 20 (v/v).
2. Coupling buffer: O.IM sodium carbonate buffer (pH9.6).
3. PBS.
4. Coating antibody: Sheep anti-mouse IgG (Sigma Ltd.) diluted 1/1000 in coupling
buffer.
5. Enzyme-conjugated antibody: Sheep anti-mouse IgG-alkaline phosphatase (Sigma
Ltd.) diluted 1/1000 in PBS.
6. Substrate for alkaline phosphatase: Phosphatase substrate 104-0 (Sigma Ltd.),
1 mg/ml in substrate buffer.
7. Substrate buffer: 0.5M glycine (pH 10.4), 5mM zinc chloride, 5mM magnesium
chloride.
8. Standard antibody: Affinity purified IgG. (Sigma Ltd.).
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Protocol.
A. Nunc Immunoplates were coated with lOOul coating antibody in coupling buffer and 
left in the dark overnight at 4‘*C.
B. The plates were washed 4 times with wash buffer.
C. Appropriate dilutions of the samples in PBS were applied to the plates in duplicate 
at lOOul (final volume) per well. Serial two-fold dilutions were carried out down 
the plate. IgG standard antibody was also applied in two-fold dilutions on each 
plate, starting at a dilution of 1/1000 (lug/ml).
D. The plates were incubated in the dark at 37"C for 1 hour then washed 4 times 
with wash buffer.
E. A 1/1000 dilution of antibody enzyme conjugate in PBS was applied to each well 
at lOOul per well and incubated for 1 hour at 37"C in the dark.
F. Plates were washed 4 times with wash buffer.
G. Enzyme substrate, at 1 mg/ml in substrate buffer, was applied to all wells at lOOul 
per well. The plates were incubated in the dark at 37°C for 30 to 60 minutes 
before reading the absorbance at 410nm in a "Dynatech" MR600 plate reader.
H. Titration curves of the IgG standard and samples were constructed. The antibody 
concentrations of the samples were read from the titration curves.
2.2.6 GLUTAMINE SYNTHETASE ASSAY.
A '^C-radiometric assay based on the method described by Tiemeir and Mil man (1972) 
was used to measure glutamine synthetase (GS) activity. The assay is based on the 
principle that GS converts glutamic acid to glutamine. Since the reaction is 
stoichiometric, the enzyme activity can be quantified by measuring the conversion of 
'^C-labelled glutamic acid to '‘'C-labelled glutamine. The ‘^ C-glutamine is then separated 
from the labelled precursor using an ion exchange column.
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Reagents.
1. Dowex-1 chloride form (8% X-linked).
2. Reaction mix: 50mM Imidazole, 20mM magnesium chloride (BDH Ltd.), 20mM
ammonium chloride (BDH Ltd.), lOmM creatine phosphokinase, 15mM Na-ATP,
1.2U creatine kinase, 20mM L-glutamic acid, 0.25uCi L-(l-‘^ C)-glutamic acid.
3. Extraction buffer: 50mM Tris-HCl and 2mM EDTA (pH7.9).
4. TRA: 0.5M triethanolamine hydrochloride and 2M potassium hydroxide (BDH 
Ltd.).
5. Potassium hydroxide (5M) (BDH Ltd.).
6. Glutamine synthetase standard: Grade V from Esherichia coli.
7. Tricine buffer: 50mM Tricine (pH7).
8. PBS.
9. pH indicator "678" (BDH Ltd.).
10. Scintillation fluid; "OptiScint Hi-Safe" (LKB).
(All reagents were obtained from Sigma Ltd. unless otherwise stated) 
iVotocol.
A cell pellet was obtained for suspension cells by centrifuging liquid culture (80g/5 
minutes), or for anchorage-dependent cells by dispersing the cell monolayer using 
trypsin-EDTA and subsequent centrifugation. Pellets were washed twice in PBS and 
resuspended in 1ml extraction buffer at 10’ cells/ml. Cells were lysed by sonication 
and the lysate incubated in ice for 10 minutes. Rat liver was used as a positive 
control tissue. This was prepared by disrupting 0.5g fresh rat liver in 4.5ml extraction 
buffer using a polytron homogeniser. The sample was incubated in ice and centrifuged 
at 4“C (10,000g/2 minutes) to remove cell debris.
40ul of sample was added to 360ul of reaction mix and incubated at 37°C for 30 
minutes. All samples were assayed in duplicate. The reaction was stopped with lOOul 
12% perchloric acid (v/v) and placed in ice. Samples were neutralised to pH7 by 
adding lOul pH indicator solution, 20ul 5M potassium hydroxide, and 70ul TRA, and 
centrifuged (10,000g/2 minutes) to remove any precipitate formed. 350ul of sample
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supernatant was passed through a Dowex-Cl column (5 x O.Scm )^ pre-equilibrated with 
Tricine buffer (pH7). At pH7 any '^C-glutamic acid should bind to the column. The 
column was then washed with 5ml Tricine buffer (pH7) and the effluent collected. 
Any '^C-glutamine formed from the labelled precursor by the action of GS should be 
removed in the effluent, leaving the ‘^ C-glutamic acid precursor bound to the column.
0.5ml samples of effluent were diluted with 4.5ml scintillation fluid the amount of 
present quantified by measuring the conversion of radioactive decay energy into light 
energy (CPM) using a beta-scintillation counter (LKB 1215 Rackbeta H). To calculate 
the true amount of activity present the disintegrations pbr minute (DPM) were then 
calculated by evaluating the amount of quenching in the samples and compensating the 
CPM result to give DPM. An external standards spectrum was used to generate an 
External Standards Channels Ratio (ESCR) to monitor efficiency. Standards were 
prepared by dissolving '“C discs containing a known amount of radioactivity (104900 
DPM per disc, Amersham) in reaction mix and scintillation fluid (1:9 v/v) and adding 
a dilution series of carbon tetrachloride (2.5 to 0.25mM).
DPM of the assay reaction mix was also measured both prior to passing through a 
column, and after passing through a column. This enabled the conditions in the 
column to be checked to ensure that the '^C-glutamic acid was binding to the column 
and not eluted with the ''*C-glutamine. Additional controls performed included purified 
Escherichia coli GS and heat inactivated samples.
GS activity (umol/min/10’ cells) in the samples was determined as follows:
_________ DPM SAMPLE - DPM BLANK___________ X DILUTION
'T-GLUTAMIC ACID SPECIFIC ACTIVITY (DPM)
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2.2.7 LOWRY PROTEIN ASSAY.
The concentration of protein in samples was determined using the Lowry protein assay 
(Lowry et û/, 1951).
Reagents.
1. Solution A: 2% (w/v) sodium carbonate, 0.05% (w/v) sodium tartrate, 0.4% #  
sodium hydroxide.
2. Solution B: 0.1% (w/v) copper "sulphate.
3. Solution C: 9:1 (v/v) dilution of solution’s A and B.
4. Folin and Ciolacalteau’s phenol reagent (Sigma Ltd.). 1:1 (v/v) dilution with 
distilled water.
5. Bovine serum albumin (BSA) standard (Sigma Ltd.).
Protocol.
Lowry solutions A and B were kept at 4°C in storage bottles covered with aluminium 
foil to exclude the light. Lowry C was prepared just before the assay. Samples were 
diluted if necessary in distilled water.
For the assay duplicate 0.2ml sample aliquots were placed in bijou tubes. 3ml Lowry 
solution C was added, the sample mixed, and incubated at room temperature for 15 
minutes. 0.3ml diluted Folin and Ciolacalteau’s phenol reagent was added to the 
samples, mixed, and tubes were incubated at room temperature for 30 minutes.
Samples were trasferred to disposable macro-cuvettes and the optical density for each 
sample was measured at 750nm. A protein concentration calibration curve was
constructed using bovine serum albumin standards in the range of 50 to 500ug/ml and 
samples read against this curve.
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2.2.8 ADENYLATE ASSAY.
Levels of ATP, ADP, and AMP were determined using a bioluminescence assay (Holm- 
Hansen and Karl, 1978). The assay is based on the principle that ATP generates a 
light reaction with luciferin and firefly luciferase:
Mg:+
LUCIFERIN + LUCIFERASE + ATP — ►
(LUCIFERIN-LUCIFERASE-AMP) + PYROPHOSPHATE
O:
(LUCIFERIN-LUCIFERASE-AMP) — ►
OXYLUCIFERIN + LUCIFERASE + CO^ + AMP + LIGHT
Under optimum conditions one photon of light is produced for each molecule of ATP. 
ADP and AMP are converted enzymatically to ATP. The bioluminescence reagents 
were supplied by "LUMAC" and used as recommended by the manufacturers.
Reagents.
1. 20% perchloric acid - 20mM EDTA (PCA-EDTA).
2. 5M potassium hydroxide.
3. pH indicator ’678’.
4. Tris-HCl buffer (TE): 20mM Tris adjusted to pH7.75 using HCl.
5. Potassium phosphate buffer: 75mM potassium phosphate adjusted to pH7.5 using
HCl.
6. IM magnesium chloride.
7. "LUMIT": Purified luciferin-luciferase reagent supplied in ffeeze-dried form
("LUMAC") and reconstituted in "LUMIT" buffer.
8. " LUMIT" buffer: Hepes buffer (pH7.75) containing EDTA, Mg^ "'^  and sodium
azide.
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9. Buffer A: Potassium phosphate buffer containing 15mM magnesium chloride and 
2.5mM phosphoenol pyruvate.
10. Buffer B: Buffer A containing pyruvate kinase (lOOOU/ml).
11. Buffer C: Buffer B containing myokinase (lOOOU/ul).
(Pyruvate kinase and myokinase were purchased from Sigma in lOOOU volumes and 
reconstituted on the day of the assay with 1ml TE).
Protocol.
For adenylate extraction duplicate aliquots of 1ml culture medium were dispensed into 
lOOul PCA-EDTA in eppendorf tubes. This was repeated for culture medium 
centrifuged at 200g for 5 minutes to remove the cells. lOul pH indicator was added 
and samples neutralised with 5M potassium hydroxide (approximately 70ul) and kept 
in ice for 5 minutes. Samples were centrifuged (12,000g/2 minutes) to remove 
percipitated potassium perchlorate, and supernatant stored at -20°C for subsequent assay.
Triplicate l(X)ul aliquots of extractant of each sample were diluted with lOOul Tris- 
HCl buffer (TE). To each sample was added either;
A. 50ul buffer A (for ATP determination)
B. 50ul buffer B (for ADP determination)
C. 50ul buffer C (for AMP determination)
Samples were incubated at 30”C for 30 minutes and then boiled for 2 minutes to stop 
the enzyme reaction. Luminescence was determined by adding 50ul sample (diluted 
if necessary) to 50ul Lumit reagent (luciferin-luciferase) in a UV cuvette and measuring 
emmision of light photons in a "LUMAC/3M" biocounter M2010A. An ATP 
calibration curve was constructed using ATP standard solutions in the range of 200 to
0.78ng/ml. The ATP concentration in samples were determined from this curve.
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From the luminescence readings relative levels of ATP, ADP, and AMP were 
determined as follows;
ATP = luminescence from "A" samples.
ADP = luminescence from "B" samples - luminescence from "A" samples.
AMP = luminescence from "C" samples - luminescence from "A" and "B" 
samples.
The "energy charge" (EC) ratio was calculated by determining ATP, ADP, and AMP 
values for the cells (ie subtracting the values obtained for medium from those obtained 
for the medium with cells) and applying the following equation;
EC = ATP + rm.S X ADP) - ATP1 
AMP
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2.3 MOLECULAR BIOLOGY TECHNIQUES.
Genetic manipulation work was undertaken according to ACGM regulations.
2.3.1 MAINTENANCE OF ESCHERICHIA CQLI STRAINS.
Escherichia coli cultures were maintained on LB-agar plates, with antibiotics if 
appropriate, and subcultured every 6 to 8 weeks. For the long term storage of 
bacteria they were frozen at -70°C in LB-broth containing 15% glycerol.
2.3.2 NUCLEOTIDE EXTRACTION METHODS.
A. EXTRACTION OF CYTOPLASMIC RNA FROM EUCARYOTIC CELLS.
RNA was isolated from mammalian cells using a modification of the method described 
by Favaloro et al, (1980). Precautions were taken throughout to minimise ribonuclease 
activity by using vanadyl-ribonucleoside complexes, a strong RNase inhibitor, during 
the initial stages of extraction, and by treating glassware overnight in a 0.1% (v/v) 
diethyl-pyrocarbonate solution (Sigma Ltd.), and by wearing disposable gloves 
throughout the procedures.
Reagents.
1. PBS.
2. Vanadyl-ribonucleoside complexes (200mM) (BRL Ltd.).
3. Lysis buffer: 0.14M sodium chloride, 1.5mM magnesium chloride, lOmM Tris- 
HCl (pH8.6) and 0.5% (v/v) Nonidet-P 40 (Sigma Ltd.).
4. TSE: 0.2M Tris-HCl (pH7.5), 25mM EDTA, 0.3M sodium chloride, 2% (w/v)
SDS.
5. Phenol/chloroform: Distilled phenol (BRL Ltd.) and chloroform (BDH Ltd.) mixed 
1:1 (v/v).
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Protocol.
A cell pellet was obtained of 5 to 10 x 10’ cells/ml for suspension cells by 
centrifuging liquid culture (80g/5 minutes), or for anchorage-dependent cells by 
dispersing the cell monolayer using trypsin-EDTA (T/V) and subsequent centrifugation. 
Pellets were washed twice in cold PBS and held in ice. Cells were lysed by adding
0.5ml vanadyl ribonucleoside complexes (VRC) directly to the pellet and resuspending 
in 4.5ml lysis buffer. The lysate was centrifuged (1630g/3 minutes) to sediment the 
nuclei and the supernatant containing the cytoplasm decanted into a 50ml oakridge tube 
containing 5ml TSE, 10ml distilled water and 15ml phenol/chloroform and mixed. The 
nuclear pellet was held in ice and used if required for DNA extraction.
RNA samples were gently inverted on a rotating wheel for 30 to 50 minutes, 
centrifuged (1630g/15 minutes), and the top aqueous layer transferred to a clean 
oakridge tube. A phenol/chloroform extraction was performed by adding an equal 
volume of phenol/chloroform to the sample and gently mixing by inverting on a 
rotating wheel for 15 to 30 minutes. Samples were centifuged (1630g/15 minutes) and 
the aqueous layer decanted. A further phenol/chloroform extraction was performed.
2.5 volumes of ice cold analar ethanol was added to the final aqueous phase, mixed, 
and the sample incubated at -70°C for a minimum of 4 hours to precipitate the RNA. 
Precipitated RNA was pelleted by centrifugation at 4°C (12,000g/15 minutes). The 
pellet was washed with 70% ethanol and air dried, RNA was resuspended in lOOul 
distilled water and stored at -70°C.
The RNA concentration was calculated spectrophotometrically by measuring the 
absorption at 260nm (section 3.3.3). An optical density (OD) of 1 at 260nm is 
equivalent to an RNA concentration of 40ug/ml, therefore;
RNA concentration = (OD^^ x 40 x dilution) ug/ml
An indication of the quality of the RNA was obtained by measuring the absorbance 
at 280, 260 and 230nm. A pure RNA preparation has an OD 260:230 ratio of around 
2.3, and an OD 260:280 ratio of around 2.
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B. DNA EXTRACTION FROM EUCARYOTIC CFAÂS.
High molecular weight DNA was isolated from mammalian cells essentially as described 
by Maniatis et al., (1982).
Reagents.
1. PBS.
2. NTH: TE (lOmM Tris-HCl (pH8) and ImM EDTA) containing 0.5% (v/v) 
Nonidet-P 40.
3. Lysis buffer: 50mM Tris-HCl (pH7.2), 5mM EDTA, 1.5% (w/v) SDS.
4. Phenol (pH8): Distilled phenol saturated with IM Tris-HCt.
Protocol.
A cell pellet of 5 to 10 x 10’ cells/ml was obtained as described above in the RNA 
extraction protocol. Pellets were washed twice in PBS and resuspended in 10ml NTE 
and left on ice for 5 minutes. The nuclei were then sedimented by centrifuging at 4“C 
(1630g/5 minutes). Alternatively, if an RNA extraction was being performed on the 
same cells, the nuclear pellet was obtained after the cells had been lysed with vanadyl 
ribonucleoside complexes and RNA lysis buffer.
Nuclei were lysed by adding 10ml lysis buffer and pipetting up and down a 10ml 
plastic pipette 5 times. Samples were incubated at 37°C for 1 hour with DNase-ffee 
RNase (50ug/ml) (BRL Ltd.), and then at 55°C for 4 hours with Proteinase K 
(50ug/ml) (Sigma Ltd.). A phenol extraction was performed by adding an equal 
volume of phenol (pH8) to the sample and gently inverting on a rotating wheel for 1 
to 2 hours. Phenol resistant 50ml oakridge tubes were used throughout the extraction 
procedures. Samples were centrifuged (1630g/15 minutes) and the top aqueous layers 
removed using a wide bore pipette. A second phenol extraction was performed and 
the samples were then mixed with an equal volume of chloroform and centrifuged as 
before.
Two volumes of ice cold analar ethanol were added to the final aqueous phase and 
samples incubated at -20°C for 1 hour to precipitate the DNA. DNA was pelleted by
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centrifugation at 4°C (12,000g/30 minutes), washed with 70% ethanol, dried, and 
resuspended in lOOul TE. Samples were stored at 4°C. The DNA concentration and 
an estimate of the DNA quality was determined spectrophotometrically (section 3.3.3).
C. SMALI^SCALE EXTRACTION OF PLASMID DNA FROM E.COLT.
Plasmid DNA was isolated on a small-scale (mini-preps) from bacterial cultures using 
the "boiling method" as described by Maniatis et al, (1982).
Reagents.
1. STET: 50mM EDTA (pH8.0), lOmM Tris-HCl (pH8.0), 8% (v/v) sucrose, 0.5% 
(v/v) triton X-100 (BDH Ltd.).
2. Lysozyme: (Sigma Ltd.) lOmg/ml in lOmM Tris-HCl (pH8.0).
3. TE buffer: lOmM Tris-HCL (pH8.0) and ImM EDTA.
Protocol.
A single colony of the culture of interest was inoculated into 2ml of LB-broth 
containing the appropriate antibiotic for selection. The culture was grown overnight 
in a 37°C shaking incubater. 1ml of the culture was transferred into a microcentrifuge 
tube and centrifuged (10,000g/5 minutes) to pellet the cells. The supernatant was 
discarded and the pellet resuspended in lOOul of STET. Cells were lysed by adding 
lOul of lysosyme solution, mixing using a vortex mixer, and boiling for 40 seconds. 
The lysate was centrifuged (12,000g/15 minutes) and the supernatant decanted and 
mixed with an equal volume of propan-2-ol. Samples were incubated at -70°C for 20 
minutes and then centrifuged at 4°C (12,000g/15 minutes) to sediment the precipitated 
DNA. The DNA pellet was washed with 70% ethanol, dried, and then resuspended 
in 30ul TE buffer.
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D. LARGE-SCALE PLASMID EXTRACTION FROM E.COLI.
Large-scale preparations of plasmids from Escherichia coli were carried out using 10ml 
Caesium Chloride-Ethidium Bromide density gradients (Maniatis et al., 1982).
Reagents.
1. Tris-Sucrose: 50mM Tris-HCl (pH8.0) and 10% (v/v) sucrose.
2. Lysozyme: (Sigma Ltd.) lOmg/ml in 0.25M Tris-HCl (pH8.0)
3. 0.25M Tris-HCl (pH8.0).
4. Brij-Doc: TE buffer (pH8.0) containing 1% (w/v) Brij 58 (Sigma Ltd.) and 0.4% 
(w/v) sodium deoxycholate (Sigma Ltd.).
5. Ethidium bromide solution: lOmg/ml in distilled water.
Protocol.
A single colony of the bacterial strain containing the plasmid of interest was 
inoculated into 10ml LB-broth containing the appropriate antibiotic for selection. The 
culture was grown overnight at 37°C in a shaking incubater. 4mls of the overnight 
culture was inoculated into 150ml of pre-warmed LB-broth (containing the appropriate 
antibiotic) and the flask re-incubated until the cells had grown sufficiently to give an 
optical density of 0.9 at 650nm (around 3 to 4 hours). Chloramphenicol was added 
(170ug/ml) and the culture incubated for a ftirther 4 to 18 hours.
Cells were sedimentated by centrifugation (800g/10 minutes). The cell pellet was 
resuspended in 3.5ml Tris-Sucrose and held in ice for 5 minutes. Cells were lysed 
by adding 2ml freshly prepared lysozyme solution, mixing, and holding in ice for 5 
minutes. 4ml Brij/Doc solution was added, samples mixed by pipetting up and down 
a 10ml plastic pipette, and the lysate re-incubated in ice for 30 minutes to ensure 
complete lysis. Cell debris and most of the chromosomal DNA was removed by 
centrifugation at 4°C (20,000g/20 minutes) and the supernatant (cleared lysate) decanted. 
Caesium chloride and ethidium bromide were added to the lysate to give final 
concentrations of 0.95g/ml and 500ug/ml respectively. The lysate was placed into a 
Beckman Quick Seal polyallomer ultracentrifuge tube and the tube heat sealed. Samples 
were placed in a "Beckman" Ti 70.1 or Ti 75.1 rotor and centrifuged at 18°C for 48
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hours at 40,000rpm in a "Beckman" L5 or L8 ultracentrifuge.
Plasmid bands were visualised using a UV light at 312nm. Bands were extracted by 
puncturing the side of the ultracentrifuge tube just below the band with a 19G 
disposable needle and drawing it into a 1ml syringe. Ethidium bromide was removed 
from the plasmid sample by adding an equal volume of propan-2-ol saturated with 
caesium chloride and mixing thoroughly. Samples were allowed to separate into 2 
phases and the top propan-2-ol phase containing the ethidium bromide was discarded. 
This process was repeated until all of the ethidium bromide had been removed.
Plasmid DNA was precipitated by adding to each 200ul of extract 250ul of distilled 
water, 50ul of 3M sodium acetate (pH5.2), and 500ul of butan-2-ol. Samples were 
incubated in ice for 30 minutes and the DNA pelleted by centrifugation at 4°C 
(12,000g/15 minutes). The pellet was washed with 70% ethanol, air dried, and 
resuspended in TE buffer.
2.3.3 IN VITRO MANIPULATION OF DNA.
A. PRECIPITATION OF DNA.
Reagents.
1. 3M sodium acetate (pH5.2).
2. Ethanol (analar).
3. Propan-2-ol (analar).
4. TE buffer (pH8.0).
Protocol.
To 1 volume of DNA solution was added a 0.1 volume 3M sodium acetate (pH5.2) 
and 2.5 volumes of ethanol or propan-2-ol. Tubes were mixed by inversion and then 
incubated either (i) in ice for 30 minutes, (ii) in a dry-ice/IMS bath for 10 minutes,
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(iii) or overnight at -2(PC. DNA was sedimented by centrifuging at 4"C (12,000g/15 
minutes) and the pellet washed in 70% ethanol and dried. It was then resuspended 
in TE buffer and stored at either 4"C or -20“C.
B. QUANTITATION OF DNA.
DNA concentration and quality was determined by two methods, (i) the 
spectrophotometricmethod (Maniatis et al., 1982), and (ii), the comparative intensity 
method.
The spectrophotometricmethod measures the amount of UV irradiation absorbed by the 
nucleic acid bases. DNA was diluted in distilled water and placed in a quartz cuvette. 
The absorbance values at 260nm and 280nm wavelengths were measured using a "Pye 
Unicam" model PU8820 UVATS spectrophotometer. The ratio of the readings at these 
wavelengths provides an estimate of the purity of the DNA preparation. An OD 
260:280 ratio of 1.7 or greater indicates a DNA solution of high purity with little 
protein contamination. An absorbance of 1.0 at 260nm is equivalent to a DNA 
concentration of 50ug/ml. Therefore, the DNA concentration of the preparation can 
be calculated.
DNA concentration = (ODj^ x 50 x dilution) ug/ml
The presence of RNA which also absorbs UV and the products of DNA degradation 
can result in a value higher than the true DNA concentration.
The comparative intensity method was used to determine the DNA concentration when 
there was insufficient sample available to use the spectrophotometer. An aliquot of 
DNA sample was electrophoresed on an agarose gel with a known amount of DNA 
molecular weight markers. The gel was stained with ethidium bromide and 
photographed using a UV transilluminator (312nm). The intensity of fluorescence of 
ethidium bromide stained DNA under UV light is directly proportional to the total
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mass of the DNA (Maniatis et al., 1982). Therefore, by comparing the intensity of 
the DNA of interest to that of the DNA size fragments of a known concentration an 
estimate of the amount of DNA in the sample can be calculated.
C. RESTRICTION ENZYME DIGESTS.
Restriction enzymes were used to "digest" DNA at specific locations for a variety of 
purposes, for example vector construction and analyses of chromosomal DNA for gene 
sequences. A typical restriction digest was set up as follows;
lOul DNA (upto lug).
2ul lOX restriction enzyme buffer.
7ul distilled water.
lul restriction enzyme (lOu/ul).
The reaction mixture was then incubated at the required temperature for 60 to 90 
minutes. Each restriction enzyme has a specified incubation temperature (usually 37°C) 
and type of buffer composition which optimises the reaction. Restriction enzymes and 
buffers were purchased from BRL Ltd. and used according to the manufacturer’s 
recommended instructions.
D. AGAROSE GEL ELECTROPHORESIS.
Agarose gels can be used to separate nucleic acid molecules of different sizes and 
shapes. Gel composition, agarose concentration, gel buffer, voltage, running time and 
the amount of sample varied according to the particular circumstances.
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DNA GELS.
Reagents.
1. Tris acetate buffer (TAE): 40mM Tris-acetate, 20mM glacial acetic acid, 2mM 
EDTA (pH8.3). Prepared as a 50X stock solution in distilled water and diluted 
as required.
2. DNA loading buffer: 10% (w/v) ficol (MW 400,000) (Sigma Ltd.), 0.05% (w/v) 
bromophenol blue (BCL Ltd.).
3. High molecular weight DNA markers: Lambda DNA Hind 3 fragments (125bp to 
23kb ladder) 400-800ug/ml (BRL Ltd.).
4. Low molecular weight DNA markers: 0X174 RF DNA Hae 3 fragments (72 to 
l,353bp ladder) 400-800ug/ml (BRL Ltd.).
5. Ethidium bromide stain: 0.5ug/ml in distilled water.
Protocol.
DNA was electrophoresed through 0.8% (w/v) TAE gels unless otherwise specified. 
Horizontal gel electrophoresis kits were used as recommended by the manufacturers 
(BRL Ltd.). Gels were prepared by dissolving 0.8g agarose (ultrapure) in 100ml TAE 
buffer by slowly boiling. The molten agarose was cooled to 50°C and then poured 
into the assembled gel plate. The gel was allowed to set, placed in the gel tank, 
submerged in TAE buffer (gel electrophoresis buffer) and the gel comb removed. 
Samples were mixed with 3ul DNA loading buffer and loaded into individual wells in 
the gel. Samples were initially electrophoresed into the agarose gel at lOOV, the 
voltage was then adjusted according to the experimental circumstances.
DNA molecular weight markers were included on each gel (500ng/track). Either high 
or low molecular weight markers were used, depending on the sizes of the DNA 
fragments to be analysed. High molecular weight markers were stored at 4°C and 
prepared by incubating at 55°C for 2 minutes and then cooling in ice prior to loading 
in the gel. Low molecular weight markers were stored at -20°C and loaded directly 
in the gel after thawing.
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Following electrophoresis the gel was stained with ethidium bromide for 5 to 10 
minutes. The ethidium bromide stained DNA bands were visualised using a UV 
transilluminator (312nm) and photographed using an orange filter (23A) and Polaroid 
665 or 667 film.
RNA GELS.
Reagents.
1. MOPS/EDTA: 50mM MOPS (BRL Ltd.) and ImM EDTA (pH7.0).
2. RNA loading buffer: 50% (v/v) glycerol, O.OIM sodium hydrogen phosphate
(pH7.0), 0.4% (w/v) bromophenol blue.
3. RNA molecular weight markers: 6 synthetic poly(A)-tailed RNA’s (0.24 to 9.5Kb 
ladder) (BRL Ltd.). Img/ml in lOmM HEPES (pH7.2) and 2mM EDTA.
Protocol.
RNA samples were electrophoresed through 1.5% formaldahyde denaturing gels. Gels 
were prepared by dissolving 1.5g agarose in 72ml distilled water, cooling to 70°C, and 
adding lOmls lOX MOPS/EDTA and 18mls 37% (v/v) formaldahyde in a fume hood. 
The gel was poured into an assembled gel plate and allowed to set. Gels were placed 
in a horizontal gel tank (BRL), submerged in IX MOPS/EDTA (electrophoresis bufier) 
and the gel comb removed.
Samples were prepared by precipitating the required volume of RNA by adding a 0.1 
volume of sodium acetate (pH5.2) and 2.5 volumes ethanol and incubating in a dry- 
ice/IMS bath for 10 minutes, or at -70°C for 60 minutes. RNA was pelleted by 
centrifugation at 4°C (12,000g/20 minutes) and the pellet dried and resuspended in 4.5ul 
sterile distilled water. 2ul MOPS/EDTA buffer, 3.5ul formaldahyde, and lOul 
formamide were added and the sample heated at 70°C for 10 minutes, and then chilled 
on ice. 2ul RNA gel loading buffer was added and the sample loaded in individual 
wells in the gel. Electrophoresis was initially carried out at lOOV for 5 minutes and
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then at 25 to 60V until the leading dye front had migrated 8-12cm. RNA molecular 
weight markers were included on each gel. If required, the gels were stained in 
ethidium bromide for 5 minutes, then destained for 1 hour and photographed as for 
the DNA gels.
E. RECOVERY OF DNA FROM AGAROSE GELS.
DNA was recovered from agarose gels using the "Gene Clean" method. The method 
utilizes a commercial kit called "Gene Clean" (Stratatech Ltd., USA), which is based 
on the affinity of DNA molecules to bind to a silica matrix (glass milk). The affinity 
can be raised or lowered by varying the conditions, enabling the recovery of DNA 
with high efficiency. All the reagents (except TE buffer) were supplied with the kit 
and used according to the instructions recommended by the manufacturer’s.
Reagents.
1. Sodium iodide stock solution.
2. "Glassmilk" silica matrix suspension.
3. "NEW" buffer (sodium chloride, ethanol. Water).
4. TE buffer (pH8): lOmM Tris-HCl and ImM EDTA.
The DNA sample was electrophoresed through TAE agarose gels as previously 
described (section 2.3.3) and the gel slice containing the DNA fragment(s) required 
excised from the gel and weighed. 2-3 volumes of sodium iodide stock solution were 
added and then incubated at 55“C until the agarose gel slice was completely dissolved.
"Glassmilk" suspension was added to the DNA solution (5ul per 5ug DNA) and mixed 
thoroughly. Samples were placed on ice for 5 minutes to allow binding of the DNA 
to the silica matrix. The silica matrix was pelleted by centrifugation (10,000g/5 
seconds) and the sodium iodide supernatant discarded. The pellet was washed by
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resuspension in 400ul ice cold "NEW" buffer and the silica matrix sedimented by 
centrifugation (10,000g/5 seconds). The supernatant was discarded and the washing 
procedure repeated twice more before resuspending the pellet in 5 to lOul of TE 
buffer. The suspension was incubated at 55"C for 3 minutes and pelleted by 
centrifugation (10,000g/10 seconds). The supernatant containing the DNA was 
recovered and the pellet resuspended in another aliquot of TE buffer and the incubation 
and centrifugation steps repeated. The recovered DNA was stored at -2(TC.
Prior to use the purified DNA fragments were incubated at 55°C and centrifuged 
(12,000g/10 seconds) to sediment any residual glassmilk from the sample. An aliquot 
was run on an agarose gel and the DNA concentration determined by the comparative 
intensity method (section 2.3.3).
F. DEPHOSPHORYLATION OF DNA.
Following digestion of DNA with restriction enzymes, phosphate groups are exposed 
at the 5’ terminus. These groups can be removed (dephosphorylated) by the enzyme 
"calf intestinal phophatase" (CIP) (Chaconas and Van de Sande, 1980). Removal of 
the 5’ phosphate groups prevents self-ligation of the DNA molecule, and consequently 
maximises the potential formation of recombinant molecules in ligation reactions.
Reagents.
1. Phenol/chloroform: Distilled phenol:chloroform 1:1 (v/v).
2. Calf Intestinal Phosphatase (CIP) lU/ul (Sigma Ltd.).
3. lOX "CIP" buffer: 0.5M Tris-HCl (pH9.0), lOmM magnesium chloride, ImM zinc 
chloride, lOmM spermidine (Sigma Ltd.).
Protocol.
The DNA was digested to completion using the appropriate restriction enzyme. The 
enzyme was then inactivated by heating at 70°C for 10 minutes and then chilled in ice.
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Alternatively, if the restriction enzyme was resistant to heat, the enzyme was inactivated 
by extracting with an equal volume of phenol/chloroform, followed by a further 
extraction with chloroform. The DNA was then ethanol precipitated (section 2.3.3) and 
resuspended in 17ul TE buffer. 2ul CIP buffer and lul CIP were added and the 
sample incubated at 37°C for 1 hour. The reaction was stopped by heat inactivating 
the enzyme at 68°C for 10 minutes followed by phenol/chloroform extraction. The 
DNA was ethanol precipitated and the dried pellet resuspended in llu l TE buffer 
(pH8). A lul aliquot was run on an agarose gel to determine the DNA concentration 
using the comparative intensity method (section 2.3.3). The remaining sample was used 
for subséquent ligation reactions.
G. PHOSPHORYLATION OF NUCLEIC ACIDS (KINASTNGI.
The 5’-hydroxy terminus of nucleic acids were phosphorylated using the enzyme T4 
polynucleotide kinase (Maniatis et al., 1982). The addition of 5’ phosphate groups 
enables the subsequent ligation of the DNA molecule.
Reagents.
1. [Gamma-^’P]ATP: Specific activity 3000Ci/mmole (Amersham Ltd.).
2. T4 polynucleotide kinase (PNK) lOU/ul (Sigma Ltd.).
3. lOX kinase buffer: 0.5M Tris-HCl (pH7.6), O.IM magnesium chloride, 50 mM
dithiothreitol (BDH Ltd.), ImM spermidine (Sigma Ltd.) and ImM EDTA.
4. lOmM ATP solution (Sigma Ltd.) prepared in distilled water.
Protocol.
The following reaction mix was set up:
2ul dephosphorylated DNA, 5’ ends (50 to lOOpmoles).
2ul lOX kinase buffer.
2ul [Gamma-^’PjATP.
lul T4 polynucleotide kinase.
12ul distilled water.
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The reaction mixture was incubated at 37°C for 15 minutes and then "chased" with 
non-radiolabelled ATP by adding;
lul lOX kinase buffer.
lul lOmM ATP.
lul T4 polynucleotide kinase.
7ul distilled water.
The reaction was allowed to proceed for a further 30 minutes and then stored at 
-2(TC.
H. SYNTHESIS OF OLIGONUCLEOTIDES.
Oligonucleotides were chemically synthesized using an "Applied Biosystems" DNA 
synthesizer model 381 A, according to the manufacturers instructions. The 
oligonucleotides were extracted from the columns on which they were synthesised using 
18M ammonium hydroxide, and deprotected at 55°C for 12 hours in 18M ammonium 
hydroxide. The nucleotides were ethanol precipitated and resuspended in TE buffer. 
The concentration of the oligonucleotide was then calculated spectrophotometrically 
(section 2.3.3).
I. DNA LIGATION (DNA WITH PROTRUDING TERMIND.
Reagents.
1. T4 DNA ligase. lU/ul (BRL Ltd.)
2. 5X ligase buffer: 20mM Tris-HCl (pH7.5), 4mM magnesium chloride, 0.5mMATP, 
lOmM dithiothreithol.
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Protocol»
The DNA molecules to be ligated were digested with the appropriate restriction 
enzyme(s) to yield fragments with protruding 5* ends ("sticky ends"). Modifications 
including adaptor attachment, dephosphorylation etc. were made if required. The DNA 
molecules were then resuspended in buffer, such that the concentrations of the DNA 
and the ratio of the different DNA molecules would result in maximum recombinant 
molecule production (Maniatis et al, 1982). Usually vector to insert ratios of 1:2 and 
1:4 were used. A typical ligation mixture was set up as shown:
lOul DNA (vector and insert).
4ul 5X ligation buffer.
5ul distilled water, 
lul T4 DNA ligase.
The mixture was incubated at 14°C overnight.
2.3.4 TRANSFORMING ESCHERICHIA COLI STRAINS WITH PLASMID DNA.
The transformation of Escherichia coli with exogenous DNA involves three stages. 
First the cells have to be made 'competent’ to take up the DNA, second, the DNA 
has to be introduced into the cell, and third, the host cells which have received the 
DNA (ie. the transformed cells) have to be selected from those which have not. Two 
strains of Escherichia coli were transformed with plasmid DNA during the project, 
Escherichia coli strain JM109 and Escherichia coli strain HBlOl, using different 
protocols.
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ESCHERICHIA CQLI STRAIN .TM109.
Transformation and storage solution (TSS): 10% (w/v) PEG (MW 3500
(Sigma Ltd.), 5.0% (v/v) DMSO, 20mM magnesium chloride and 20mM 
magnesium sulphate. Prepared in LB-broth and the pH adjusted to 6.5.
Protocol.
Escherichia coli JM109 cells were made competent using the method of PEG assisted 
transformation (Chung and Miller, 1988). In this method bacterial cells were grown 
to early log phase (OD0.6 at 600nm) in LB-broth. Cells were sedimented by 
centrifugation at 3,000rpm for 10 minutes at 4°C (MSE chillspin), resuspended in 0.1 
volumes of transformation and storage buffer (TSS), and incubated in ice for 10 
minutes. The competent cells were then dispensed into pre-cooled microcentrifiige tubes 
in lOOul aliquots and either used for transformation or frozen in a dry ice/IMS bath 
and stored at -70°C.
Competent cells were transformed by adding 1 to lOng of DNA to the cells. The 
cells were incubated in ice for 30 minutes. 0.9mls TSS containing 20mM glucose was 
added and the cells incubated at 37°C in a shaking incubator for 1 hour. Aliquots 
were then plated out on selective media, to select for the cells transformed with the 
exogenous plasmid, usually IPTG-Xgal plates were used.
ESCHERICHIA COLI STRAIN HBIOI.
SOC medium: 2% (w/v) Bactotryptone (Oxoid Ltd.), 0.5% (w/v) yeast extract 
(Oxoid Ltd.), lOmM sodium chloride, 2.5mM potassium chloride, 20mM 
magnesium chloride, 20mM magnesium sulphate and 20mM glucose (pH7.0). 
Prepared without magnesium salts and glucose and autoclaved. The magnesium 
salts and glucose solutions were made up as separate lOX solutions and filter- 
sterilised prior to use.
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Protocol.
Commercially prepared competent Escherichia coli HBlOl cells were obtained from BRL 
Ltd. (Paisley, Scotland) in 0.5ml aliquots. The cells were thawed slowly on ice, 
dispensed into 20ul aliquots in pre-chilled microfuge tubes, then rapidly frozen in a dry 
ice/IMS bath and stored at -70°C.
Competent cells to be transformed, were thawed gently and mixed with 1 to lOng of 
plasmid DNA (in a total volume of lul). The cells were held in ice for 30 minutes 
and then heat shocked at 42°C for 40 seconds and chilled in ice for 2 minutes. 80ul 
of SOC complete medium was then added to each tube and the tubes shaken a^  37°C 
at 225rpm for 1 hour. Cells were plated out on LB-plates with the appropriate 
antibiotic to select for the cells transformed with the plasmid DNA, and incubated at 
37°C overnight. Transformants were subsequently re-plated for single colonies on LB- 
plates (with antibiotics). Control transformations were performed in duplicate using 
pBR322 DNA and cultured on LB-plates with and without antibiotics.
2.3.5. HYBRIDIZATION TECHNIQUES.
Hybridization techniques are based on the ability of complementary single stranded 
DNA or RNA molecules to bind or re-associate with one another to form a hybrid. 
They provide a very sensitive method of detecting related nucleotide sequences. The 
stability of the hybrid is affected by several factors, such as; the temperature, G+C 
content, and the degree of homology between the two nucleic acid strands.
Hybridization reactions involve 5 stages:
1. Immobilization of the nucleotide onto a solid support.
2. Preparation of the probe and labelling.
3. Hybridization.
4. Washing.
5. Autoradiography.
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1. IMMOBILISATION OF THE NUCLEOTIDE TO A SOLID SUPPORT. 
Reagents.
1. 20X SSC: 3M sodium chloride, 0.5M sodium citrate (pH7.0).
2. Denaturing solution: 0.5M sodium hydroxide, 2.5M sodium chloride.
3. Neutralising solution: 3M sodium acetate (pH5.5).
4. Restriction buffer 3: 50mM Tris-HCl ^H8.0), lOmM magnesium chloride, lOOmM 
sodium chloride.
Protocol. "
Nylon membrane filters (Hybond-N, Amersham International Ltd.) or nitrocellulose 
membrane filters (Hybond-C, Amersham International Ltd.) were used as a solid 
support. DNA was immobilized onto the membranes using Southern blot transfer 
(Southern, 1975), and RNA by Northern blot transfer.
"SOUTHERN" BLOTTING.
DNA to be analysed was first digested with the appropriate restriction enzyme(s) and 
electrophoresed through a TAE agarose gel (section 2.3.3). DNA molecular weight 
markers included on the gels were labelled using [û//?/w-^P]-dATP as described in the 
subsequent "labelling" section.
The Southern gel was stained with ethidium bromide and photographed on a UV 
transilluminator (section 2.3.3). The gel was rinsed with distilled water, submerged 
in several volumes of denaturing buffer, and gently shaken. After 30 minutes the gel 
was rinsed with distilled water, placed in several volumes of neutralising solution, and 
agitated for a further 30 minutes.
The DNA was transferred onto a nylon membrane by blotting with SSC buffer. The 
gel was first rinsed in 2X SSC buffer and placed on a piece of 3MM Whatman paper, 
supported by a glass plate, with both ends of the paper dipping into a reservoir of 
20X SSC buffer. A piece of membrane filter, cut slightly larger than the gel, was
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then placed on top and air bubbles were removed by rolling a 10ml pipette over the 
filter. Two pieces of 3MM paper slightly larger than the gel were saturated with 2X 
SSC and placed on top of the membrane filter, followed by 2 dry pieces of 3MM 
paper, and finally a stack of tissues. A glass plate was placed on top of the assembly 
followed by a weight of at least 500g. This was left blotting for a minimum of 12 
hours. The tissues were replaced when they became saturated with SSC.
The blotting apparatus was dismantled and the filter rinsed in 6X SSC. The filter was 
baked at 80°C for 90 minutes to "fix" the DNA on the membrane filter and stored in 
the dark.
COLONY HYBRIDIZATION (ESCHERICHIA COLD.
Colony hybridization was carried out when large numbers of isolated clones needed to 
be screened for the presence of a particular DNA insert in the plasmid vector. The 
protocol used was essentially as described by Grunstein and Hogness (1975).
antiWotic
A nitrocellulose filter was placed on a LB-plate containing the appropriate,required to 
select colonies containing the plasmid of interest. Using sterile toothpicks, individual 
bacterial colonies were transferred onto both the filter and a master LB-plate. Small 
streaks (2-3mm) were made in a grid pattern, with up to 100 colonies streaked per 
plate. A non-recombinant plasmid was included as a control. Plates incubated at 3TC  
until the bacterial streaks had grown to a width of 0.5-1mm. The filter was 
transferred to a LB-plate containing chloramphenicol (lOug/ml) to amplify the plasmid 
and the plates were incubated for a further 10 hours at 37°C. The filter and master 
plate were marked so that the orientation of the colonies could be determinal. The 
master plate was stored at 4°C.
Bacterial colonies on the filters were lysed and the liberated DNA bound to the 
nitrocellulose filter. This was performed by placing the filters, colony side up, on
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3MM paper - saturated with 10% (w/v) SDS to lyse the cells - for 3 minutes, 
followed by denaturing by transferring the filters to 3MM paper saturated with 
denaturing solution. After 5 minutes, the filter was neutralised, by transferring it to 
3MM paper saturated with neutralising solution for 5 minutes. The filters were then 
air-dried for 30 minutes and baked at 80”C in a vacuum oven for 90 minutes to ’fix’ 
the DNA.
"NORTHERN" BLOTTING.
RNA to be analysed was electrophoresed through a denaturing formaldahyde gel as 
previously outlined (section 2.3.3). The gel was rinsed in 2X SSC buffer and the 
RNA transferred, by blotting, to a nylon membrane filter - as described for the 
Southern blot. To fix the RNA on the the membrane filter the membrane was air 
dried for up to an hour, wrapped in Saran-Wrap, and placed RNA-side down on a 
UV transilluminator (312nm) for 4 minutes.
2. "LABELLING" THE PROBE AND DNA MARKERS.
DNA probes were used to detect the presence of the specific gene sequence of interest. 
Probes were labelled by random primers using the "MultiPrime" labelling kit method 
according to recommended instructions by the manufacturer’s (Amersham International 
Ltd.). All the reagents were supplied in the kit.
In this method, random hexanucleotide sequences, which hybridize to single stranded 
DNA at numerous points along its length, are used to prime DNA synthesis along the 
length of the DNA probe template. The addition of a labelled dNTP, with other cold 
dNTP’s, results in the production of radioactive DNA probes. The newly synthesized 
strand, carrying the label, was separated from the template by heating in a boiling 
water bath for 5 minutes followed by cooling on ice.
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DNA molecular weight markers run on Southern gels were labelled with [alpha-^V] 
dATP using the following reaction:
lOul DNA molecular weight markers (40ng). 
lul lOX restriction enzyme buffer 3.
6ul distilled water.
lul [alpha-^B] dATP (specific activity lOmCi/ml). 
lul DNA polymerase 1 (lOU/ul).
The reaction mixture was incubated at room temperature for 5 minutes and then at 
55°C for 10 minutes. It was cooled on ice and then diluted with 3Oui TE. lOul was 
loaded per well. The labelled markers were stored in a lead pot at -20^C for upto 
2 weeks.
3. HYBRIDIZATION.
Reagents.
1. DNA hybridisation buffer: 5X Denhardt’s solution, 5X SSPE, 0.5% (w/v) SDS,
0.5mg/ml single stranded salmon sperm DNA.
2. RNA hybridisation buffer: 5X Denhardt’s solution, 5X SSPE, 50% (v/v) deionized 
formamide (BRL Ltd.), 0.25% (w/v) SDS, 0.65mg/ml single stranded salmon sperm 
DNA (Sigma Ltd.).
3. 20X SSPE: 3.6M sodium chloride, 0.2M sodium phosphate, 0.02M EDTA 
(pH7.7).
4. lOOX Denhardt’s solution: 2% (w/v) bovine serum albumin (Sigma Ltd.), 2%
(w/v) ficoll, 2% (w/v) polyvinylpyrollidone (BCL Ltd.).
Protocol.
During this project, hybridisation reactions were initially performed in heat-sealable
plastic bags containing luer ports through which buffers and solutions were introduced
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or removed. The bags were purchased from Hybaid Ltd. The membrane filter (step 
1) was placed in a bag, sandwiched between 2 gauze meshes, and the bag heat sealed. 
25ml pre-warmed hybridization buffer was placed in the bag and the air removed using 
a vacuum pump. Any remaining air bubbles were removed with a 20ml syringe. The 
bag was then incubated at the required temperature in a shaking water bath for a 
minimum of 2 hours. Typically 65°C was used for Southern blots and 42°C for 
Northern blots.
After incubation, air was re-introduced into the bag. The probe (step 2) was diluted 
with 5ml of hybridization buffer and placed in the bag. The probe was thoroughly 
mixed with the buffer and dispersed over the filter, then air was removed and the bag 
incubated overnight.
Later in the project a "Hybridization oven" (Hybaid Ltd.) was used for hybridization 
reactions. The filters were soaked in 2X SSC and then rolled in a nylon gauze and 
placed into a hybridization bottle. 10ml of pre-warmed hybridization buffer was added 
to the bottle which was then transferred to the hybridization oven and incubated at the 
required temperature, with rotation, for 1 to 3 hours. Hybridization buffer was 
removed from the bottle into a universal, the probe added and mixed. This solution 
was replaced in the bottle and incubated in the oven, with rotation, for a minimum 
of 12 hours.
4. FILTER WASHING.
Reagents.
1. Wash solution: 3 to O.IX SSC and 0.1% (w/v) SDS. The concentration of 
SSC depended on the stringency of the washing conditions.
2. Southern blot probe-removing solution: O.IX SSC, 0.1% (w/v) SDS, and 03^ 
Tris-HCl (pH7.5).
3. Northern blot probe-removing solution: 5mM Tris-HCl (pH8), 2mM EDTA, 
O.IX Denhardt’s solution.
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Protocol.
Hybridization buffer was discarded from either, the bag or the bottle, and the filter 
removed into a plastic container. Standard procedures for working with radioactive 
material were carefully followed. The filter was rinsed in 2X SSC, submerged in pre- 
warmed wash buffer and gently agitated. Wash buffer was replaced every 15 minutes. 
The concentration of SSC used in the wash buffer ranged from 3 to O.IX SSC, and 
the wash temperature from 65 to 45°C, depending on the stringency required. Usually 
DNA filter membranes were washed at 65°C and RNA filter membranes at 45°C. A 
final rinse was given in 2X SSC for 5 minutes, the filter was then placed on a glass 
plate and wrapped in Saran Wrap.
To enable filters to be hybridised with more than one type of DNA probe, the original 
probe was removed using stringent washing conditions. DNA filters were washed in 
0.4M sodium hydroxide at 45°C in a shaking water bath for 30 minutes, then 
transferred to Southern blot probe-removing solution at 45°C for a ftirther 30 minutes. 
RNA filters were washed for 1 to 2 hours at 65°C in Northern blot probe-removing 
solution. Filters were checked with a monitor and autoradiographed for 24 hours to 
ensure removal of the probe. Stored filters were kept moist by wrapping in Saran- 
Wrap and placing at -70°C.
5. AUTORADIOGRAPHY.
The filter wrapped in Saran Wrap was placed in an autoradiograph cassette. A piece 
of RX X-Ray film (Fuji) was put on top of the filter. The autoradiograph was left 
at room temperature or -70°C for 3 hours to several days depending on the strength 
of the signal. Autoradiograph cassettes used at -70°C contained an intensifying screen. 
The autoradiograph film was developed by submerging in Kodak liquid X-ray developer 
for 5 minutes, rinsing in a water bath, and transferring to Kodak rapid fixer for 5 
minutes. The film was washed in running water for 15 minutes and dried in a warm 
cabinet.
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CHAPTER 3.
PHYSIOLOGICAL STUDIES OF POXBl/2 HYBRIDQMAS.
3.1 SUMMARY.
Physiological studies have been made of the PQXBl/2 hybridoma during stirred batch 
culture. The cell growth kinetics were found to be similar to the classical microbial 
kinetics outlined by Monod (1942), with a discernable lag phase followed by exponential 
growth phase and decline phase. During the culture, glutamine and glucose were used as 
substrates and their uptake was paralleled by the accumulation of ammonia and lactate in 
the culture medium.
From metabolic exchange studies, a three phase culture physiology, which characterised 
growth and antibody synthesis, was identified using partial cubic spline interpolation. 
During this triphasic sequence there were defined periods of growth, antibody synthesis 
and substrate assimilation and production kinetics. Antibody synthesis was found to be 
independent of the specific growth-rate, and there was an increase in the mean specific 
production rate during the decline phase of the culture.
Phases were found in the uptake and production of ammonia and glutamine throughout the 
culture. Ammonia assimilation was observed and firm evidence obtained indicating that 
it was utilised by incorporation into alanine by glutamate dehydrogenase (GDH) and 
subsequent transamination. Glutamine was found to be a key metabolite required for cell 
proliferation. Glutamine synthetase (GS) activity and associated mRNA production were 
found to vary, apparently in relation to the observed phasic culture physiology. During 
the main biosynthetic growth phase there was a notable decline in the levels of ATP.
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Maximum ATP specific production rates were found to preceed the onset of the main 
period of growth. Substantial evidence was obtained which indicates that energy charge
reflects the cells physiological status and is involved in the regulation of antibody 
synthesis.
3.2 INTRODUCTION.
Many problems experienced in animal cell biotechnology are reputed to arise because cells 
are not always in prime physiological condition. Consequently, a number of studies aimed 
at improving the culture environment have been made (Glacken et al., 1983 and 1986; Hu 
et al., 1987; Low and Harbour, 1985a and 1985b; Reuveny et al., 1986). These have 
resulted in increased cell yields, improved cell survival and higher antibody titres. 
However, it has also become apparent, with hybridoma cells, that optimum physiological 
conditions for growth are not necessarily the same as for antibody production. Antibody 
production has been found to be enhanced by growing the cells under conditions of stress, 
such as "low" pH (Miller et al., 1987), low serum or serum free medium (Glassy et al., 
1988), reduced oxygen concentrations (Reuveny et al., 1986), and at reduced growth-rates 
(Birch et al., 1985). To improve cell growth and productivity the underlying physiological 
processes need to be defined. A prerequisite to this is a deeper understanding of how 
the culture environment affects the cells growth kinetics and metabolism.
Hybridoma growth kinetics appear to follow similar growth kinetics to the classical 
microbial kinetics first described by Monod (1942). A number of different phases occur 
which reflect changes in the cells and their enviroment (Figure 3.1). Following inoculation 
of the culture there is a discernable lag phase during which the cells adjust to the new 
conditions. This may be contributed to by the population density dependence of cell 
growth found in animal cell culture (Eagle and Piez, 1962). Cells are dependent on a 
pool of metabolic intermediates in the medium in order to proliferate, if these are not 
present they must first be synthesised before cell replication can proceed. The rate at
87
which they are_
synthesised will depend on the number of cells present. After the lag period the growth 
rate accelerates and cells enter a period of exponential growth where all nutrients are in 
excess concentration and the cells grow at their maximum specific growth rate. This 
growth ceases either; due to lack of one or more nutrients, accumulation of one or more 
inhibitory catabolite(s), or, some change in the physical enviroment. There may then be 
a stationary phase where the amount of biomass remains constant, followed by a decline 
phase which is characterised by a reduction in cell viability and biomass.
FIGURE 3.1. GROWTH CURVE OF A BACTERIAL CULTURE.
0n
E Cl
C CO.
Q .
Q .
O)
C L
OCDÜ
U)O—1
Time
Batch culture has been used extensively to cultivate mammalian cells for both research 
purposes and production of monoclonal antibodies (Miller, 1987; Reuveny et o/., 1986; 
Rhodes and Birch, 1985) viruses (Pay et o/., 1985; Radlett et a/., 1985), interferons 
(Phillips et al.y 1985), and recombinant DNA products such as tissue-plasminogen activator
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(Lubiniecki et al.y 1989). Maximum cell densities acheived depend on the cell type and 
culture vessel. For hybridomas 10* cells per ml are generally obtained (Boraston et al.y 
1984; Reuveny et al.y 1987). A variety of culture vessels are used which range in design 
and complexity from shake flasks and roller-bottles to fully automated production reactors. 
The conventional stirred tank reactor (STR) originally designed for microbial fermentations 
has been extensively used and scaled-up to 8,000 litres (Phillips et al.y 1985).
The growth parameters occurring during batch culture can be defined by a number of 
equations (Pirt, 1965);
The population growth rate is described by the equation:
dx = ux [equation 3.1]
dt
where if all of the growth requirements are satisfied during a time interval (dt), the
increase in biomass (dx) is proportional to the amount of biomass (x) present, the specific
growth rate (u), and the time interval.
The doubling time (td) i.e. the time for a population to double in number/mass is
determined by:
td = ]n2 = 0.693 [equation 3.2]
u u
The specific growth rate (u) is defined by rearranging equation 3.1:
1 X dx = u [equation 3.3]
X dt
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The parameter u represents the rate of growth per unit amount of biomass and is 
expressed in h‘*. When excess substrate is present and u is constant equation 3.3 can be 
integrated to give:
Inx = Inx, + ut [equation 3.4]
where x is the biomass when t = o. By plotting Inx against time a straight line will 
be obtained of which the gradient of the slope is u. Equation 3.4 can be rearranged:
X = X , e"‘ [equation 3.5]
Growth which follows this equation is defined as "constant exponential" or "logarithmic"
growth. Practice, however, has shown that the growth rates during exponential phase is 
subject to constant change and this was also observed during this study.
When growth of a batch culture becomes limited by the concentration of one substrate the 
specific growth rate (u) becomes a function of three parameters: the concentration of the 
limiting substrate (S), the maximum specific growth rate (urn) and a substrate-specific
constant (Ks). The constant Ks is the substrate concentration at which half the maximum 
specific growth rate is obtained and indicates the affinity of the cell for the substrate 
concerned.The specific growth rate can be predicted from these growth parameters 
according to the Monod Equation (Monod, 1942):
u = um S [equation 3.6]
Ks + S
The Monod equation can be used to determine the specific growth rate until more than 
one substrate becomes rate limiting, or inhibitory factors effect growth.
A cubic spline curve fitting programme was used in this project to "smooth" curves to 
experimental data (section 1.5). The generated curves were then differentiated to yield
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volumetric rates of change The programme was obtained from Dr M.E.Bushell (Surrey 
University, UK) and the programme parameters are listed in appendix 4 . Leudeking 
(1967) has demonstrated the advantages of analysing data using volumetric rates compared 
to a time course or specific rates (Figure 3.2). For example, by plotting the rates of 
production (dx/dt) during penicillin synthesis, he was able to determine the phases during 
which growth, substrate utilisation, and product synthesis occurred (Figure 3.2b). 
However, if the experimental results were analysed conventionally, using either a time 
course (Figure 3.2a), or specific rates of production (dx/dt . 1/x) (Figure 3.2c), the data 
were less informative.
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Figure3.2 More complex kinetics Tor production of penicillin, a secondary metabolite: (a) time 
course, (fc) volumetric rates, and (c) specific rates. [Reprinted from  R. Leudeking, '^Fermentation 
Process Kinetics,” in N. Blakebrough (ed.), “Biochemical and Biological Engineering,” vol. I, p. 205, 
Academic Press, Inc. (London) L td, London, 1967.]
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Determination of how the cell’s metabolism is influenced by the environment, and responds 
to physiological factors, is complicated by their requirement for an ill-defined and complex 
culture milieu. The effect of the culture enviroment on cells has been discussed in some 
depth during chapter 1. Glucose and glutamine are the major carbon and energy sources 
used by mamalian cells in culture (section 1.6). Both nutrients have essential anabolic 
roles but are also complementary for the production of certain metabolites and energy.
The fate of each nutrient and the proportion of each used by the pathways is influenced
by the metabolic state of the cells. The catabolic end products, notably lactate, ammonia 
and carbon dioxide are excreted into the medium where they may accumulate and become 
inhibitory to cell growth and/or product formation. Lactate accumulation can lower the 
pH of the culture, inhibiting growth, since mammalian cells grow optimally over narrow 
pH ranges (Paul, 1965). Lactate has also been found to inhibit antibody production in 
hybridomas (Glacken etal.y 1986). Ammonia has been shown to inhibit the growth of a 
number of different cell lines such as MDCK’s, Mc-Coy’s, HeLa’s and hybridomas (Butler 
1985; Glacken, 1988; Reuveny et al.y 1986). Ammonia has also been found to inhibit 
the production of viruses (Jensen et al. y 1961), and at high concentrations monoclonal
antibody (Reuveny et al. y 1986).
The reason for the toxicity of ammonia to mammalian cells is not completely understood. 
Ammonia has a relatively high pKa (9.25 at 25°C) - thus in the cell it occurs almost 
entirely as the ammonium (NH^^  ^ ion. NH^^ ions do not readily permeate the plasma 
membrane, and consequently they accumulate in the cell where they affect the acid-base 
homeostasis (Glacken et al.y 1986). This may be one of the mechanisms contributing 
towards ammonia toxicity. Weak bases such as ammonia have been reported to cause 
"vacuolation" in cells due to their accumulation within the cell in regions of low pH 
(DeDuve et al.y 1974). This can result in a loss of cellular integrity and viability.
A third important "substrate" involved in cell growth is oxygen. Oxygen is specifically 
involved in the oxidative metabolism of Krebs cycle intermediates. The oxygen uptake rate 
has been reported to be related to cell growth rate (Katinger et al.y 1979). Optimum 
oxygen concentrations required for cell growth vary with cell type but have generally been
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found to be in the range of 40 to 50% air saturation (Radlett et al.y 1985; Reuveny et 
al.y 1986). However, a study by Boraston et al (1984) found that the growth rate of 
hybridomas was only marginally affected by oxygen concentrations ranging from 8 to 100% 
air saturation, while oxygen concentrations higher than those of atmospheric air have been 
reported to be toxic to mammalian cells (Cooper et al.y 1958; Mizrahi et al.y 1972).
An assessment of the cell’s physiological status can be made from determinations of the
"cellular energy levels". All organisms require a source of energy to synthesise cell 
and
material for growth ^ for product formation, and for "maintenance" (Pirt, 1965). The 
maintenance energy requirement for hybridomas has been studied by Miller and c o l l i e s  
(1987) and estimated to comprises 60% of the total energy demand. This implies that
■i
mammalian cells require more energy for maintenance than biosynthesis, which is in 
contrast to microbial cells, where the maintenance energy demand is usually quite low 
(Wang et al.y 1979). Two functions of maintenance energy in mammalian cells are, to 
keep ionic gradients across membranes and to drive "futile cycles". Futile cycles are 
cyclic reactions during which the hydrolysis of ATP is the only net result, for example 
the glutamate dehydrogenase/transhydrogenase cycle in the mitochondria which is driven by 
ammonia (Tagler et al.y 1975). If the cellular energy required to synthesise a product is 
a substantial fraction of the total energy capacity of the cell, and ATP synthesis is 
limiting, high growth rates may retard product formation.
In mammalian cells ATP is formed as a result of the catabolism of the substrates glucose 
and glutamine. The proportion of the cellular ATP derived from glutamine, as opposed 
to glucose, varies according to the cell type and the environmental conditions. In a 
review Glacken (1988) has reported that glutamine oxidation can account for 40% of the 
ATP formed in Chinese hamster cells, 30% in human fibroblasts, 70% in HeLa cells and 
98% in HeLa cells grown on fructose instead of glucose. Glutamine can also yield 
different amounts of ATP depending on the metabolic pathway through which the carbon 
is catabolised. If all the glutamine is catabolised to lactate, each mole of glutamine yields 
6 to 9 moles of ATP, assuming that each mole of oxidised NADH produces 3 moles of 
ATP. On the other hand, complete oxidation of glutamine to carbon dioxide would
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provide 24 to 27 moles of ATP per mole of glutamine utilised, and the incomplete 
oxidation to alanine and aspartate would result in at the most 9 moles of ATP per mole 
of glutamine.
ATP plays an important role in the regulation of metabolism by acting as a modulator of 
enzyme activity and enzyme synthesis. To a lesser extent ADP and AMP have a similar 
function. The relative concentration of ATP, ADP, and AMP in the cell can be used in 
the following formula to calculate the energy charge (EC) ratio:
EC = (ATP^ + 0.5(ADP>
(AMP) + (ADP) + (ATP)
Energy charge has been reported to act as an indicator of metabolic regulation (Atkinson, 
1969). Studies have shown that if the energy charge ratio is high, the activities of 
enzymes involved in ATP synthesis are inhibited by feed back inhibition. For example, 
isocitrate dehydrogenase is inhibited when the energy charge is above 0.8. Conversely, 
the activities of anabolic enzymes such as aspartokinases which consume ATP are activated 
by a high energy charge ratio.
The purpose of this chapter was to investigate the physiology of a "model" hybridoma cell 
line grown in batch culture. From the study it was aimed to establish the characteristics 
defining cell growth, metabolism, and antibody synthesis. The work described in this 
chapter was an integral part of an associated study being carried out in this laboratory 
concerned with the growth kinetics, metabolism, and physiology of hybridomas. 
Consequently, a number of people were involved in obtaining the results of the bioreactor 
experiments, whose help, expertise and technical skills enhanced the investigation, and are 
gratefully acknowledged.
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3.3 MATERIALS AND METHODS.
Details of cell growth media and materials, and determinations of cell number and 
viability, all metabolite concentrations, and RNA extraction and hybridization protocols, are 
given in chapter 2. The protocol for NMR analysis of cell culture media (section 
3.4.3), which was carried out elsewhere, is outlined in appendix 5.
3.4 EXPERIMENTAL RESULTS.
3.4.1 HYBRIDOMA GROWTH AND METABOLISM IN BATCH CULTURE.
Investigation of PQXBl/2 hybridoma cell growth in stirred batch culture was carried out 
in a 14 litre capacity LH series 2000 fermenter. Temperature was maintained at 37°C, 
pH at 7.1, DOT at 40% and agitation at 200rpm (see section 2.1). Cells were inoculated 
at a density of 2x10^ per ml in 10 litres of RPMI-1640 with 10% (v/v) heat inactivated 
horse serum. Cell number and viability were determined at six-hourly intervals. Samples 
were simultaneously taken for determination of the levels of antibody, glucose, lactate, 
glutamine and ammonia, and stored at -20°C for later analysis. Samples for RNA 
extraction were collected daily and used immediately.
Figure 3.3 shows a typical growth curve for the PQXBl/2 hybridoma in stirred batch 
culture. Growth was characterised by a lag phase to 20 hours, followed by an exponential 
growth phase to 55 hours, and a decline phase. There was no apparent stationary phase. 
A maximum cell density of 9.5 x 10* was achieved after 55 hours with a total cell 
viability of 97%. The cell viability then declined leading to total cell death after 100 
hours. Specific growth rates were calculated from cubic spline gradient data (section 3.2) 
and a single peak was observed at 35 hours. A specific growth rate of 0.042h ' was 
determined.
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Figure 3.3 Growth curve for POXBl/2 hybridomas in 
stirred batch culture.
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Glucose concentration in the growth medium was found to decrease (Figure 3.4). A 
sigmoidal curve with 30% overall glucose utilisation indicated that glucose was not the 
growth limiting substrate under the conditions studied. Lactate accumulated in the medium 
reaching a plateau concentration of 6 to 7mM shortly after the peak in cell density. 
Approximately 1.5 moles of lactate were produced for each mole of glucose consumed.
Glutamine was found to be completely exhausted from the culture medium after 65 hours 
(Figure 3.5). This coincided with a decline in cell number and viability. Continuous 
calculation of volumetric glutamine utilisation rates using cubic splines revealed three peaks 
at 25, 45, and 58 hours. The first of these corresponed to the onset of the maximum 
growth phase and the third coincided with the period of maximum antibody production 
rate. Glutamine production rates were calculated and a major peak was found which 
spanned 30 to 40 hours.
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Ammonia accumulated in the medium and reached a maximum concentration of 3mM at 
70 hours when glutamine was exhausted (Figure 3.6). The increase in ammonia 
concentration corresponded to the decrease in glutamine concentration with approximately 
one mole of ammonia liberated for each mole of glutamine metabolised. Calculation of 
ammonia production rates indicated three peaks at 25, 48, and 60 hours. The first two 
occurred prior to and following the maximum growth phase, and the third coincided with 
the period of maximum antibody production rates. Ammonia utilisation rates were
calculated and had positive values between 30 to 40 hours.
FIGURE 3.4
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Figure 3.5 Changes in glutamine (Gin) concentration 
and rate of change \+dG\n/dt].
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Figure 3.6 Changes in ammonia (NHjj) concentration 
and rate of change l+dNUj/dt].
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Antibody titre increased throughout the batch culture and continued to accumulate in the 
medium after the peak in cell concentration at 55 hours (Figure 3.7). A period of 
antibody production was observed with the peak production occurring after 50 hours (0.73 
ug/10* cells/hr). This corresponded to a decline in the specific growth rate of the culture 
and as mentioned is coincident with the third glutamine utilisation peak and third ammonia 
production peak. Antibody titres of 45 ug/ml were obtained. The data are consistent 
with non-growth associated antibody production.
Figure 3.7 Antibody (MAh) titre and rate of 
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The data gathered reveal three main phases occurring during the batch culture (Figure 
3.8), this is consistent with a lag phase, growth phase, and production phase. Phase 1 
is characterised by very slow biomass accretion, the first peak in glutamine utilisation rate, 
and the first peak in ammonia production. Phase 2, by maximum biomass accretion rate, 
glutamine production, and ammonia utilisation. Phase 3, by the termination of growth, 
the peak rate of antibody production, and glutamine utilisation and ammonia production. 
This triphasic sequence of events characterising PQXBl/2 cell growth in stirred batch 
culture was shown to be reproducible in subsequent bioreactor experiments.
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FIGURE 3.8. THE TRI PHASIC SEQUENCE CHARACTERISING GROWTH 
OF THE POXBl/2 HYBRIDOMA IN STIRRRED BATCH CULTURE.
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3.4.2 THE EXPRESSION OF GS IN POXBl/2 HYBRIDOMAS.
In the previous section apparent phases of glutamine production and ammonia utilisation 
were observed during the culture profile. Glutamine is synthesised in cells from ammonia 
and glutamic acid by the enzyme glutamine synthetase (chapter 1).
The expression of glutamine synthetase (GS) in PQXBl/2 hybridomas during batch culture 
was investigated. Cells were cultivated in a 10 litre capacity stirred tank fermenter as 
previously outlined (section 3.4.1). Cell number and viability were evaluated every 6 
hours and samples for glutamine, ammonia, and antibody determination were taken 
simultaneously and stored at -20°C for later analysis. Additional samples were taken and 
processed immediately for GS enzyme assays and RNA extraction.
The growth curve is shown in Figure 3.9, a maximum cell density of 9 x 10* cells per 
ml was obtained after 75 hours. In comparison to the previous batch culture there was 
an extended lag phase. Specific growth rates were calculated as before and a single peak 
was observed which spanned 15 to 75 hours with a maximum specific growth rate of 
0.051h*'. A low antibody titre of 14 ug/ml was obtained.
Glutamine was found to be completely exhausted from the culture medium after 80 hours 
which was consistent with the termination of cell growth (Figure 3.10). Glutamine 
production rates were calculated and a major peak observed at 50 hours, which 
corresponded to a rise in the concentration of glutamine in the culture medium. Three 
peaks in glutamine utilisation occured at 15, 70, and 90 hours.
There was an overall rise in ammonia levels in the culture medium with maximum 
concentrations occurring when the glutamine had been completely utilised (Figure 3.11). 
Continuous calculation of volumetric ammonia ^utilisation rate indicated a single peak at 
50 hours. Three peaks in ammonia production were found at 1, 30, and 70 hours from 
derived data.
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Figure 3.9 Growth curve for POXBl/2 hybridomas 
in stirred batch culture.
Viable
Cells
Wo') U(h-')
10.0 5.9E-2
9.0 5.3E-2
4.7E-2
7.0 4.1E-2
6.0 3.5E-2
5.0 2.9E-2
4.0 2.3E-2
3.0 1.7E-2
2.0 l.lE-2
5.9E-3
hours
KEY.
9 #  = Viable cells
GS specific activity was assayed and two peaks of activity were found after 15 and 80 
hours (Figure 3.12). These corresponded to observed peaks in glutamine utilisation rates. 
The periods of GS activity occurred prior to and after the ammonia assimilation phase. 
Consequently, it does not appear that ammonia is assimilated directly into glutamine by 
GS. Using cubic splines the derivative of the GS specific activity was used to determine 
enzyme production rates (Figure 3.13). Two peaks were observed at 1 and 70 hours. 
Between 10 and 55 hours and after 80 hours there was no apparent synthesis of the 
enzyme.
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Figure 3.10 Changes in glutamine (Gin) concentration 
and rate of change (^dQXnldO,
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Figure 3.11 Changes in ammonia concentration
and rate of change.
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Figure 3.12 Phases of glutamine synthetase (GS) specific 
activity and ammonia utilisation.
Specific
Activity
(Aimol/min/lO^cells )
Rate of 
ammonia 
utilisation 
(mM/h)
6.0 -  lE-3
J9E-45.4^ 
4.2 !_ 
3.6 L
8E-4
■6E-43.6 L 
3.0 L
J4E-42.4 L
j3E-4
0.61
100
hours
§*GS specific activity tNHt utilisation rate
Figure 3.13 Glutamine synthetase specific activity and 
production rates.
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Cytoplasmic RNA was extracted from the culture until the cessation in cell growth and 
hybridized with a radioactive DNA probe specific for the GS-gene. The probe consisted 
of a 2Kb Bgl 2 to Hind 3 endonuclease restriction fragment of GS-cDNA from plasmid 
pSV2GS. The nucleotide sequence of GS-cDNA and a restriction map of pSV2GS are 
shown in appendix 3. The results of the hybridization are shown in Plate 3.1. GS- 
mRNA was found to be transcribed during two periods of the batch culture, the first 
period of transcription spanned 0 to 10 hours and the second 50 to 80 hours. This 
corresponded to the observed peaks in enzyme production rates which is illustrated in 
Figure 3.14). Two additional RNA samples were included in the hybridization studies to 
act as controls for the detection of GS. Both samples were extracted from cell lines 
which were known to transcribe the GS gene (CHO KGSB and PQXB1/2-EX2).
To quantitate the observed fluctuations in the levels of GS-mRNA, the RNA filter was re­
hybridized with an actin gene probe. Actin is constitutively expressed in eucaryotic cells, 
and thus can be used as a control for the loading of the same amount of RNA sample 
in each track on the gel. The probe consisted of a 2Kb mouse Wa-actin cDNA fragment 
obtained following Pst 1 restriction endonuclease digestion from plasmid 41 (Alonso et al, 
1986). The resulting autoradiograph is shown in Plate 3.1 and confirms that equal amounts 
of RNA were present in each sample. This confirms that GS-mRNA is transiently 
expressed in PQXBl/2 cells during batch culture. The autiorad ographs were scanned 
with a LKB densitometer and GS gene expression quantitated (Figure 3.15). The intensity 
of the 2.8Kb GS-mRNA signal was found to be approximately twice that of the smaller 
1.4Kb message, indicating a 1:1 ratio between the levels of the two mRNA’s.
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PLATE 3.1 LEVELS OF GS mRNA EXPRESSED BY POXBl/2 CELLS 
DURING A STIRRED BATCH CULTURE.
Kb GS Probe
4 ,4"
2,8-
1. 4"
4 .4"
2 .8"
1.4 -
f
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Actin Prot
LEGEND FOR PLATE 3.1.
RNA was extracted from PQXBl/2 hybridomas at time intervals throughout the course 
of a stirred batch culture. 25ug of sample RNA was then electrophoresed by running 
through a 1.5% formaldehyde denaturing gel, transferred to a nylon membrane, and 
hybridized with a GS-gene probe. Subsequently, the GS-probe was removed and the 
filter rehybridized with an Actin-gene probe.
Lane A. PQXB1/2-EX2 RNA (control)
Lane B. CHO KGSB RNA (control)
Lane C. PQXBl/2 RNA extracted 1 hour into the batch culture.
Lane D. PQXBl/2 RNA extracted 10 hours into the batch culture.
Lane E. PQXBl/2 RNA extracted 18 hours into the batch culture.
Lane F. PQXBl/2 RNA extracted 34 hours into the batch culture.
Lane G. PQXBl/2 RNA extracted 50 hours into the batch culture.
Lane H. PQXBl/2 RNA extracted 68 hours into the batch culture.
Lane I. PQXBl/2 RNA extracted 80 hours into the batch culture.
FIGURE 3.14 LEVELS OF GS mRNA AND ENZYME PRODUCTION
RATES WITH TIME.
A. GS mRNA transcription. (refer to legend for Plate 3,1)
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Levels GS expressed in POXBl/2 during 
a stirred batch culture
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Figure 3.15
3,4.3 INVESTIGATION OF AMMONIA ASSIMILATION,
Incorporation of N H / into intracellular metabolites was investigated by '^N-ammonia
labelling studies. PQXBl/2 cells were grown in a 14 litre capacity series 2000 LH
15n
fermenter as described earlier, except the medium was supplemented with ImM^ammonium 
chloride. Every 12 hours a 100ml sample of the culture was removed and centrifuged 
to pellet the cells (200g/10 minutes). The supernatant was collected and immediately 
freeze dried for subsequent analysis by '^N-NMR spectroscopy. This was carried out by 
Dr. K.Brindle and Peta Braddock (Oxford University, UK), and the protocol is outlined 
in appendix 5.
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Results of the '^N-labelling studies are given in Table 3.1. The cells showed incorporation 
of '^N into alanine. The concentration of labelled alanine increased with the time of 
incubation. Towards the end of the batch culture a low level of glutamic acid labelling 
was also detected.
TABLE 3.1 *^N-LABELLING IN POXBl/2 HYBRIDOMAS.
Culture
age
(hr)
Alanine
labelling
(%)
Cone.
Alanine
labelled
(uM)
Glutamic acid 
labelling 
(%)
Cone. 
Glutamic acid 
labelled 
(uM)
18 1.8 6.8
30 1.8 10.2 - -
42 2.0 13.6 - -
54 3.1 22.3 - -
66 1.7 12.7 - -
76 2.6 26.3 - -
90 5.3 33.6 1.1 1.9
Labelling of alanine indicates that ammonia is assimilated by the action of glutamate
• I
dehydrogenase (GDH). It is envisaged that GDH catalyses the conversion of alphà^ketoglutarate! 
and NH^  ^ into glutamic acid which is then transaminated via alanine transaminase
(ALT) to alanine (Figure 3.16). The increased labelling of alanine during the batch
culture presumably indicates the continuing activity of GDH. GDH activity in the culture 
has since been confirmed (M.F.Scott, pers. comm.).
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*GDH is a reversible enzyme which may either act as mentioned above by salvaging ammonia 
for amino acid synthesis. Alternatively, it can act in the reverse direction and catalyse the 
deamination of glutamic acid to alpha-ketoglutarate.
FIGURE 3.16. ASSIMILATION OF AMMOMIA fNHt) BY GLUTAMATE 
DEHYDROGENASE (GDH) AND ALANINE TRANSAMINASE (ALT).
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3.4.4 THE ENERGY CHARGE STATUS OF PQXBI/2 CELLS.
All organisms require a source of energy to synthesise cell material for growth, product 
formation, and for 'maintenance'. An assessment was made of the energy charge status 
of PQXBl/2 hybridomas over the duration of a batch culture. This was achieved by 
determining the levels of ATP, ADP, and AMP occurring in both the cells and the culture 
supernatant. These were related to cell growth and productivity, and used to calculate 
cellular energy charge ratios (EC).
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Cells were grown in a 10 litre capacity LH series 2000 stirred tank fermenter as 
previously outlined. Cell number and viability were evaluated every 6 hours and samples 
for antibody determination stored at -20°C for later analysis. Additional samples were 
taken for ATP, ADP, and AMP determinations. Nucleotide extraction was performed 
immediately from both the cells and culture supernatant, and stored at -20°C for subsequent 
assay (section 2.2).
The growth curve for the batch culture and antibody production rates are shown in Figure 
3.17. A maximum cell density of 11 x 1(P cells per ml was obtained after 60 hours with 
a cell viability of 94%. Specific growth rates were calculated and found to be maximum 
at around 50 hours with a mean specific growth rate of 0.041h '. An antibody titre of 
12ug/ml was obtained. Determination of antibody production rates revealed a maximum 
peak occurring at 44 hours.
Figure 3.17 Growth curve and Antibodv (MAh') production 
rates (dM.AhIdf).
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Cellular ATP levels were assayed and found to fluctuate with two peaks in ATP occurring 
at 30 and 56 hours (Figure 3. IS). After the first peak there was a rapid decline in ATP 
which coincided with onset of the main growth phase and the observed period of maximum 
antibody production. The second decrease in ATP after 56 hours corresponded to the 
cessation of cell growth. Biosynthesis of antibody was found, therefore, to decrease the 
cells ATP accumulation rate significantly, despite low antibody titres. ATP production rate 
only recovered when the rate of antibody accumulation dropped.
Figure 3.18 Changes in the concentration of ATP in the 
cells and rate of change (dkTŸldO.
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Cummulative levels of ADP and AMP found in the cells during the batch culture are 
shown in Figure 3.l9. Up to 24 hours levels of both nucleotides were neglible. There 
was then a rapid increase with a plateau concentration occuring after 40 hours. This 
corresponded to the onset of cell growth and later to antibody synthesis. ADP and AMP 
levels dropped after 70 hours portraying the decline in cell viability.
Figure 3.19 Changes in the concentration of ADP and AMP 
in POXBl/2 cell in stirred batch culture.
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The energy charge (EC) status of the cells was calculated from the data obtained after 
assaying the levels of ATP, ADP and AMP in the cells. Initially the cells had an EC 
ratio of 1 which then gradual declined as the culture progressed (Figure 3.20). The 
relationship between the cells energy charge status, specific growth-rate, and antibody 
production was investigated. A time trajectory plot was constructed in which specific 
growth-rate is plotted on the X axis and energy charge ratio on the Y axis (Figure 3.21). 
From the plot, as the culture progressed the energy charge ratio was found to reach a 
particular value (0.59) when antibody production commenced. Antibody production 
continued until the energy charge dropped below a certain ratio (0.38). Such observations 
were found to be entirely reproducible.
Figure 3.20 Change in the enersy charge in POXBl/2 cells.
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FIGURE 3 .2 1  Time trajectory plots showing variation 
of energy charge with specific ^ow th rate.
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3.4.5 THE energy charge OF POXBI/2 CELLS IN SERUM FREE MEDIUM.
section
Antibody production in PQXBl/2 hybridomas was found in the previous'^to occur when 
the energy charge status of the cell was in a specific domain. Investigations were carried 
out to determine whether this observation was consistent when the cells were grown in 
serum free medium.
115
PQXBl/2 cells adapted to serum independence were grown as previously described but 
serum free medium was used (chapter 2). Cell number and viability were evaluated at 
6-hourly intervals throughout the batch culture and samples for antibody determination 
stored at -2(PC for later analysis. Additional samples were taken for ATP, ADP, and 
AMP determinations. Nucleotide extraction was performed immediately from both the cells 
and culture supernatant, and stored at -20°C for subsequent assay.
Cells reached a maximum density at 80 hours of 7.5 x 10* per ml with a viability of 
88% (Figure 3.22). A prolonged growth curve due to an extended lag phase was notable. 
Specific growth rates were calculated and found to peak at 60 hours with a mean specific 
growth rate of 0.02h ‘. An antibody titre of 60ug/ml was obtained, and the maximum 
antibody production rates were observed at 80 hours (Figure 3.23). Antibody production 
was apparently growth dissociated which is consistent with data from cells grown in the 
presence of serum (section 3.4.1).
ATP levels in the cells were determined and a major rise in ATP was observed after 48 
hours prior to the onset of the main growth phase (Figure 3.23). Levels rapidly declined 
after 65 hours which corresponded to the antibody production phase. ATP production 
rates were calculated and a major peak occured at 50 hours, which coincided with the 
start of the main antibody production phase. This trend is consistent with data from 
serum dependent cells.
An initial energy charge (EC) ratio of 0.9 was calculated and the EC ratio subsequently 
declined as the culture progressed, an observation also made in serum dependent cultures. 
Time trajectory plots were constructed to investigate the relationship between the cells 
energy charge status, specific growth-rate, and antibody production. Antibody was found 
to be produced when the EC ratio was between 0.38 and 0.59 which is consistent with 
data obtained from serum dependent cells (Figure 3.24).
116
Figure 3.22 Growth curve for POXBl/2 hybridomas in 
serum-free media during stirred hatch culture.
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Figure 3.23 Changes in ATP concentration in relation to 
antibodv (MAh) production rates (dbAkhldù.
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FIGURE 3»24 Time trajectory plots showing variation 
of eneryy charge with specific growth rate in 
serum-containing and serum-free media.
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3.5 DISCUSSION.
Data presented in this chapter have shown that PQXBl/2 hybridoma cells exhibit 
"Microbial type" growth characteristics during batch culture with three main growth phases 
occurring, consistent with; lag phase, exponential growth phase, and decline phase. Similar 
kinetics have been observed by other authors (Hayter, 1989; Glacken et al.y 1986). 
Maximum cell densities approaching 10^  cells per ml were obtained which is consistent 
with previous cell yields found in stirred batch cultures (Boraston et al. y 1984; Reuveny 
et al.y 1985). However, it has been shown that cell numbers can be greatly increased 
in batch culture by substrate feeding and medium optimisation (Rhodes and Birch, 1988).
Studies on the metabolism of PQXBl/2 cells found that glutamine was consumed during 
the culture at a high rate and was exhausted at the point at which cell growth ceased, 
implying that glutamine was an essential nutrient for hybridoma proliferation. Other studies 
on amino acid utilisation by hybridomas have also found that growth is accompanied by 
the rapid utilisation of glutamine (Miller et al. y 1989b; Seaver et al. y 1984). Glucose was 
not fully utilised by the hybridoma under the conditions described. The cessation in 
glucose utilisation in this investigation coincided with the exhaustion of glutamine and 
termination of growth.
Throughout the culture the uptake of glucose and glutamine were paralleled by the 
accumulation of lactate and ammonia respectively. Lactate accumulation followed glucose 
utilisation very closely with 1.5 moles of lactate formed for each mole of glucose 
consumed. Proliferating cells, including hybridomas, characteristically show a rapid
conversion of glucose to lactate (Adamson et al.y 1983; Low and Harbour, 1985b). 
Likewise the rise in ammonia levels corresponded with a decline in glutamine concentration 
indicating that glutamine catabolism is the principle pathway leading to ammonia 
production. Both lactate and ammonia are known to be toxic to cells at high
concentrations (Butler, 1985; Glacken, 1988; Paul, 1965). Previous studies with a related 
murine hybridoma have shown that the cumulative levels of ammonia and lactate which 
occurred during the culture were not cytotoxic (Thorpe, 1989).
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The use of partial cubic spline interpolation has revealed peaks and troughs in the 
accumulation rates of biomass, antibody, glutamine and ammonia. These suggest that there 
is a three phase culture profile characterising growth and antibody production in the 
PQXBl/2 cell line which has been summarised in Figure 3.8. During phase 1 growth 
rate is neglible and there are peaks in glutamine assimilation and ammonia production. 
Phase 2 is characterised by maximum specific growth rate, glutamine production and 
ammonia disappearance, and phase 3 by the cessation of growth, maximum period of 
antibody production and further peaks in anunonia and glutamine assimilation rates. 
Unfortunately there is a paucity of similar studies in the literature with which to compare 
these data.
Antibody was found to be continuously produced during cell growth but there was a 
notable increase in the specific production rate during the decline phase of the culture, 
which is consistent with antibody production being non-growth rate associated. Several 
authors have found similar production kinetics in hybridomas (Birch et al. y 1987; Emery 
et al.y 1987; Reuvny et al.y 1987). Emery et al. (1987) have presented data which 
showed increased intracellular antibody concentrations during the latter phase of the culture. 
From this they infer that the increase in the apparent production rate was due to the 
release of accumulated intracellular antibody from dying cells. However in a similar
investigation, Birch et al. (1987) failed to detect an accumulation of antibody during the 
decline phase, and they concluded that the specific antibody production rate increased
during the decline phase. Antibody production kinetics have since been found to be linked
to the integral of the viable cell growth curve which indicates that the antibody production 
during the decline phase is secreted by the viable population and not released from dying 
cells (Renard et al.y 1988).
During the culture profile, phases of glutamine and ammonia uptake and disappearance 
were observed. Maximum glutamine utilisation occurred prior to both the onset of the 
growth phase and maximum antibody production phase, which is consistent with glutamine 
acting as a key energy substrate. Levels of glutamine synthetase (GS) activity and
associated mRNA production were found to be transiently expressed, adding corroborative
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evidence that the cell’s metabolism is influenced according to the culture enviroment at the 
level of transcription. Transcription of GS was found to cease during the main growth 
phase. It has been reported that GS is inhibited by the presence of glutamine in the 
medium, with glutamine depletion causing the enzyme to assume a more stable 
configuration, resulting in increased enzyme activity (Smith et al. y 1984; Tiemeier and 
Milman 1972). The increase in GS activity observed in this investigation during the latter 
phase of the culture when glutamine is depleted is consistent with this. However, the 
enzyme was also detected initially in the culture when the glutamine concentration was 
high. A plausible explanation for this discrepancy is that GS production responds to 
intracellular glutamine depletion. This is evident from the data since GS production rate 
corresponded to the phases of glutamine utilisation by the cell.
Variations in levels of GS-mRNA, and the accompanied enzyme activities, with time have 
also been observed in neural tissues (Magnuson and Young, 1988). It is of note that 
glutamine was present in the culture medium. The regulation of mRNA turnover is 
known to play a significant role in the overall control of gene expression and hence 
metabolism (reviewed by Cosman, 1987). Shaw and Karmen (1986) have identified AT- 
rich sequences which appear to confer instability upon a mRNA molecule under certain 
physiological circumstances. The occurrence of these sequences in GS-mRNA was not 
found to be significant. Among eucaryotes mRNA life expectancy can vary from minutes 
to days. mRNA with a short half-life enables a burst of new protein synthesis in 
response to external or internal stimuli. Unfortunately the half life of GS-mRNA has not 
yet been determined.
Ammonia was shown to be metabolised by the cells during culture by the incorporation 
of NH^  ^ into alanine. This observation was unexpected since ammonia is regarded as a 
toxic metabolite and not as a substrate (Butler, 1985; Glacken, 1988; Reuveny et al.y 
1986). These results are consistent with glutamate dehydrogenase (GDH) catalysing the 
synthesis of glutamic acid from ammonia and alpha-ketoglutarate with subsequent 
transamination to alanine. GDH is a reversible enzyme which acts either as described by
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"salvaging" ammonia to use in the synthesis of amino acids, or by the deamination of 
glutamic acid.
GDH
alpha-Ketoglutanate + NADPH Glutamic add + NADHP^
+ H+ + + H3O
During glycolysis, glutamic acid is converted to alpha-ketoglutamate either by the action 
of GDH or by aspartate aminotransaminases, leading to the production of alanine and 
aspartate respectively. The conversion of glutamic acid to alpha-ketoglutarate by GDH, 
and the consequent production of alanine, has been found during other studies (K. Brindle, 
pers. comm.. Miller et al., 1987). However, Ardawi and Newsholme (1982) have 
reported that in lymphocytes aspartate aminotransaminases are responsible for the conversion 
of glutamic acid to alpha-ketoglutarate and that aspartate, not alanine, is the primary amino 
acid produced. These apparently contradictory findings could be explained by taking into 
account the physiological status of the cells - which has been shown to influence the 
pathway through which carbon is directed during glutaminolysis (Glacken, 1988).
Levels of ATP in the cells were found to decline rapidly during the main biosynthetic 
phase of the culture, indicating that the demand for ATP by energy requiring reactions 
exceeded the rate of cell respiration. To further these studies it would be interesting to 
determine the NAD-NADH ratio. An increase in specific ATP production rate was 
observed to precede the increase in biosynthetic activity. These data are consistent with 
that of Miller and co-workers (1989a) who detected an increase in specific ATP production 
prior to the onset of the maximum specific growth and production phase during the growth 
of hybridoma cells in continuous culture using glucose pulse and step changes. They also 
found that the levels of ATP and the ATP specific production rates were affected by the 
concentration of available substrates.
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A further finding in this investigation was the relationship between the energy charge status 
of the cell, the specific growth rate, and productivity. Antibody production was observed 
to occur when the energy charge was in a particular domain, indicating that a minimum 
energy charge level is needed to support biosynthesis of antibody, but that antibody 
production is inhibited at high energy charge levels. It can be inferred from this that the 
energy charge of the cell, or factors affecting this, plays an important role in the 
regulation of antibody synthesis. More detailed studies are required in order to elucidate 
the mechanisms involved. However, Crueger and Crueger (1982) have reported that the 
relative concentrations of ATP, ADP and AMP (and hence the energy charge ratio) in the 
cell regulate enzyme activity.
In addition to its role as an indicator of metabolic regulation energy charge was found to 
portray the physiological status of the cells during batch culture. Theoretically if the total 
adenine nucleotide pool is fully phosphorylated to ATP the cells will have an energy 
charge ratio of 1, and if the phosphorylated adenine pool is "empty" and only AMP is 
present the energy charge ratio will be 0. Initially cells in batch culture had an EC of 
1 to 0.9, indicating that the adenylate system was almost completely phosphorylated. As 
the culture progressed the energy charge gradually decreased indicating that energy 
requiring cell activities were occurring at a greater rate than the regeneration of ATP from 
ADP by oxidative phosphorylation. Later in the culture as substrate became limiting and 
cell viability decreased, resulting in an increase in AMP, the energy charge declined 
further. Similar trends in energy charge have been observed during batch culture 
(M.Butler, pers. comm.). Ryll (1990) investigated the energy charge status of hybridomas 
during continuous culture in which substrate levels and conditions were maintained optimal 
for growth. Under these conditions the energy charge was found to remain constant, 
which provides evidence that energy charge is affected by the cell’s enviroment and reflects 
the physiological status of the cell.
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CHAPTER 4.
ADAPTATION OF POXBl/2 CELLS TO GLUTAMINE FREE MEDIA.
4.1 SUMMARY.
The ability of the PQXBl/2 hybridoma to adapt and grow in glutamine-free media was 
assessed. The cell-line was found to be incapable of adaptation to grow in the absence 
of glutamine in the culture media. Glutamic acid was not able to replace glutamine 
in the media.
Two variant hybridomas growing in glutamine limited media (G-DMEM containing
0.5mM glutamine), either in the presence or absence of 4mM glutamic acid, were 
obtained. The cells were found to; (i) have uncharacteristically low specific growth 
rates, (ii) attain low population densities, and (iii) secrete neglible antibody. This latter 
trait was apparently a consequence of low antibody producing cell-lines having been 
selected during the adaptation process.
Levels of glutamine synthetase (GS)-mRNA and the accompanied GS enzyme activities 
were shown to be elevated in the variant cell-lines, and there was amplification of the 
GS-gene. The levels of GS expressed, however, were insufficient to enable the 
synthesis of adequate amounts of endogenous glutamine by the PQXBl/2 hybridomas 
for its metabolic requirements.
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4.2 INTRODUCTION.
Many lymphoid derived cell-lines such as myelomas and hybridomas, have been found 
to be incapable of growth in vitro in media lacking glutamine (Ardawi and Newsholme, 
1982; Bebbington and Yarranton, 1989). In the preceding chapter it was established 
that the PQXBl/2 hybridoma required exogenous glutamine in the media for growth.
Cells can synthesise endogenous glutamine by the enzyme glutamine synthetase (GS) 
from glutamic acid and ammonia (see section 1.8) according to the equation:
GS
GLUTAMIC ACID 4- AMMONIA 4- ATP GLUTAMINE 4- ADP 4- Pi
Glutamine synthetase is believed to be a universal enzyme found in all cells (Meister, 
1985), and its presence in the PQXBl/2 hybridoma has been shown (chapter 3). 
Consequently, increasing the levels of GS in the cell should establish variant cell-lines 
capable of synthesising sufficient glutamine to enable their cultivation in glutamine-free 
media.
The presence of glutamine in cell culture media is undesirable since it is unstable and 
prone to chemical decomposition (Tritsch and Moore, 1962) and to be degraded by 
serum-derived enzymes (Wein and Goetz, 1973) which release free ammonia which is 
cytotoxic (Butler, 1985; Glacken, 1988). However, the culture media currently in use 
are the same as, or modifications of, the original formulation based on the composition 
of plasma reported by Eagle (1959), and contain glutamine at the relatively high 
concentrations of 2 to 4mM. Hence media may only be kept for a limit ed time 
period at 37°C as the daily spontaneous decomposition rate of glutamine amounts to 
2 to 3%. This is affected though by the pH and serum concentration (Lin and 
Agrawl, 1988; Zielke et al., 1987). The rapid metabolism of glutamine by cells via 
glycolysis also results in the accumulation of ammonia. Reports have linked high 
concentrations of ammonia with growth inhibition (Butler, 1985; Glacken, 1988; 
Reuveny et at., 1986), and to-date there is no effective method of removing ammonia
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in situ from the culture medium, unless a perfusion system is employed. The growth, 
therefore, of cells in non-glutamine containing media provides a number of potential 
advantages.
During Eagle’s early studies on essential medium components, he described unsuccessful 
attempts to substitute glutamine with either glutamic acid or 2-oxoglutarate for growth 
of both HeLa and mouse fibroblast cell-lines (1955). However, in a later study he 
reported the successful use of high concentrations (20mM) of glutamic acid as a 
substitute for glutamine for several unspecified cell-lines (Eagle, 1959). Growth was 
found to be permitted due to the cells increasing the levels of cellular GS activity. 
Griffiths and Pirt (1967) further developed a protocol by which human diploid cells 
could be grown in a medium without added glutamine. The basis of this protocol was 
to transfer cells to a medium containing a high concentration (20mM) of glutamic acid, 
which was then gradually reduced in concentration at subsequent cell passages. A 
similar approach has since been employed to adapt BHK 21, McCoy and HeLa cells 
to grow in non-ammoniagenic media (Hassell and Butler, 1989).
During the adaptation of cells into glutamine-free media a number of physiological 
changes have been observed, including; higher population densities*, alterations in cell 
size and protein content; morphological changes of fibroblastic cell growth to epithelial- 
like growth; increased metabolic activity; increased levels of GS; altered glucose 
consumption and accompanying lactate accumulation (DeMars, 1958; Griffiths and Pirt, 
1967; Hassell and Butler, 1989). Different cell-lines have also been found to have 
varying abilities to adapt to glutamine free-media (Hassell and Butler, 1989). This may 
be a reflection of differences in the abilities of cells to transport glutamic acid across 
cell membranes. It has been found that the uptake rates into the cell for glutamic acid 
are lower than the corresponding rates for glutamine, glutamic acid crossing the cell 
membrane less readily (reviewed by Christensen, 1990). When mouse fibroblasts are 
incubated in a buffer containing 0.7mM '^N-glutamine and no glutamic acid, the 
intracellular '^N-glutamine concentration reaches a plateau of 80% within 20 minutes. 
In contrast, intracellular '^N-glutamic acid rose only to only 40% after 4 hours in the 
same buffer, but containing 0.5mM pure ‘^ N-glutamic acid and no glutamine.
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Changes in the behaviour of a population of cells can arise either through adaptation
of the phenotype, or through the appearance of, or overgrowth by, cells with an
altered genotype. The mechanism by which cultured cells can be adapted to grow in 
glutamine-free media can involve either or both of these changes:
1. Phenotypic adaptation can be exemplified by the induction of enzymes to utilize
an alternative substrate once the preferred substrate has become depleted. These
adaptive changes tend to be both rapid and reversible. The adaptation of mammalian 
cells to grow on glutamic acid in place of glutamine, as a result of an increase in the 
activity of GS, is a consequence of a phenotypic change (DeMars, 1955; Griffiths, 
1973).
2. Alterations of the cell’s genotype arise through mutation (including reversion of a 
defective gene to functional status) and is a "chance" event. The proportion of cells 
within the population carrying the mutation will initially be very small. Selection, 
therefore, for a population that predomina tely contains the mutation will be a slow 
process, unless the mutation confers some advantage over the remaining cells. 
However, the changes that have occurred are not readily reversible. When cells are 
grown in the presence of certain toxic chemicals at sub-lethal concentrations variant 
clones can arise with an increased resistance to that drug. This may be due to the 
overproduction of an essential enzyme whose activity the drug inhibits. It has been 
found that this involves a genotypic change, and is a result of an increase in the copy 
number of the enzymes structural gene (ie "gene amplification"), and the accompanied 
elevation in the levels of its particular mRNA (Stark and Wahl, 1984). Subsequent 
rounds of selection of variant clones in progressively increasing concentrations of the 
drug leads to further amplification of the gene, paralleled by an augmented resistance 
to the drug. "Promoter-up" mutations may also occur, or mutant enzymes can be 
produced which have an increased resistance to a toxic drug or chemical. Simonsen 
and Levinson (1983) isolated a mutant dihydrofolate reductase (DHFR) with an 
abnormally low affinity for MTX. Analysis of the nucleotide sequence of the cDNA 
of this enzyme showed that it differed from the wild-type DHFR at a single amino 
acid site, in which an arginine residue was substituted by a leucine residue, in a 
region of the polypeptide thought to form a hydrophobic pocket essential for inhibitor 
binding.
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Gene amplification has become an established mechanism for bringing about desired 
genotypic alterations in cells, and has been exploited to enable the overproduction of 
certain proteins in mammalian cells (reviewed by Schimke, 1984 and Stark and Wahl, 
1984). The dihydrofolate reductase (DHFR) gene was the first gene found to 
"amplify" in this way in mutant mouse and hamster cell lines following selection for 
resistance to the specific inhibitor of DHFR, methotrexate [MTX] (Stark and Wahl, 
1984). Subsequently, at least twelve genes have been shown to be amplifiable when 
selected with a specific inhibitor (Schimke, 1984). Mutant CHO cells and mouse 3T6 
cells containing amplified levels of the GS-gene have also been obtained following 
selection with the GS inhibitor methionine sulphoxamine (Msx) in glutamine-free media 
(Bebbington and Hentschel, 1987; Sanders and Wilson, 1984; Young and Ringold,
1983). A review by Bebbington and Hentschel (1987) has reported that both genomic 
DNA sequences encoding certain enzymes, and their cDNAs, are amplifiable when 
transferred into mammalian cells in appropriate vectors. A number of amplifiable genes 
which have been over expressed in mammalian cells are shown in below Table 4.1.
TABLE 4.1. AMPLIFIABLE GENES EXPRESSED IN MAMMALIAN CELLS.
GENE SELECTIVE AGENT
Adenosine deaminase (ADA) Deoxycoformycin (dCF)
Dihydrofolate reductase (DHFR) Methotrexate (MTX)
Glutamine synthetase (GS) Methionine
sulphoxamine
(Msx)
Metallothionein-I (MT-1) Heavy metals eg Cd^ ^
Multi-drug resistance (mdr) Adriamycin (ADM)
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The mechanism of gene amplification is not fully understood. One proposal is that 
"there is uncontrolled replication at a single initiation site within the gene sequence 
which generates an onion skin structure containing multiple repeats" (Botchan et al., 
1980; Roberts et al., 1983). An alternative model which has been put forward 
involves the production of an inverted duplication in the DNA sequence, followed by 
recombination across the duplication, to generate a molecule with two replication forks 
moving in the same direction (Passanati et al., 1987). This is analogous to the 
mechanism of replication proposed to occur in the 2um circle in yeasts, and is 
supported by the observation that many amplified sequences in mammalian cells are 
flanked by inverted duplications. Consistent with both of these theories is a general 
feature of gene amplification in that the region of chromosomal DNA amplified is much 
greater than the enzymes coding sequence. Frequently more than 1000Kb of DNA 
have been found to be amplified. Consequently, when an amplifiable gene is 
transfected into a cell and selected for by amplification, other nearby sequences are also 
"co-amplified". Using selection for either MTX or Msx resistance due to DHFR or 
GS gene amplification as part of an expression vector system, desired proteins located 
adjacent to the amplifiable gene have been attained at high levels by their co­
amplification. Examples of pharmaceutically important proteins which have been 
amplified in this way include the Hepatitis B surface antigen (HBsAg), tissue 
plasminogen activator (tPA), human chimeric B.6 IgG, c-myc, and CD4 IgG 
(Bebbington and Hentschel, 1985b; Dorai and Moore, 1987; Kaufman et al., 1985; 
Warum et al., 1986 and 1990).
In this chapter work was carried out to determine the ability of the PQXBl/2 
hybridoma to adapt to grow in glutamine-free media, and then to investigate the 
consequence of this on the cell’s physiology and metabolism.
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4.3 MATERIALS AND METHODS.
Details of the materials and methods employed are outlined in chapter 2. Any 
modifications made are described where relevant in the text.
4.4 EXPERIMENTAL RESULTS.
4.4.1 ADAPTATION OF CELLS TO GROW WITHOUT GLUTAMINE.
The adaptation of cells to growth in glutamine free media was investigated. Two
approaches were used: (i) adaptation by weaning, and (ii) adaptation by selection. In
the first method, cells were cultured in tissue culture flasks and the concentration of
glutamine in the medium decreased in a stepwise manner over a 6-week period.
Samples were taken at regular intervals to assess cell number and viability. In the
a t 2 x107ml
second approach, the cells were directly transferred into media containing varying levels 
of glutamine ranging from 0 to 2mM, in 24-well Costar plates. The cells were 
incubated until growth was visible, or for up to 6 weeks.
Two media were employed for the above investigations, RPMI-1640 and G-DMEM, 
both of which contained 10% (v/v) dialysed foetal calf serum (dFCS). Serum contains 
low levels of glutamine which is effectively removed by dialysis. RPMI-1640 was the 
routine culture medium used for the growth of PQXBl/2 hybridomas. G-DMEM is 
a "richer" growth medium consisting of DMEM supplemented with non-essential amino- 
acids (NEAA), nucleotides, and sodium pyruvate. The supplements were added to 
compensate for the absence of glutamine, since glutamine serves as a carbon source 
for the synthesis of non-essential amino acids, and also as an amino group donor in 
the synthesis of non-essential amino acids and nucleotides.
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The results of the weaning experiments are summarised in Figure 4.1, and the selection 
experiments in Table 4.2. PQXBl/2 hybridomas were found to be completely incapable 
of growth in either G-DMEM or RPMI-1640 unless a minimal level of glutamine was 
present. Reduction in the glutamine concentration resulted in a decline in cell viability, 
with a notable decrease occuring below 0.8mM glutamine. In RPMI-1640 media a 
minimal concentration of 0.5mM glutamine was found to be essential to support 
growth, and in G-DMEM media 0.4mM glutamine. Similar results were obtained for 
both the weaning and ihQ selection strategy. A cell-line growing in G-DMEM 
containing O.SmM glutamine was expanded for further investigations, this was referred 
to as "PQXB-EX2".
FIGURE 4.1 : SURVIVAL OF PQXBl/2 CELLS IN 
----------------  DIFFERENT GLUTAMDÎE CONCENTRATIONS
o G-DMEM C ulture m ed ium  
.  RPMl 1640 C ultu re  m ed ium
100
8 0 -
20 -
0
0^.0 2.00 . 8  1. 2  
G lutam ine (mM)
0 .4
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TABLE 4.2 GROWTH OF POXBl/2 CELLS IN GLUTAMINE LIMITED MEDIA
CELL GROWTH
(mM) RPMI-1640 G-DMEM
2.0 + +
1.0 + 4-
0.8 + +
0.6 + +
0.5 + +
0.4 - +
0.3 - -
0.1 - -
0.0 - -
where; + = growth
- = no growth
4.4.2. SUBSTITUTING GLUTAMINE WITH GLUTAMIC ACID.
An alternative strategy to adapt cells to growth in glutamine-ffee media is to replace 
glutamine with glutamic acid. Cells were grown in tissue culture flasks in G-DMEM 
containing 10% (v/v) dFCS and 4mM glutamic acid (as the sodium salt) with various 
levels of glutamine. Cell number and viability was assessed at 12-hourly intervals and 
used to construct growth curves (Figures 4.2 to 4.5). Characteristic growth profiles 
were obtained in the glutamic acid containing media in the presence of glutamine, but 
the cells failed to grow when the glutamine was removed altogether. A cell-line 
growing in G-DMEM containing 4mM glutamic acid and O.SmM glutamine was 
expanded for further investigations, this was referred to as "PQXB-EX3".
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Glutamine has been reported to be successfully substituted with glutamic acid by 
transferring cells directly into media containing a high concentration (20mM) of 
glutamic acid, which is then gradually reduced over several generations (Griffiths and 
Pirt, 1967; Paul and Fottrell, 1963). This approach was investigated with PQXBl/2 
cells but growth was not attained (Figures 4.6 and 4.7). The resulting effects 
observed, from these adaptation studies, on the cell’s maximum specific growth rates 
(um), maximum population densities, and generation doubling times (td) are summarised 
in Table 4.3. The results clearly demonstrate that the hybridoma would not grow in 
glutamic acid containing media unless glutamine was also added.
TABLE 4.3. GROWTH OF POXB CELLS IN VARIOUS MEDIA.
MEDIA UM
(h->)
MAXIMUM 
POPULATION 
DENSITY 
(cells 10 /^ml
GENERATION 
DOUBLING 
TIME (td)
(hrs)
G-DMEM -f- 2.0mM gin 0.032 10.7 23
G-DMEM + 2.0mM gin 
+ 4.0mM glu
0.034 10.9 22
G-DMEM + O.SmM gin 
+ 4.0mM glu
0.00 6^5 61
G-DMEM + O.OmM gin 
+ 4.0mM glu
- - -
G-DMEM -f 2.0mM gin 
+ 20.0mM glu
0.033 10.6 22
G-DMEM + O.OmM gin 
+ 20.0mM glu
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Figure 4.2 Growth of POXBl/2 hvhridomas in G-DMEM
supplemented with 2mM glutamine.
Viable
cells
(10E5)
U(h-’)
11.0 u 4.1E-2
9.9 3.7E-2
8.8 3.3E-2
7.7 2.9E-2
6.6 15E-2
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1.2E-2
82E-3
4.1E-3
hours
KEY.
• • • = Viable cells
- =  y
Figure 4.3 Growth of POXBl/2 hybridomas in G-DMEM supplemented 
with 2mM glutamine and 4mM glutamic acid.
Viable
cells
(10E5)
U(h*’)
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134
Figure 4.4 Growth of POXBl/2 hybridomas in G-DMEM supplemented
with 0.5mm glutamine and 4mM glutamic acid.
Viable
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F i^ re  4.5 Growth of POXBl/2 hybridoma in G-DMEM without glutamine.
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Figure 4.6 Growth of POXBl/2 hvbridomas in G-DMEM supplemented
with 20mM glutamic acid and no glutamine.
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4.4.3 GROWTH AND ANTIBODY PRODUCTION OF POXB HYBRIDOMA^S 
CULTURED IN LOW GLUTAMINE CONTAINING MEDIA.
The growth characteristic’s and the production of antibody were investigated in PQXB 
hybridomas adapted to grow in culture media containing reduced levels of glutamine. 
The "PQXB-EX2" hybridoma was cultivated in G-DMEM containing 10% (v/v) dPCS 
and 0.5mM glutamine, and the "PQXB-EXS" variant in the same medium but also 
supplemented with 4mM glutamic acid. Cell number and viability was assessed at 12- 
hourly intervals throughout the duration of the culture, and samples stored at -20°C for 
subsequent antibody assay.
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Growth curves were constructed and the specific growth rates calculated (Table 4.4).
In comparison to analogous data obtained for the parent PQXB 1/2 hybridoma, growing 
in media (either RPMI-1640 or G-DMEM) containing 2mM glutamine, there was a 
notable reduction in both the cell population densities attained and the specific growth 
rates. Antibody production by the cells was determined by ELISA (section 2.2). The 
results revealed that the two variant hybridomas synthesised neglible levels of antibody 
in comparison to the titres obtained for PQXB 1/2 hybridomas grown in the presence 
of 2mM glutamine (Table 4.4).
The variant PQXB-EX hybridomas were transferred into G-DMEM containing 2mM 
glutamine, and cell growth and antibody production evaluated as before. The growth 
rate (um) of the "re-adapted" cells was found to return to the rate observed in the 
parent PQXBl/2 , and equivalent population densities were attained (Table 4.4). 
However, the variants still produced a neglible amount of antibody.
TABLE 4.4 SPECIFIC GROWTH-RATES AND ANTIBODY TITRES OF CELL-LINES.
CELL-LINE MEDIA CELL YIELD
(cells l(F/ml)
UM.
(h')
W b
W
"ADAPTED"
PQXBl/2 RPMI/2mM gin 10.6 0.034 5 5 0
PQXB 1/2 G-DMEM/2mM gin 11.2 0.036 45-0
PQXB-EX2 G-DMEM/0.5mM gin 4.5 0.006 2 .4
PQXB-EX3 G-DMEM/0.5mM gin 4.2 
4.0mM glu
0.007 1 .5
"RE-ADAPTED"
PQXB-EX2 G-DMEM/0.5mM gin 10.5 0.034 1.7
PQXB-EX3 G-DMEM/0.5mM gin 10.8 
4.0mM glu
0.035 2.1
where; gin = glutamine 
glu = glutamic acid
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PLATE 4.1 LEVELS OF GS mRNA IN VARIANT POXBl/2 HYBRIDOMA LINES.
1 2 3 4 5  1 2 3 4 5
Kb I ,1 I .1 I. I J I I I K
4 .4 -
2.8 -
1.4 -
- 4
- 2
* " # # # #
- 1 .
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LEGEND FOR PLATE 4.1.
25ug of sample RNA were electrophoresed through a 1.5% formaldehyde denaturing 
gel, transferred to a nylon membrane, and probed initially with a radiolabelled GS- 
gene probe. The probe was then removed and the filter subsequently re-hybridised 
with a radiolabelled Actin-gene probe, to act as a control for the loading of the same 
amount of RNA in each track.
Lane 1. RNA from PQXBl/2 hybridomas grown in RPMI +  2mM glutamine.
Lane 2. RNA from PQXBl/2 hybridomas grown in G-DMEM + 2mM 
glutamine.
Lane 3. RNA from PQXB1/2-EX2 hybridoma grown in G-DMEM + 0.5mM 
glutamine.
Lane 4. RNA from PQXB1/2-EX3 hybridoma grown in G-DMEM 4- 0.5mM 
glutamine + 4mM glutamic acid.
Lane 5. RNA from SPG2 cells grown in G-DMEM without glutamine.
4.4.4 GS EXPRESSION IN VARIANT POXB HYBRIDOMAS.
The expression of glutamine synthetase (GS) in the variant PQXB cel 1-lines was 
investigated by examining the levels of mRNA production, and the accompanied enzyme 
activity. PQXB-EX2 variants were grown in G-DMEM containing^^§nM glutamine, and 
PQXB-EX3 cells in the same medium but also supplemented with 4mM glutamic acid, 
and used for either RNA extraction or GS enzyme assays.
LEVELS OF GS mRNA.
The level of GS mRNA in the variant PQXB hybridomas was analysed by Northern 
blotting and subsequent hybridization with a labelled GS-gene probe. The extracted 
RNA was electrophoresed through a 1.5% denaturing formaldahyde gel. RNA extracted 
from SPG2 cells, which have amplified levels of the GS-gene, was included on the gel 
to act as a "positive" control for the detection of GS. The RNA samples were then 
transferred by blotting to a nylon membrane filter and hybridized with a labelled GS- 
gene probe - the probe consisting of a 12Kb Bgl 2 to Hind 3 endonuclease restriction 
fragment of GS cDNA from pSV2.GS (appendix 3).
The result(s) of hybridizing to RNA from the various cell-1 ines the GS-gene probe are 
shown in Plate 4.1. GS-mRNA was only detected in the two variant hybridomas 
growing in media containing reduced levels of glutamine, and in the SPG 2 
control cells. No GS-mRNA was detected in the PQXBl/2 hybridoma growing in 
either G-DMEM or RPMI-1640 media containing 2mM glutamine. To ensure that this 
observation was not an artefact caused by unequal quantities of sample being present 
the GS-gene probe was removed from the filter and the filter re-hybridized with a 
labelled actin-gene probe. The latter probe contained the mouse Wa-actin gene coding 
sequence on a 2kb Pst 1 endonuclease restriction fragment from plasmid p41. Results 
show that equal volumes of RNA sample were present in each track on the gel, 
confirming the original observation (Plate 4.1). To quantify the differences in the 
levels of GS-mRNA transcription the autoradiographs were scanned using a LKB 
densitometer (Figure 4.7).
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Comparison of GS mRNA levels in PQXB1/2  
variant cell lines
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Figure 4.7
KEY.
A = PQXBl/2 hybridoma grown in RPMI+ 2mM glutamine 
B = PQXBl/2 hybridoma grown in G-DMEM + 2mM glutamine 
C = PQXB1/2-EX2 hybridoma grown in G-DMEM + 0.5mM glutamine 
D = PQXB1/2-EX3 hybridoma grown in G-DMEM + 0.5mM glutamine 
4- 4mM glutamic acid 
E = SPG2 cells grown in G-DMEM without glutamine.
GS ENZYME SPECIFIC ACTIVITY.
The GS specific activity in the hybridoma cell-lines was determined using a '^C- 
radiometric assay. CHO-KGSB cell samples were included in the assay to perform as 
positive controls for the detection of GS activity, and heat inactivated samples (75°C
1 4 0
for 10 minutes) to act as negative controls. The results revealed a basal level of 
enzyme activity in the PQXBl/2 hybridoma growing in G-DMEM containing 2mM 
glutamine which was notably elevated in both the PQXB-EX variants growing in media 
containing 0.5mM glutamine. The CHO-KGSB. positive control cells growing in 
glutamine-free medium had an even greater increased level of GS specific activity 
compared to the basal activity. No activity was detected in the negative control (Table 
4.5).
TABLE 4.5 LEVELS OF GS SPECIFIC ACTIVITY IN HYBRIDOMA LINES.
CELL-LINE GS SPECIFIC ACTIVITY 
(umol/min/10^ cells)
PQXBl/2 0.11
PQXB-EX2 2.12
PQXB-EX3 1.83
CHO-KGSB (positive control) 3.21
CHO-KGSB (negative control) 0.02
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LEGEND FOR PLATE 4.2.
DNA samples were digested with either Eco R1 and Sal 1, or Bam HI,
electrophoresed through a 1% TAE agarose gel, transferred to a nylon membrane, and
probed with a radiolabelled GS-gene probe.
Lane 1. Molecular weight markers.
Lane 3. lOug DNA from PQXBl/2 cells grown in RPMI + 2mM glutamine
and digested with Eco R1 - Sal 1.
Lane 4. lOug DNA from PQXBl/2 cells grown in RPMI 4- 2mM glutamine
and digested with Bam HI.
Lane 5. lOug DNA from PQXBl/2 cells grown in G-DMEM 4- 2mM
glutamine and digested with Eco R1 - Sal 1.
Lane 6. lOug DNA from PQXBl/2 cells grown in G-DMEM 4- 2mM
glutamine and digested with Bam HI.
Lane 7. lOug DNA from PQXB1/2-EX2 cells grown in G-DMEM 4- 0.5mM
glutamine and digested with Eco R1 - Sal 1.
Lane 8. lOug DNA from PQXB1/2-EX2 cells grown in G-DMEM 4- 0.5mM
glutamine and digested with Bam HI.
Lane 9. lOug DNA from PQXB1/2-EX3 cells grown in G-DMEM 4- 0.5mM
glutamine4- 4mM glutamic acid and digested with Eco R1 - Sal 1.
Lane 10. lOug DNA from PQXB1/2-EX3 cells grown in G-DMEM 4- 0.5mM 
glutamine4- 4mM glutamic acid and digested with Bam HI.
Lane 11. lOug DNA from SPG2 cells grown in G-DMEM and digested with 
Eco R1 - Sal 1.
Lane 12. lOug DNA from SPG2 cells grown in G-DMEM and digested with 
Bam HI.
PLATE 4.2 DNA HYBRIDISATION ANALYSIS OF POXBl/2 VARIANT HYBRIDOMAS
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LEGEND FOR PLATE 4.3.
DNA samples were digested with either Eco R1 and Sal 1, or Bam HI, 
electrophoresed through a 1% TAE agarose gel.
Lane 1. Molecular weight markers.
Lane 3. lOug DNA from PQXBl/2 cells grown in RPMI +  2mM glutamine
and digested with Eco R1 - Sal 1.
Lane 4. lOug DNA from PQXBl/2 cells grown in RPMI + 2mM glutamine 
and digested with Bam HI.
Lane 5. lOug DNA from PQXBl/2 cells grown in G-DMEM + 2mM
glutamine and digested with Eco R1 - Sal 1.
Lane 6. lOug DNA from PQXBl/2 cells grown in G-DMEM 4- 2mM
glutamine and digested with Bam HI.
Lane 7. lOug DNA from PQXB1/2-EX2 cells grown in G-DMEM 4- 0.5mM 
glutamine and digested with Eco R1 - Sal 1.
Lane 8. lOug DNA from PQXB1/2-EX2 cells grown in G-DMEM 4- 0.5mM 
glutamine and digested with Bam HI.
Lane 9. lOug DNA from PQXB1/2-EX3 cells grown in G-DMEM 4- 0.5mM 
glutamine4- 4mM glutamic acid and digested with Eco R1 - Sal 1.
Lane 10. lOug DNA from PQXB1/2-EX3 cells grown in G-DMEM 4- O.SmM 
glutamine4- 4mM glutamic acid and digested with Bam HI.
Lane 11. lOug DNA from SPG2 cells grown in G-DMEM and digested with 
Eco R1 - Sal 1.
Lane 12. lOug DNA from SPG2 cells grown in G-DMEM and digested with 
Bam HI.
PLATE 4.3 DIGESTED GENOMIC DNA FROM POXBl/2 VARIANT HYBRIDOMAS 
PRIOR TO SOUTHERN HYBRIDISATION A N A T .Y S T S
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4.4.5. DNA HYBRIDISATION ANALYSIS.
In order to assertain if gene amplification was involved in raising GS levels in the 
variant PQXB hybridomas the GS-gene copy number was investigated using Southern 
blotting and subsequent hybridization with a labelled GS-gene probe. The cell-lines 
were grown in media as described previously, and the total genomic DNA extracted 
from the cells. DNA samples were digested to completion with endonucleases; either 
an Eco R1 and Sal 1 double digest, or a Bam HI digest, and lOug samples were 
electrophoresed through a 1% TAE agarose gel. The DNA was transferred to a nylon
membrane filter using the Southern blotting procedure, and the filter hybridized with 
a GS-gene probe. The probe was obtained from pSV2.GS as previously described.
The Southern blot hybridization analysis is shown in Plate 4.2. The DNA probe was 
found to cross-hybridize with the endogenous mouse GS-gene in the PQXBl/2 derived 
cell-lines. All of the PQXBl/2 cells gave the same DNA restriction map with the 
three restriction enzymes used. Eco R1 - Sal 1 double digests yielded 7 fragments 
(6.5, 4.0, 2.5, 2.0, 1.3, 0.9 and 0,7 Kb) and Bam HI digestion yielded 3 
fragments (6.5, 4.1 and 3.6 Kb). A photograph of the DNA gel prior to transfer by 
Southern blotting is shown in Plate 4.3, and indicates that, as far as one can visibly 
tell, the DNA was completely digested. A similar pattern of restriction fragments was 
found in subsequent hybridization experiments.
In both the variant PQXB1/2-EX2 and PQXB1/2-EX3 cell-lines a number of the 
restriction fragments were found to be amplified, inparticular the 4.0, 2.5, 2.0 and 0.9 
Kb Eco R1 - Sal ,1 restriction fragments, and the 4.1 and 3.6 Kb Bam HI restriction 
fragments. This apparent GS gene amplification is consistent with the previous data 
which found increased levels of GS-mRNA production, and accompanying enzyme 
activities, in the variant PQXB 1/2-EX cell-lines.
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4.5. DISCUSSION.
In the proceeding chapter the importance of glutamine in the culture medium for the 
growth of PQXBl/2 cells was established, since it was shown to be a key metabolite, 
and exhaustion from the culture coincided with the cessation of growth. An assessment 
has now been made of the ability of the PQXBl/2 hybridoma to adapt and to grow 
in culture medium containing no glutamine. Glutamine is normally essential for the 
growth of lymphocyte related cell lines (Ardawi and Newsholme, 1982).
Two experimental approaches were described. Then first of these involved growing 
the cells in culture media containing progressively lower concentrations of glutamine, 
and the second replacing glutamine with glutamic acid. To facilitate the adaptation of 
cells during these experiments a medium composition was used which partly 
compensated for the absence/limitation of glutamine. Glutamine serves as a carbon 
source in the synthesis of non-essential amino acids, and also as an amino group donor 
in the synthesis of non-essential amino acids and nucleotides (or their precursor 
nucleosides). The medium, G-DMEM, therefore, contained a relatively high 
concentration of glucose and sodium pyruvate, and was supplemented with non-essential 
amino acids, glutamic acid and nucleosides. Full details of the medium composition 
are given in chapter 2. CHO cells and mouse SP2/0 myelomas have been successfully 
adapted to grow without glutamine using analogous media (Bebbington and Yarranton, 
1989; Sanders and Wilson, 1984).
The PQXBl/2 hybridoma could not be adapted to grow independently of glutamine in 
the growth medium either in the presence or absence of glutamic acid. A minimum 
concentration of O.SmM glutamine was found to be essential for cell growth. This 
demonstrated not only that glutamine is essential, but also that it can not be readily 
replaced by glutamic acid even in the presence of compounds whose synthesis would 
otherwise be dependent upon glutamine. The data are consistent with the findings of 
Ardawi and Newsholme (1982) who have reported that glutamine is essential for growth 
of lymphocytes derived cells, and can not be replaced by glucose, 3-hydroxy-butyrate, 
or any other amino acid including glutamic acid. However, Eagle (1955b) reported 
the successful substitution of glutamine with glutamic acid in the culture medium used 
to grow HeLa cells, which has subsequently been repeated with a number of cell-lines,
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including CHO and human diploid cell-lines (Hassell and Butler, 1989; Griffiths and 
Pirt, 1967). The nature of the adaptation process is unknown, but it may be related
to changes in enzyme activities or altered uptake rates of glutamic acid.
The ^parent discrepancy concerning whether cells can grow independent of glutamine, 
or whether glutamic acid can be used to replace glutamine in the growth medium, 
infers that there is an inherent difference in glutamine requirement and metabolism 
between cell types. As discussed during chapter 3 it is known that cells can utilise
glutamine as a substrate via different glycolytic pathways, and consequently the energy
derived from glutamine metabolism varies (Glacken, 1988). The more rapidly a cell 
proliferates, and the higher its rate of biosynthetic activity is, the greater its 
dependency on glutamine appears to be (McKeehan, 1986). It has been speculated that 
this explains why a number of cell-lines, such as CHO and human fibroblasts, which 
have a relatively low rates of metabolic activities, will adapt to grow in glutamine free 
media. Whereas lymphocyte derived cells, including hybridomas, which are specialised 
to secrete proteins and have a notably higher degree of metabolic activity, can not be 
adapted to grow in such media.
A contributing factor to this may be that glutamic acid does not readily permeate the
outer cell membrane, and consequently has a relatively low uptake rate (Christensen,
1990). There is also some evidence that exogenous glutamic acid is metabolised
differently to glutamic acid derived from glutamine, it appears that exogenous glutamic
acid is more likely to be converted to a(pAa-ketoglutamte by transamination reactions,
whereas glutamic acid derived from glutamine is oxidatively deaminated by glutamate
dehydrogenase (GDH) (Borst, 1962; Kovacevic, 1971; Schoolwerth and LaNoue, 1980).
lisa
This may be an efffect of compartmentAion because both glutaminases and GDH are 
located in the mitochondria whereas the transaminases are located primarily in the 
cytosol.
During the study two variant hybridomas were adapted to grow in media containing 
reduced levels of glutamine; the "PQXB-EX2" cell-line in G-DMEM containing 10% 
(v/v) dPCS and O.SmM glutamine, and the "PQXB-EX3" cell-line in the same medium 
but also containing 4mM glutamic acid. It was found that under these growth 
conditions the cells had uncharacteristically low growth rates, viabilities, and population
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densities. Such limitations in cell growth have been reported to occur as a 
consequence of low substrate levels for both glutamine and glucose (Birch and 
Edwards, 1980; Griffiths and Pirt, 1967). The cells also secreted neglible antibody. 
This trait was found to be irreversible with similar titres being attained when the 
glutamine concentration in the medium was increased to 2mM; indicating that cells 
producing low levels of antibody had been selected during the adaptation process. It 
would be expected that cells which produce low levels of antibody would have a 
reduced metabolic burden, and hence a growth-rate advantage under the prevailing 
conditions of glutamine limitation, which would result in the overgrowth of the culture 
by these low-producing cells.
The levels of expression of the glutamine synthetase (GS) enzyme in the adapted 
PQXB-EX hybridoma cell-lines were investigated. The level of GS-mRNA in both cell- 
lines was found to be increased, which was paralleled by an elevation in the GS 
specific activity. From this it can be inferred that under conditions of low glutamine 
concentrations, the cell responds by increasing the rate at which it synthesises 
glutamine. This may involve elevating levels of GS mRNA transcription, and post- 
translational mechanisms affecting enzyme stability and secretion. In a variety of 
mammalian cell-lines, including human diploid cells, CHO, and rat hepatoma cells, the 
measured specific activities of GS have been reported to be inversely proportional to 
the concentration of glutamine present in the culture medium (Arad et a/., 1976; 
DeMars, 1958; Milman et al., 1975; Young and Ringold, 1983). Changes in GS 
biosynthesis in rabbit reticulocyte lysates have been found to be related to
accompanying variations in the cellular content of translated GS-mRNA (Miller and 
Bums, 1983). It has also been reported that the levels of GS-mRNA and accompanied 
enzyme activities are increased by the presence of methionine sulphoxamine (Msx), an 
irreversible inhibitor of the enzyme, and the hormone dexamethasone, and decreased by 
the hormones insulin and dibutyryl cAMP (Bhandari et al., 1986; Sanders and Wilson,
1984). However, Sandrasagara and colleagues (1988) have reported that in mouse GFl 
fibroblasts the level of GS-mRNA was not affected by the presence or absence of 
glutamine in the medium. This discrepancy again highlights the dilemrna,discussed in 
the previous chapter, concerning drawing conclusions about the regulation and
expression of GS. The enzyme is evidently regulated at multiple levels and affected
by various parameters in a manner which as yet has not been fully elucidated.
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GS-gene amplification appeared to have occurred as shown by Southern blot and 
hybridization studies of the genomic DNA of the variant cell-lines. This is consistent 
with observed increases in the levels of transcribed GS-mRNA and enzyme specific 
activities. GS-gene amplification has been reported in mutant CHO cells and mouse 
3T6 cells which overproduce GS as a consequence of adaptation to grow in glutamine 
free medium in the presence of Msx (Sanders and Wilson, 1984; Young and Ringold,
1983).
The pattern of the restriction fragments obtained after digestion of the PQXBl/2 cell- 
lines with three restriction enzymes were found to be contrary to those obtained for 
mouse 3T3-L1 cells by Bhandari and co-workers (1988). Double digestion of the 
PQXBl/2 cell-lines with EcoR 1 and Sal 1 restriction enzymes yielded 7 restriction 
fragments (6.5, 4.0, 2.5, 2.0, 1.3, 0.9 and 0.7 Kb), and Bam HI digestion gave 3 
fragments (6.5, 4.1 and 3.6 Kb). However, Bhandari and colleagues found that with 
3T3-L1 cell DNA; EcoR 1 digestion yielded four fragments (7.6, 4.5, 2.7 and 1.3 
Kb), Sal 1 digestion gave two fragments (11.9 and 6.0 Kb), and Bam HI also yielded 
2 fragments (8.4 and 7.6 Kb). This discrepancy between the coding regions of the 
GS-genes may be attributable to polymorphism between the GS sequence between the 
different cell-lines. It could also be contributed to by differences in the experimental 
conditions (eg. the amount of salt present in the DNA, the gel running conditions, the 
volume of sample).
The inability of the PQXBl/2 hybridoma to adapt to growth in glutamine-free media 
prevented the study of the effect of culturing cells in the absence of external glutamine 
on the cell’s physiology and metabolism. It had been hoped that the cells would adjust 
to glutamine independence by either switching their metabolism to use glutamic acid 
as an alternative substrate, or by using GS to synthesise sufficient endogenous 
glutamine for their metabolic requirements. Variant cell-lines adapted to grow in 
glutamine limited media were obtained, however, their poor growth characteristics 
hampered further studies of their physiology and metabolism. Consequently, an 
alternative strategy to obtain glutamine-independent PQXBl/2 cells by increasing the 
levels of GS using recombinant DNA technology was implemented. This is discussed 
in the following chapter.
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CHAPTER 5.
TRANSFORMATION OF POXBl/2 HYBRIDOMAS 
TO GLUTAMINE INDEPENDENCE
5.1 SUMMARY.
The PQXBl/2 hybridoma has been transformed with glutamine synthetase (GS) cDNA 
under the control of the human cytomegalovirus (hCMV) promoter. Sufficient GS 
enzyme was expressed to enable growth in glutamine-ffee media. Transformation of 
the hybridoma, with vectors containing GS cDNA under the control of a SV40 early 
promoter, yields insufficient active GS enzyme for the transformed cells to grow 
independent of glutamine in the culture medium. Electroporation was found to be an 
effective means of transforming the PQXBl/2 hybridoma, with transformation frequencies 
of 10^ to 10^ regularly obtained.
Physiological aspects of the transformed cell-line (CMGSE-PQXB), growing in 
glutamine-free media, were investigated during stirred batch culture. Cell yields were 
found to increase and the specific growth rate to decrease, compared to untransformed 
cells growing in media containing glutamine. Overall, a higher percentage of glucose 
utilisation was observed, and there was a lower ratio of lactate produced to glucose 
consumed. Neither glutamine or ammonia were detected in the growth medium 
throughout the course of the batch culture. Lower antibody titres were obtained with 
the transformed hybridomas compared to the untransformed cell-lines.
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5.2 INTRODUCTION.
Over the last ten years recombinant DNA technology has been used to produce 
previously scarce, or completely novel proteins, by the expression of their cloned genes 
in an appropriate host cell-type (see reviews by Bebbington and Hentschel, 1985a and 
1985b; Kingsman and Kingsman, 1988; Sanders, 1990; Rigby, 1984). A number of 
studies have been made, centered primarily around exploiting and improving the existing 
technology, and increasing the effeciency of gene expression. These have led to the 
production of high yields of previously scarce proteins, including tPA, interferons, and 
growth hormones. For example, using recombinant DNA technology CHO-myeloma 
hybrid cells have been developed, containing the genes coding for tPA and DHFR, 
which subsequent to DHFR amplification using methotrexate, produce yields of 9.75mg 
tPA per 10’ cells every 24 hours (Cartwright and Crespo, 1990).
Advances in the field of recombinant DNA technology have also led to the development 
of a new area of recombinant gene products, for example chimeric antibodies and 
second generation molecules (including tPA and Factor Vni). CD4 chimeric molecules 
have been reported to be expressed in myelomas, and yields in the region of 60 to 
80ug per litre attained (Schlaeger and Schump, 1990). A chimeric antibody for use 
in tumour imaging and therapy, B72.3 IgG, has been expressed using a "GS-gene 
expression vector", in recombinant CHO and myeloma cells, and following GS 
amplification using methionine sulphoxamine, yields of 240mg per litre reported (Field 
et al., 1990) . However, the potential of recombinant DNA technology to alter the 
cells’ metabolism has received little attention, and there is a paucity of similar studies 
in the literature.
A variety of vector-host systems have been devised for the expression of eukaryotic 
genes in mammalian cells, most of which utilize viral regulatory elements (Wahl et al.,
1984). The level of expression is determined by various factors including; the site of 
integration of the gene into the host cell’s chromosome (Grosveld et al., 1987; Talbot 
et al., 1989), transcriptional control elements (Ptashne, 1989; Mitchell and Tjian,
1989), RNA processing and stability signals (Jackson and Standart, 1990; Wicken,
1990) and gene copy number (Sanders and Wilson, 1984). To transform mammalian
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cells with foreign DNA, several techniques have been developed including, DEAE- 
dextran and calcium phosphate/DNA co-precipitation (Graham and Van der Eb, 1973 
and McCutchan and Pagano, 1968), protoplast fusion (Schaffher, 1980), liposomes 
(Feigner et al., 1987 and Kawai and Nishizawa, 1985), microinjection (Capecchi, 1980), 
electroporation (Potter et al., 1984), and retroviral vectors (Cepko et al., 1984). The 
efficiency of gene transfer using these transformation methods varies widely from cell- 
type to cell-type. The various aspects involved in the genetic engineering of 
mammalian cells, including gene expression and transformation techniques, have been 
discussed in more detail (chapter 1).
Electroporation can provide a highly efficient means of introducing DNA molecules into 
cultured cells, including lymphoid-derived cells, (Bebbington and Yarranton, 1989; 
Hendricks et al., 1988; Tonguzzo et al., 1986) and was the method employed during 
this study to transform the PQXBl/2 hybridoma. Electroporation uses high voltage 
electric pulses to induce the uptake of DNA from the surrounding medium (Potter et 
al., 1984). It is presumed that this takes place through the formation of transient 
micropores in the cell membrane (poration) and diffusion into the cytoplasm. The 
precise mechanism of DNA uptake after electroporation though is not well understood. 
Recently, Andreason and Evans (1989) have carried out biophysical studies on the 
effect of electric pulses on erythrocyte ghosts. From these they have suggested that 
electroporation involves both poration, and electro-osmosis, inducing a unidirectional 
flow of material into the cell.
The equipment used to generate the electric pulse field, whether of commercial or 
experimental design, normally provides facilities allowing control over the amplitude, 
duration, and number of pulses, as well as the time between pulses. Optimisation of 
these parameters is required for each cell-type before efficient transformation can be 
obtained (Winterboume et al., 1988). A comprehensive outline of a number of the 
variables found to affect the uptake of DNA by electroporated cells is given in 
appendix 6.
In a number of circumstances high levels of transient gene expression are required, for 
example, to generate analytical quantities of a gene product, or to confirm the effective
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expression of a gene construct. To enable this a rapid and simple transient expression 
system has been developed, involving DEAE-dextran/DNA co-precipitation transfection 
into COS-1 cells (Gluzman, 1981). COS-1 cells are monkey CV-1 cells transformed 
with SV40 DNA, which has integrated into their genome. The cells constitutively 
express the large T antigen, which is required to start replication of SV40 viral DNA. 
However, due to a six base-pair deletion in the viral origin of replication (ORI) in the 
transformed SV40 DNA, the viral DNA is unable to replicate. When a construct 
containing a functional SV40 ORI is transformed into these cells, the large T antigen 
can then bind to the ORI, and initiate DNA replication. A high gene copy number 
is obtained, thus enabling the high level expression of the gene construct, as 
illustrated below in Figure 5.1. Using the COS-1 transfection system, sufficiently high 
levels of transiently expressed chimeric antibodies have been rapidly obtained to enable 
their physical, and immunological, characterisation (Whittle et al., 1987).
FIGURE 5.1 THE INITIATION OF DNA REPLICATION IN COS CELLS.
COS cells expressing large T antigen
1 -  a n t i g e n
m R N A
SV40 ORI
X
The binding of the large 
T antigen to the ORI which 
initiates DNA replication
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(from P.G.Sanders)
In this chapter recombinant DNA technology was used to develop a PQXBl/2 
hybridoma cell-line which expresses sufficient levels of glutamine synthetase (GS), to 
enable glutamine independent growth. As previously mentioned, GS is the enzyme 
responsible for synthesising glutamine in cells (chapter 1). To achieve this recombinant 
cell-line, the CHO-GS coding sequence under the control of viral regulatory elements, 
was inserted into the cell, and recipients selected on the basis of their ability to grow 
in glutamine-free media (G-DMEM). Previous investigations with this cell-line have 
revealed that it is incapable of growth in glutamine-free media, thought to be a 
consequence of insufficient expression of GS (chapters 3 and 4). The transformation 
of the hybridoma to glutamine independence would provide a "model" system for 
investigating the feasability/problems associated with trying to manipulate cellular 
physiology, and the resulting affects.
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5.3 MATERIALS AND METHODS.
Details of the materials and methods employed are outlined in chapter 2, unless 
otherwise specified in the text.
5.4 EXPERIMENTAL RESULTS.
5.4.1 RECLONING THE POXBl/2 HYBRIDOMA.
Prior to developing a transformed PQXBl/2 hybridoma the cell-line was screened to 
ensure that it had acceptable growth characteristics, and secreted adequate antibody. 
The hybridoma was then re-cloned, and subsequently used as the host for DNA- 
mediated transformation.
Cloning was performed using the "limiting dilution" procedure. Initial attempts were 
made to clone the hybridoma without feeder cells, employing media containing varying 
levels of foetal calf serum, ranging from 10 to 20% (v/v). No growth was obtained. 
In subsequent cloning experiments mouse spleen feeder cells were used. Clones were 
obtained with growth becoming visible after 7 to 10 days. The wells containing single 
clones were fed with additional media, and once sufficient growth had been achieved 
they were screened for antibody production.
It was observed that on average 89% of the clones secreted antibody. A number of 
the clones were expanded for more detailed investigations to ensure that they produced 
adequate antibody titres, and exhibited suitable, stable growth characteristics. Frozen 
cell stocks of selected clones were made, and stored under liquid nitrogen, until 
required for subsequent transformations.
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5.4.2 ELECTROPORATION PROTOCOL.
The PQXBl/2 cell-line was "transformed" with exogenous DNA using electroporation 
(Potter et al., 1984). In order to establish a suitable electroporation protocol, and 
selection procedure, which would enable the successful DNA-mediated transformation 
of the PQXBl/2, the vector pEE6.gpt was used as a "test" system. Vector pEE6.gpt 
contains the E.coli xanthine guanosine phosphoribosyl gene ( ^ t )  which confers 
resistance to the drug mycophenolic acid, as outlined in chapter 1. A "Gene Puiser" 
(Biorad), which generates an exponential decay waveform, was employed to insert the 
vector into the cells, and the recipient cells were selected using "gpt" selective media, 
which contained mycophenolic acid (MPA).
PQXBl/2 cells were electroporated using a protocol developed for hybridoma and 
myeloma cell-lines (C.R.Bebbington, pers. comm.). To assess the optimal 
electroporation conditions required for transformation of the PQXBl/2 hybridoma a 
number of the parameters in this protocol were investigated;
A. ELECTROPORATION - BASIC PROTOCOL.
PQXBl/2 hybridomas were transformed with pEE6.gpt using an established protocol for 
the DNA-mediated transformation of hybridoma and myeloma cell-lines. Exponentially 
growing cells (minimum viability 92%) were washed in PBS by centrifugation (80g for 
5 minutes), and resuspended at a density of 10^  cells/ml in ice-cold PBS. A sterile 
suspension of 40ug plasmid pEE6.gpt, linearised by digestion with Sal 1 restriction 
enzyme , was added to the cells to give a total volume of 0.8ml. (Plasmids were 
linearised with an appropriate restriction enzyme which cut at a single site in the 
plasmid in a location that did not interfere with the ensuing transcription of relevant 
genes in mammalian cells) The cell-DNA mix was then subjected to two pulses (2kV 
and 3uF), with a 10 second interval in between pulses, in a "Gene Puiser". Cells 
were then stood on ice for 5 to 10 minutes, resuspended in non-selective growth 
medium, and then distributed in 0.5ml volumes along 24-well culture plates. After 24 
hours 0.5ml gpt-selective medium was added, followed by a further 0.5ml X2 gpt- 
medium after 48 hours, and the transformation frequencies subsequently determined from 
the number of clones obtained.
155
B. THE EFFECT OF ALTERING THE ELECTRICAL PARAMETERS.
The above electroporation protocol was followed to transform PQXBl/2 cells with 
pEE6.gpt, except that the number of pulses, the pulse duration, and the voltage, were 
all varied. Cells were exposed to either 1 or 2 pulses at 2kV or 1.5kV, with a 
capacitance of 3 or 25uF. The resulting mean transformation frequencies are shown 
below in Table 5.1.
TABLE 5.1. AFFECT OF ALTERING THE ELECTROPORATION
PULSE CONDITIONS.
SAMPLE PULSE
NUMBER
VOLTAGE
(kV)
CAPACITANCE
(uF)
TRANSPCmiAHON 
FREQUENT 
(colonies/10®cells)
A 1 2.0 3 30
B 2 2.0 3 52
C 1 2.0 25 18
D 2 2.0 25 20
E 1 1.5 3 21
F 2 1.5 3 49
G 1 1.5 25 11
H 2 1.5 25 8
From the results, it was found that by employing the electroporation protocol described 
earlier (part A) to insert pEE6.gpt into PQXBl/2 hybridomas, transformation frequencies 
in the range of 30 to 50 colonies per 10® cells were regularly achieved. To improve 
the transformation frequency the effect of altering a number of electrical conditions 
during electroporation were examined (ie. the pulse number, pulse duration, and 
voltage). Results obtained are shown in Table 5.1. It was observed that; (i) 
subjecting the cells to 2 pulses normally obtained higher efficiencies of transformation
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than using a single pulse, (ii) increasing the capacitance from 3uF to 25uF (and hence 
pulse duration from 0.1msec to 0.5msec) decreased the transformation frequencies, and 
(iii), altering the voltage from 2kV to 1.5kV had little significance. The highest 
transformation frequencies were attained from using two pulses at 2kV and 3uF, as 
consistent with the conditions outlined during the electroporation protocol outlined in 
section A.
C. THE EFFECT OF ALTERING THE INCUBATION CONDITIONS.
The electroporation protocol described in section A was employed to introduce 
pEE6.gpt into PQXBl/2 hybridomas, however, the incubation temperature, both *pre-’ 
and post-pulsing the cells, and the duration of the post-pulse incubation period were 
all altered. Cells were pre-incubated with the DNA at either 0”C, 22°C or 37®C for 
10 minutes, exposed to a single pulse (2kV and 3uF), and then incubated at either 
0®C, 22®C or 3TC for 10 or 30 minutes. The mean transformation frequencies 
obtained are shown in Table 5.2.
TABLE 5.2. AFFECT OF ALTERING THE ELECTROPORATION 
INCUBATION CONDITIONS.
SAMPLE PRE-PULSE 
TEMP CQ
POST-PULSE 
TEMP CO
POST-PULSE 
TIME (min)
TRANSFCmiAHON
F R E Q U E N C Y
(colonies/10®)
A 0 0 10 49
B 22 0 10 41
C 37 0 10 12
D 0 22 10 54
E 0 37 10 31
F 0 0 30 48
G 0 22 30 52
H 0 37 30 33
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It was found that; (i) the transformation efficiency decreased if the cells/DNA were 
incubated above 0°C prior to pulsing, (ii) higher transformation frequencies were 
obtained if the cells were incubated at 22®C after pulsing, as apposed to 0°C or 37°C, 
and (iii), there were no marked differences in the transformation efficiencies attained 
when cells were incubated for either 10 minutes or 30 minutes following 
electroporation.
In conclusion, the electroporation protocol outlined in section A was found to 
consistently enable a relatively high transformation frequency to be obtained, when 
PQXBl/2 cells were transformed with pEE6.gpt. By altering various parameters only 
a marginal improvement of the transformation frequency was observed, i.e. when the 
post-pulse incubation temperature was increased from 0°C to 22®C. Consequently, this 
protocol was employed to electroporate PQXBl/2 hybridomas.
5 .43  SELECTION PROTOCOL FOR TRANSFORMED CELLS.
To determine a suitable protocol for selecting transformed hybridomas the potential of 
two different selectable marker genes; "gpt" and "neo", was assessed. The gpt-gene 
confers resistance to the drug mycopbenolic acid to cells, and the neo-gene resistance 
to the drug geneticin (G418). The basis behind the two selection procedures has been 
reviewed during chapter 1.
Two vectors, pEE6.gpt which contains the gpt-gene coding sequence, and pSV2.neo 
which contains the neo gene coding sequence were used. The former was linearised 
by digestion with Sal 1, and the latter with Eco Rl. Both plasmids were
independently inserted into PQXBl/2 hybridomas using the electroporation protocol 
described above. Separate aliquots of 10^  cells were "mock" transfected by performing 
electroporation without added DMA. The cells were then resuspended in 12ml non- 
selective medium (DMEM) and dispensed in 0.5ml aliquots in 24-well plates. After 
24 hours selection was applied. The gpt-transformed cells were selected by adding 
0.5ml gpt-selective medium on day 1, and an additional 0.5ml X2 gpt- medium on day
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2, and neo-transformants by adding 1ml of DMEM supplemented with geneticin 
(0.8mg/ml) on day 1. The number of transformed colonies were scored after 10 and 
15 days, and the results obtained are shown below in Table 5.3.
TABLE 5.3. RESULTS OBTAINED FROM TRANSFORMING POXBl/2 
HYBRIDOMAS WITH pEE6.gnt AND pSV2.neo
PLASMID TRANSFORMATION FREQUENCY
(colonies/10® cells)
10 DAYS 15 DAYS
pEE6.gpt 51 51
pSV2.neo 35 46
From the results obtained from transforming the PQXBl/2 hybridoma with either 
pEEô.gpt and pSV2.neo, it was found that after 10 days all of the gpt-transformants 
had started to form visible colonies. No additional colonies were established when the 
transformants were re-examined after 15 days. A transformation frequency of 51 
colonies per 10^  cells was obtained. The number of neo-transformants, though, was 
found to be 35 colonies per 10^  cells after 10 days. After further incubation more 
clones became apparent, and by 15 days a transformation frequency of 46 colonies 
per 10® cells was attained. Therefore, it appears that under the conditions used, 
similar levels of transformation can be achieved by employing either the gpt- or neo­
selection system; however, clones can be more rapidly obtained using the former.
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5.4.4 TRANSFORMATION WITH dSV2.GS.
PQXBl/2 hybridomas were transfected with pSV2.GS in order to obtain a cell-line 
expressing elevated levels of the GS-gene. Plasmid pSV2.GS contains the CHO-GS 
cDNA coding sequences under the control of an SV40 early promotor. The plasmid 
was linearised by restriction endonuclease digestion with Pvu 1 and inserted into 
PQXBl/2 cells by electroporation. Two control transformations were also performed. 
In one of these the gpt-gene was transformed into the cells as described in the 
previous section. In the other, a "mock" transformation was carried out in which 
electroporation was performed in the absence of DNA.
Electroporated cells were resuspended in 12mls DMEM containing 10% (v/v) dialysed 
foetal calf serum (dFCS) and 2mM glutamine, and distributed in 0.5ml aliquots along 
24-well culture plates. Selection for the GS-gene was applied 24 hours later to wells 
of both the "mock" and DNA transformation plates. A glutamine-free selective medium 
(G-DMEM) was used which contains 10% (v/v) dFCS, nucleotides, non-essential amino 
acids, and additional sodium pyruvate. The media composition has been discussed 
(chapter 4).
Selection was applied as follows;
A. added 1ml G-DMEM.
B. added 1ml G-DMEM containing 200uM glutamine on day 1, left for 3 days, then 
aspirated and replaced with G-DMEM.
C. left on day 1, and then aspirated on day 2 and replaced with 1ml G-DMEM. On 
day 4 aspirated the plates again and replaced with G-DMEM.
D. added 1ml G-DMEM containing ImM NH^Cl and 4mM glutamic acid.
E. to the gpt transformation plates only was added 0.5ml gpt selective media on day 
1, and a further 0.5ml X2 gpt selective medium on day 2.
The numbers of surviving colonies were assessed after 10 to 14 days. In all of the 
GS transformation plates clones were found to be initially present. However, after a 
period of 14 to 17 days the colonies stopped proliferating, irrespective of the selection
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strategy used. In the gpt control transformations a mean frequency of 43 colonies 
per 10® cells was obtained, which is consistent with previous data. No colonies were 
observed in the "mock" transformation plates.
5.4.5 CO-TRANSFORMATION OF POXBl/2 HYBRIDOMAS WITH 
PSV2.GS AND pEE6.gpt.
To obtain GS transfected PQXBl/2 hybridomas, an alternative approach was 
investigated. The cells were co-transformed with both pSV2.GS and pEE6.gpt, and 
transformants selected using gpt selective media, both in the presence and absence of 
glutamine.
Vectors pSV2.GS and pEE6.gpt were linearised, using Pvu 1 and Sal 1 restriction 
enzymes, respectively. The two plasmids were inserted together into the cells by 
electroporation. The total plasmid DNA concentration was maintained at 40ug per 
transfection, but the ratio of pSV2.GS to pEEô.gpt was varied with a 5- to 10-fold 
excess of pSV2.GS being used. A "mock" transformation was also performed by 
electroporating cells in the absence of plasmid DNA. The cells were resuspended 
in 12ml DMEM containing 10% dFCS and 2mM glutamine, and dispensed in 0.5ml 
aliquots along 24-well culture plates. After 24 hours various selective media were 
added to wells of "mock" and DNA transfected plates as follows;
A. added 0.5ml gpt-selective medium, then on day 2 added 0.5ml X2 gpt-selective 
medium.
B. added 1ml gpt-selective medium containing no glutamine but supplemented with 
nucleotides, non-essential amino acids, and sodium pyruvate (as for G-DMEM).
C. added 1ml gpt-selective media containing no glutamine but supplemented with 
nucleotides, non-essential amino acids and sodium pyruvate (as above), and also 
4mM glutamic acid and ImM NH4CI.
D. added 1ml media used in B above but containing 200uM glutamine, then on day 
3 aspirated this medium and replaced it with 1ml of the same medium containing 
no glutamine.
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E. added 1ml media used in C above but containing 200uM glutamine, then on day 
3 aspirated this medium and replaced it with 1ml of the same medium containing 
no glutamine.
Using gpt selective media as outlined in selection strategy A above a transformation 
frequency of 30 to 50 transformants per 10® cells was obtained. A number of these 
clones were expanded, and found to be stable in gpt-selective media. However, no 
transformed cell-1 ines were obtained when glutamine free gpt-media were employed as 
a dual selection strategy for both the gpt- and GS-genes (selection A, B, C or E 
above). Furthermore, attempts to adapt the gpt-transformants (obtained from selection 
A above), to growth in glutamine-free media, were unsuccessful. From this it was
inferred that during the co-transformation, cell-1 ines expressing sufficient GS for 
glutamine independent growth had not been obtained.
5.4.6 CONSTRUCTION OF oKSVlQ.lGS.gpt.
A vector (pKSVlO.lGS.gpt) was constructed that contained both the GS-cDNA and gpt- 
gene coding sequences, in which the SV40 early region promoter (SV40 E promoter) 
directed the expression of the GS-cDNA, and downstream to this the gpt-gene was 
expressed under the control of another SV40 E promoter.
A. INSERTION OF GS-GENE INTO dKSVIO.
The strategy used to construct the expression vector pKSVlO.lGS.gpt is outlined in 
Figure 5.2. The CHO-GS cDNA coding sequence was isolated from pSV2.GS, on a 
1.2Kb Bgl 2 to Hind 3 restriction fragment, by digesting pSV2.GS with Hind 3 and 
Bgl 2 restriction endonucleases. The resulting fragment was isolated by TAE gel 
electrophoresis and subsequent "Gene Clean". A restriction map of pSV2.GS is given 
in appendix 3. A synthetic oligonucleotide adaptor, with both Bgl 2 and Hind 3 ends, 
was chemically synthesised using an Applied Biosystems DNA synthesiser. A Not 1 
endonuclease restriction site was included in the oligonucleotide sequence to; (i) increase 
the number of bases annealing to each other, and (ii), to provide an additional unique 
restriction site.
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The complementary strands synthesised were;
Bgl 2
F I 5’ GA TCT GCG CCG CA 3’
F2 y  A CGC GGC GTT CGA 5'
Hind 3
The adaptor was then phosphorylated and ligated onto the Hind 3 ends of pSV2.GS 
previously linearised by digestion with Hind 3 restriction enzymes. Subsequent 
digestion with Bgl 2 cut out the GS-gene on a 1.2Kb Bgl 2 fragment. The 
incorporation of gamma-^^P-ATP during the phosphorylation of the oligonucleotide 
enabled the above adaptor-vector ligation, and the following ligation of the gene into 
the vector, to be followed.
Plasmid pKSVlO was digested to completion with Bgl 2 and de-phosphorylated to 
prevent self-ligation of the molecule. The GS-gene sequence on a Bgl 2 fragment was 
then inserted into the Bgl 2 site of pKSVlO by ligating the two DNA molecules 
overnight at 14°C, and then transforming E.coli HBlOl with the ligation mixture.
E.coli transformants containing the ligated DNA were selected on the basis of ampicillin 
resistance confered to cells containing the pKSVlO sequences.
Twenty of the transformed bacterial colonies were expanded in LB-broth culture and 
small scale extractions made of their pDNA. Digestion of the DNA with Bgl 2 
restriction endonucleases, and the subsequent electrophoresis of the restriction fragments 
through 0.8% TAE agarose gels, revealed that six clones contained two fragments of 
7.9Kb and 1.2Kb. These corresponded to the size of the vector and insert DNA 
respectively. Large scale extractions of the plasmid DNA were performed and the 
plasmid purified by banding on a ceasium chloride - ethidium bromide density gradient. 
Restriction digests of the resulting DNA confirmed that the recombinant vector was 
pKSVlO ligated with the GS-gene, and that in four of the plasmids the GS-gene was 
in the correct orientation to enable its expression to be directed by the SV40 early 
promoter from pKSVlO. The constructed plasmids were referred to as pKSVlO.GS 
clones, and clone pKSVlO.lGS was used in the subsequent work.
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Figure 5,2 A diagramatic illustration of the strategy used 
to construct oKSVlQ.lGS.gpt.
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B. INSERTION OF THE "GPT EXPRESSION CASSETTE” INTO pKSVlO.lGS.
The gpt-gene was excised from pEE6.gpt, together with the SV40 early promoter which 
directed its transcription, on a 2Kb Bam HI restriction endonuclease fragment. A 
restriction map of pEE6.gpt is given in appendix 3. The fragment was isolated by 
TAE gel electrophoresis and subsequently purified using "Gene Clean". The construct 
pKSVlO.lGS was cut at its unique Bam HI site using Bam HI restriction 
endonucleases, and then phosphatased to prevent the vector from subsequently self- 
ligating.
The Bam HI digested pKSVlO.lGS was ligated overnight with the Bam HI-gpt gene 
fragment, and the ligation mixture used to transform E.coli HBIOI. Bacterial 
transformants were selected using LB-agar plates containing ampicillin. Small-scale 
extractions of plasmid DNA from 20 of the resulting transformants were performed, 
and the DNA obtained digested with Bam HI endonucleases and electrophoresed 
through TAE agarose gels. From the resulting restriction pattern it was found that 
four of the recombinant plasmids contained fragments of 9.1Kb and 2kb, which 
corresponded to the sizes of the vector, and the insert, DNA sequences respectively. 
Large-scale extractions of the plasmid DNA from these isolates were conducted, 
followed by purification by banding on ceasium chloride-ethidium bromide density 
gradients. Further restriction digests of the plasmids were performed to determine the 
orientations of the gpt-gene. The resulting recombinant plasmids were referred to as 
pKSVlO.lGS.gpt clones (Figure 5.3).
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FIGURE 5.:; THE EXPRESSION VECTOR pKSVlO.IGS.mt.
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5.4.7 TRANSIENT EXPRESSION OF DKSVIO.IGS.ypt IN COS-1 CELLS.
The pKSVlO.lGS.gpt constructs were transiently expressed in COS-1 cells to ensure 
that they correctly transcribed and translated the cloned GS- and gpt-gene sequences.
COS-1 cells were grown in DMEM containing 10% (v/v) foetal calf serum and 2mM 
glutamine. The four pKSVlO.lGS.gpt constructs were individually introduced into the 
cells by DEAE-dextran DNA-mediated transformation. Two control samples were
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PLATE 5.1 COS CELLS TRANSFORMED WITH DKSV10.lGS.gDt2 USING 
DEAE-DEXTRAN (I DAY POST-TRANSFORMATIONS
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LEGEND FOR PLATE 5.2.
DNA samples were digested with either Bam HI or Bgl 2, electrophoresed through a 
1% TAE agarose gel, transferred to a nylon membrane, and hybridized with a GS- 
gene probe. Subsequently, the probe was removed and the filter was re-hybridized 
with a gpt-gene probe.
Lane 1. Molecular weight markers.
Lane 3. 5ug DNA from COS cells digested with Bam HI.
Lane 4. 5ug DNA from COS cells digested with Bgl 2.
Lane 5. 5ug DNA from COS cells transformed with pKSVlO digested with
Bam HI.
Lane 6. 5ug DNA from COS cells transformed with pKSVlO digested with 
Bgl 2.
Lane 7. 5ug DNA from COS cells transformed with pKSV10.lGS.gpt2 digested 
with Bam HI.
Lane 8. 5ug DNA from COS cells transformed with pKSV10.lGS.gpt2 digested 
with Bgl 2.
Lane 9. lOng pKSV10.lGS.gpt2 digested with Bam HI.
Lane 10. lOng pKSV10.lGS.gpt2 digested with Bgl 2.
PLATE 5.2 DNA HYBRIDIZATION ANALYSIS OF COS CELLS
TRANSFORMED WITH pKSVlO.lGS.mt.
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LEGEND FOR PLATE 5.3.
lOug of RNA sample was electrophoresed through a 1.5% formaldehyde denaturing gel, 
transferred to a nylon membrane, and hybridized with a radiolabelled GS-gene probe. 
Subsequently, the probe was removed and the filters re-hybridised with first a gpt-gene 
probe, and then an actin gene probe. Half of the samples were incubated with DNAse 
for 15 minutes at 37°C prior to electrophoresis.
Lane A. COS cell RNA.
Lane B. COS cells transformed with pKSVlO.
Lane C. COS cells transformed with pKSV10.lGS.gpt2 RNA.
Lane D. COS cell RNA incubated with DNase.
Lane E. COS cells transformed with pKSVlO RNA incubated with DNase.
Lane F. COS cells transformed with pKSV10.lGS.gpt2 RNA incubated with
DNase.
PLATE 5.3 NORTHERN BLOT HYBRIDIZATION ANALYSIS OF COS CELLS
TRANSFORMED WITH nKSVlO.lGS.gnt.
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also set up by either (i) transforming COS-1 cells with pKSVlO, or (ii), performing 
"mock" transformations in the absence of DNA. After two days the cells were 
removed from the tissue culture plates using trypsin-EDTA, their RNA and DNA 
extracted, and the levels of the GS enzyme assayed. A photograph of transformed 
COS-1 cells is shown in Plate 5.1.
A. SOUTHERN BLOT ANALYSIS.
The presence of plasmid DNA in the transformed COS-1 cells was confirmed by 
Southern blot hybridization studies, the results of which are shown in Plate 5.2.
B. NORTHERN BLOT ANALYSIS.
The presence of GS mRNA in the transformed COS-1 cells was analysed by Northern 
blot hybridization studies. The extracted RNA was electrophoresed through a 1.5% 
formaldahyde denaturing gel, along with RNA molecular weight markers. A total 
volume of lOug RNA was used per sample, some samples of which were incubated 
in the presence of DNases prior to loading on the gel. The filters were hybridized 
with a labelled GS-gene probe derived from pSV2.GS as previously mentioned (section 
3.4.5).
The hybridization results are shown in Plate 5.3. The probe was found to cross- 
hybridize to a mRNA fragment of approximately 2Kb in the RNA of the COS-1 cells 
transformed with pKSVlO.lGS.gpt constructs. This corresponded to the anticipated size 
of the exogenous GS-mRNA, inferring that the transformed gene was expressed. In 
the pKSVlO.lGS.gpt RNA samples, which had not been treated with DNases, an 
additional band of approximately 4.4Kb was also detected, which is thought to be due 
to contaminating vector DNA. RNA samples extracted from COS-1 cells transformed 
with pKSVlO, and from untransformed COS-1 cells, were included in the hybridization 
studies. The probe did not hybridize at a detectable level to RNA in these samples.
To confirm that the observed hybridisation results were not an artefact caused by using 
unequal volumes of sample, the GS-gene probe was removed from the filters, which
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were subsequently re-hybridized with a labelled actin-gene probe derived from p41 (as 
described in section 3.4.3). The actin-gene probe was found to hybridise to each 
sample with similar intensity, indicating that the volume of RNA was similar in each 
sample.
The RNA filter was hybridized with a labelled gpt-gene probe, which consisted of 
2Kb Bam HI restriction fragment containing the gpt-gene coding sequence isolated 
from pEE6.gpt (as described in section 3.3.1). From the hybridization results the 
probe was found to cross-hybridize to a fragment of approximately 2.2Kb, which 
corresponded to the anticipated size of the transformed gpt-mRNA. An additional band 
was also observed of approximately 3.8Kb, which was thought to be a consequence of 
contaminating plasmid DNA.
C. GS ASSAYS.
The translation of GS mRNA into active protein was investigated by assaying the levels 
of the GS enzyme. Positive and negative controls were performed using untransformed 
COS-1 cells, and heat inactivated samples from transformed cells, respectively. All 
determinations were carried out in triplicate.
The assay demonstrated that the level of GS enzyme activity was higher in the cell- 
lines transformed with the GS-gene construct, than in the corresponding untransformed 
hybridomas (Table 5.4). However, the amount of enzyme activity varied significantly 
between the four different constructs.
171
TABLE 5.4. GS SPECIFIC ACTIVITIES IN TRANSFORMED COS-1 CELLS.
CELL-LINE MEAN GS ACTIVITY 
(umol/min/ lO^cells)
COS-1 (negative control) 0.03
COS-1 (positive control) 0.09
COS-1-pKSVlO 0.08
COS-1-pKSVlO.lGS.gptl 0.68
COS-l-pKSV10.lGS.gpt2 0.74
COS-l-pKSV10.lGS.gpt3 0.39
COS-l-pKSV10.lGS.gpt4 0.44
The transformants were also able to survive in the presence of my cophenol ic acid, 
which was taken as an indication that they also expressed the gpt-gene. These results, 
therefore, confirmed that both the cloned gpt- and GS-genes in the pKSVlO.lGS.gpt 
constructs were correctly translated into active proteins when transfected into COS-1 
cells. The construct pKSV10.lGS.gpt2, which expressed the highest levels of GS 
enzyme activity, was subsequent used to transform hybridoma cell-lines.
5.4.8 TRANSFORMATION OF POXBl/2 CELLS WITH pKSVlG.lGS.gnt.
The PQXBl/2 hybridoma was transformed with pKSV10.lGS.gpt2 by electroporation 
in order to derive a cell-line which expressed sufficiently elevated levels of the GS- 
gene to enable growth in glutamine-ffee media.
Plasmid pKSV10.lGS.gpt2 was linearised with Tth 3 restriction endonucleases, and then 
introduced into PQXBl/2 cells using the electroporation protocol established earlier 
(section 5.4.1). Control transformations were performed by (i) transforming cells with
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the gpt-gene as described previously (section 5.4.1), and (ii), "mock" transforming cells 
by carrying out electroporation in the absence of DNA. The electroporated cells were 
resuspended in 12mls DMEM containing 10% dFCS and 2mM glutamine, and 
distributed along 24-well culture plates as before. After 24 hours selection was applied 
to both the "mock" and DNA transformation plates.
The selection strategies employed were as follows;
A. added 1ml G-DMEM (glutamine free medium).
B. added 0.5ml-gpt medium on day 1, and a further 0.5ml X2 gpt medium on day 
2.
C. as above but using gpt media not containing glutamine, but supplemented with 
nucleotides, non-essential amino acids, and sodium pyruvate (as in G-DMEM).
The number of surviving clones were assessed after 10 to 14 days. When 
transformants were selected with gpt-media (as specified in selection strategy B above) 
a mean transformation frequency of 64 colonies per 10* cells was attained with 
pKSVlO.lGS.gpt transformed cells, and a similar frequency of 55 transformants per 10* 
cells, following transformation with pEE6.gpt. However, no transformed colonies were 
obtained subsequent to selection in either G-DMEM or gpt-glutamine free media. In 
these transformations colony growth was initially observed in the wells, but proliferation 
ceased after 10 days. These results are similar to those found earlier during attempts 
to transform PQXBl/2 hybridomas with pSV2.GS (section 5.3.4).
In conclusion, from the electroporation results to-date, it is apparent that the failure to 
achieve GS transformed hybridomas capable of growing in glutamine-free media is 
probably a consequence of the levels of GS expression attained, rather than the 
transformation and selection protocols. Evidence for this comes from consistent success 
at transfecting hybridomas with the gpt-gene.
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PLATE 5.4 A COLONY OF POXBl/2 TRANSFORMED CLONES 10 DAYS
AFTER TRANSFECTION.
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PLATE 5.5 A COLONY OF PQXBl/2 TRANSFORMED CLONES 15 DAYS
AFTER TRANSFECTION.
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5.4.9 INVESTIGATION OF hCMV PROMOTER CONSTRUCTS.
A vector containing the GS-gene under the regulatory control of the human 
cytomegalovirus (hCMV) promoter was used to transform the PQXBl/2 hybridoma. 
The ability of this transcription system to express the GS-gene in the hybridoma was 
compared to the SV40 early promoter transcription unit used earlier.
PQXBl/2 cells were transformed with either pKSV10.lGS.gpt2 or pEE6.gpt as 
described above. The transformation frequencies obtained were compared to those 
obtained from transforming the hybridoma with two additional vectors, pCMGS and 
pCMGS.gpt. Plasmid pCMGS had been constructed so that the major inunediate early 
gene promoter, enhancer and the complete 5’-untranslated sequence from the human 
cytomegalovirus (hCMV), directed expression of the GS-gene coding sequence. A 
restriction map of the vector is given in appendix 3. Plasmid pCMGS.gpt was derived 
from pCMGS by the insertion of the gpt-gene, under the control of the SV40 early 
promoter, downstream to the GS-gene. Both hCMV plasmids were obtained from 
Celltech (Slough, UK). The plasmids were linearised with appropriate restriction 
endonucleases; pCMGS with Bam HI and pCMGS.gpt with Pvu 1, and then 
independently transformed into PQXBl/2 cells by electroporation. Additional mock 
transformations were performed by electroporating cells in the absence of DNA.
The cells were then resuspended in 12mls of non-selective growth medium (DMEM), 
and 24 hours later were selected for either the GS- or the gpt-gene, using G-DMEM 
(glutamine-free media) or gpt media, respectively. The number of transformed colonies 
was determined after 14 days, and the results are shown below in Table 5.5. The 
appearance of PQXBl/2 transformed clones, 10 days and 15 days post-transfection, are 
shown in Plates 5.4 and 5.5 respectively.
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TABLE 5.5. POXBl/2 TRANSFORMATION RESULTS.
VECTOR SELECTIVE MEDIA COLONIES/10* CELLS
pCMGS G-DMEM 250
pCMGS.gpt G-DMEM 250
pCMGS.gpt GPT 20
pEE6.gpt GPT 42
pKSVlO.lGS.gpt G-DMEM 0
pKSVlO.lGS.gpt GPT 12
MOCK GPT 0
MOCK G-DMEM 0
The hCMV-GS transcription unit, and G-DMEM selection protocol, enabled PQXBl/2 
clones to be attained at a high frequency in glutamine-free medium (G-DMEM). 
However, no glutamine independent transformants were obtained when the SV40 early 
promoter was used to express the GS-gene, which is consistent with earlier data. 
These results add evidence that the SV40 early promoter is unable to transcribe the 
GS gene in GS-transformed PQXBl/2 hybridomas at sufficient levels to enable 
glutamine independent growth. The hCMV promoter though, was capable of expressing 
sufficient GS to enable growth in glutamine-free media. It was noticed that the 
transformation frequency when selecting for clones transformed with pCMGS.gpt was 
10-fold higher if glutamine free selection was used than when using gpt selection. 
This is thought to be due to interference ("promoter occlusion") occurring between the 
two transcription units.
Due to the high transformation frequencies obtained with both pCMGS and pCMGS.gpt, 
more than one clone was obtained per well of the 24-well plates. Consequently, the 
transformants were recloned by limiting dilution, employing mouse spleen feeder cells. 
The pCMGS clones were expanded in G-DMEM, and the pCMGS.gpt clones in both
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G-DMEM and gpt-selective media. Frozen cell stocks were made and stored under 
liquid nitrogen. The cell-lines were subsequently referred to as CMGS-PQXB (pCMGS 
transformants), and CMGSgpt-PQXB (pCMGS.gpt transformants) respectively.
5.4.10 MOLECULAR STUDIES OF THE CMGS-PQXB HYBRIDOMA.
Molecular studies of CMGS-PQXB hybridoma cell-lines were performed to confirm that 
their ability to grow in glutamine-ffee media was a consequence of transformation with 
the hCMV-GS transcription unit, and not a result of an alteration in the levels of 
expression of the endogenous gene.
A. SOUTHERN BLOT HYBRIDIZATION ANALYSIS.
DNA was extracted from both transformed and untransformed PQXB hybridomas and 
lOug samples were digested with Bgl 1 and Bgl 2 restriction enzymes. The resulting 
restriction fragments were separated by TAE agarose gel electrophoresis. Labelled 
DNA size markers were included on the gel, along with a range of different 
concentrations of pCMGS, digested with Bgl 1 and Bgl 2, to enable subsequent gene 
copy number analysis. The DNA was transferred to nylon membrane filters using 
Southern blotting and then probed with a 0.5Kb Bgl 2 to Eco Rl GS cDNA fragment, 
isolated from pCMGS (appendix 3). The results of a typical Southern blot 
hybridization are shown in Plate 5.6.
The GS-probe was found to cross-hybridize with the mouse endogenous GS-gene in 
PQXBl/2 cells, which was seen as a doublet of 6Kb and 5.5Kb, and a lower doublet 
of 3.5Kb and 3Kb. These bands served as an internal control for loading of the same 
amount of DNA on each track of the gel. In the cells transfected with pCMGS a 
2.1Kb fragment was also detected, which is the size predicted for the exogenous GS- 
gene in pCMGS (from a Bgl 1 site on the SV40 promoter 5’ of the GS cDNA to the 
Bgl 2 site at the 3’ end of the GS cDNA). By comparison with known amounts of 
vector DNA loaded in adjacent tracks, the average vector copy number in the CMGS- 
PQXB 1/2 hybridomas was estimated to be approximately one GS-gene copy per cell.
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LEGEND FOR PLATE 5.6
DNA samples were digested with Bgl 2 and Bgl 1, electrophoresed through a 1% TAE 
agarose gel, transferred to a nylon membrane, and hybridized with a GS-gene probe.
Lane 1. Molecular weight markers.
Lane 3. lOug PQXBl/2 DNA.
Lane 4. lOug CMGS-PQXBl/2 clone C DNA.
Lane 5. lOug CMGS-PQXB 1/2 clone E DNA.
Lane 7. pCMGS equivalent to 10copy per cell.
Lane 8. pCMGS equivalent to 50 copies per cell.
Lane 9. pCMGS equivalent to 100 copies per cell.
^  = Position of endogenous murine GS-gene.
= Position of exogenous CHO GS-gene from pCMGS.
PLATE 5.6 DNA HYBRIDIZATION ANALYSIS OF GS TRANSFORMED HYBRIDOMAS.
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LEGEND "fo r  PLATE 5.7.
25ug of RNA sample was electrophoresed through a 1.5% formaldehyde denaturing gel, 
transferred to a nylon membrane, and hybridized with a radiolabelled GS-gene probe. 
Subsequently, the probe was removed and the filters re-hybridised with 
an actin gene probe.
Lane 1. O.Sug pCMGS
Lane 2. RNA from PQXBl/2 cells grown in RPMI + 2mM glutamine.
Lane 3. RNA from PQXBl/2 cells grown in G-DMEM + 2mM glutamine.
Lane 4. RNA from SPG2 cells grown in G-DMEM.
Lane 5. RNA from CMGS-PQXBl/2 clone E grown in G-DMEM
PLATE 5.7 NORTHERN BLOT ANALYSIS OF GS TRANSFORMED HYBRTDOMAS.
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B. NORTHERN BLOT HYBRIDIZATION ANALYSIS.
RNA was extracted from both pCMGS transformed hybridomas and from PQXBl/2
untransformed hybridomas, and 25ug samples were electrophoresed through a 1.5%
formaldahyde denaturing gel. RNA from SPG2 cells, which have increased levels of 
the GS-gene, were included on the gel as "positive" controls. The samples were 
transferred to nylon membrane filters by Northern blotting and subsequently hybridized 
with the above GS-gene probe. The probe was found to cross-hybrid ise with the 
endogenous GS-mRNA*s of 2.8Kb and 1.4Kb, in the SPG2 control, but did not 
hybridise with RNA from the PQXBl/2 cell-1 ines. In the cells transformed with
pCMGS, an additional band of approximately 2Kb was detected. The results from
the Northern blot hybridization experiments are shown in Plate 5.7.
The GS probe was subsequently removed from the filter, and the filter re-hybridized 
with an actin-gene probe as described previously (section 3.3.1). The actin-probe was 
found to hybridise with the RNA from each sample with equal intensity, demonstrating 
that the same volume of RNA was present in each sample. This confirmed that the 
additional band present in the RNA extracted from transformed cells, and absent from 
the RNA extracted from untransformed cells, was a consequence of the transcription 
of the exogenous GS-gene from pCMGS, and not a "loading artefact".
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5.4.11 PHYSIOLOGICAL STUDIES OF CMGS-POXB CELL-LINES.
A. ELISA
To determine whether or not the pCMGS transformed hybridomas secreted antibody, 
20 of the CMGS-PQXB clones were screened for antibody production using ELISA 
(section 2.2). The clones were found to secrete varying levels of antibody, ranging 
from 2.5 to 25ug/ml (Table 5.6). Six of the transformants (ie. 30%) did not secrete 
detectable levels of antibody.
TABLE 5.6. ANTIBODY PRODUCTION BY CMGS-POXB CLONES.
CMGS-PQXBl/2
CLONE
MEAN ANTIBODY TITRE 
(ug/ml)
A 10.4
B 00.0
C 23.6
D 09.8
E 25.3
F 02.5
G 09.6
H 14.4
I 00.0
J 21.7
K 18.9
L 00.0
M 05.7
N 18.9
0 00.0
P 06.5
Q 15.6
R 00.0
S 11.2
T 00.0
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B. GS ENZYME SPECIFIC ACTIVITIES.
Levels of the specific activity of the GS enzyme were measured using a '^C-radiometric 
assay (section 2.2) in the two transformed CMGS-PQXBl/2 clones which secreted the 
highest titres of antibody (clones C and E). Negative controls were heat inactivated 
PQXBl/2 cells. The results demonstrate that the level of GS enzyme activity was 
greater in the hybridomas transformed with the GS-gene construct than in the 
corresponding untransformed hybridomas (Table 5.7). The level of enzyme activity was 
found to be greater, under the present conditions, for clone E than for clone C.
TABLE 5.7. GS SPECIFIC ACTIVITY IN CMGS-POXB CLONES.
CELL-LINE MEAN GS ACTIVITY 
(umol/min/10^ cells)
PQXB (negative control) 0.02
PQXBl/2 0.25
CMGS-PQXB (clone C) 0.57
CMGS-PQXB (clone E) 0.63
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c. GROWTH AND METABOLISM IN STIRRED-FLASK BATCH CULTURES.
Growth and metabolism of CMGS-PQXB clone E (CMGSE-PQXB) was investigated 
in batch culture in 1 litre stirrer flasks. Temperature was maintained at 37°C, pH 
at approximately 7.1, and agitation at 250rpm. Cells were inoculated at a density of 
2 X 1(P per ml in SOOmls of glutamine-ffee media (G-DMEM) with 10% (v/v) dialysed 
foetal calf serum. Cell number and viability were determined at twelve-hourly 
intervals, and samples were simultaneously taken and stored at -20®C for later analysis 
of; antibody, glucose, lactate, glutamine and ammonia. To act as a "control", 
untransformed PQXBl/2 hybridomas were grown under analagous conditions but in 
G-DMEM supplemented with 2mM glutamine. Samples were taken for the
.i
determination of cell number, cell viability, and metabolite concentrations, as for the 
transformed cells.
The growth curve for the CMGSE-PQXB transformed hybridoma in stirrer-flask batch 
culture is shown in Figure 5.4. A maximum cell density of 12 x 1(P was achieved 
after 85 hours, with a total cell viability of 90%. Specific growth rates (u) were 
calculated from cubic spline gradient data (section 3.2) and a single peak was observed 
at 70 hours, from which a maximum specific growth rate of 0.023h ' was determined. 
In comparison, the untransformed cell-line had a maximum cell density of 10 x 10^  
after 40 hours, and also a higher maximum specific growth rate of 0.042h*‘ after 28 
hours.
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Figure 5.4 Growth curve for the transformed CMGSE-PQXB hvbridoma during 
stirrer-flask batch culture and the growth rate \dx/dt\
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Figure 5.5 Growth curve for the untransformed PQXB 1/2 hvbridoma during 
stirred (flask') batch culture and the growth rate \dx/dt\
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Changes in the glucose and lactate concentrations in the growth medium of both the 
transformed CMGSE-PQXB hybridoma and the untransformed PQXBl/2 hybridoma are 
shown in Figure 5.6. For both, the glucose concentration in the growth medium was 
found to decrease, and the lactate to accumulate. Approximately 1.2 moles of lactate 
were produced for each mole of glucose consumed by the transformed hybridoma, and 
1.5 moles of lactate were produced for each mole of glucose utilised by the 
untransformed hybridoma.
FIGURE 5.6 : CHANGES IN GLUCOSE AND LACTATE CONCENTRATIONS.
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Levels of glutamine and ammonia present in the culture media were measured. For 
the transformed CMGS-PQXB hybridoma they were both found to be neglible. 
However, in the untransformed hybridoma, growing in medium initially containing 2mM 
glutamine, changes in the concentration of both glutamine and ammonia were found to 
occur. Figure 5.7 shows the concentration of glutamine present in the medium of the 
untransformed hybridoma during the course of the stirrer flask culture, and the phases 
of glutamine utilisation. Glutamine was found to be completely exhausted from the 
medium after 65 hours, which coincided with the decline in cell viability. Peaks in 
the rate of glutamine utilisation were observed after 25 hours and 50 hours of the 
culture. Ammonia was found to accumulate in the , medium, reaching a maximum 
concentration of 3mM after 50 hours (Figure 5.8). Three distinct phases of ammonia 
production were revealed by cubic spline interpolation, occurring after 20 hours, 40 
hours, and 78 hours of culture. The phases of glutamine utilisation and ammonia 
production are consistent with previous data which outlines a "tri-phasic culture 
physiology" for the PQXBl/2 hybridoma (section 3.3).
Antibody titre increased throughout batch culture of both transformed and untransformed 
hybridomas, and antibody continued to accumulate in the medium after the peaks in 
cell concentration at 85 hours and 40 hours respectively (Figures 5.9 and 5.10). 
Antibody titres of 11 ug/ml were obtained in the transformed cell-line, with a period 
of antibody production occurring at 65 hours (0.09ug/10*  ^ cells/hr). This corresponded 
to a decline in the specific growth rate of the culture. In the untransformed 
hybridoma an antibody titre of 2lug/ml was obtained, with a period of antibody 
production occurring after 40 hours (0.25ug/10® cells/hr). The data are consistent with 
non-growth associated antibody production.
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Figure 5.7. Changes in Glutamine (Gin) concentration in the medium 
and rates of utilisation (-dG\nldù.
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Figure 5.8. Changes in Ammonia CNH/1 concentration in the medium 
and rates of production
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Figure 5.9 Antibody (MAh') concentration and specific production 
rates \dMkhldt\ in the transformed CMGSE-PQXB hvbridoma.
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Figure 5.10 Antibody (MAb) concentration and specific production 
rates \dMAhldi\ in the untransformed PQXB 1/2 hybridoma.
Antibody
concentration
(ug/ml)
Antibody
production
rates
(ugAnl/h)
024
0.18
0.16
0.13
0.10
a.OE-2
53E-2
16E-2
hours
KEY.
•  = Antibody concentration 
— = Antibody production rates
1 8 9
D. GROWTH AND METABOLISM IN BATCH CULTURE IN A BTQREACTQR.
The stability of the transformed CMGSE-PQXB cell-line in "large-scale" culture in a 
controlled enviroment was investigated. The hybridoma was grown in stirred batch 
culture in a 14 litre capacity LH series 2000 fermenter. Temperature was maintained 
at 36.5’’C, pH at approximately 7.1, DOT at 40% and agitation at 200rpm (see section 
2.1). Cells were inoculated at a density of 2 x 10^  per ml in 10 litres of glutamine- 
free media (G-DMEM) with 10% (v/v) dialysed foetal calf serum. Cell number and 
viability were determined at twelve-hourly intervals. Samples were simultaneously taken 
for determination of the levels of antibody, glucose, lactate, glutamine and ammonia, 
and stored at -20°C for later analysis.
The growth curve for the CMGSE-PQXB transformed hybridoma in stirred batch culture 
is shown in Figure 5.11.
Figure 5.11 Growth curve for CMGSE-PQXB 1/2 hvbridomas during stirred batch 
culture in a bioreactor and the growth rate \dx/dt\
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Growth was characterised by a lag phase to 22 hours, followed by an exponential 
growth phase to 100 hours, and a decline phase. A maximum cell density of 2 x 10^  
was achieved after 100 hours, with a total cell viability of 91% Specific growth rates 
were calculated from cubic spline gradient data (section 3.2) and a single peak was 
observed at 30 hours. A specific growth rate of 0.041h ' was determined.
The glucose concentration in the growth medium was found to decrease, with 50% of 
the glucose utilised after 180 hours of culture (Figure 5.12). Lactate accumulated in 
the medium reaching a plateau concentration of 13mM shortly after the peak in cell 
density at 100 hours. Approximately 1.2 moles of lactate were produced for each 
mole of glucose consumed. The levels of glutamine and ammonia present in the 
culture media were measured and found to be neglible.
FIGURE 5.12
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Antibody titre increased throughout the batch culture and continued to accumulate in 
the medium after the peak in cell concentration at 100 hours (Figure 5.13). Antibody 
titres of 16ug/ml were obtained. A period of antibody production was observed with 
peak production occurring at 105 hours (0.11 ug/10^ cells/hr), which corresponded to 
a decline in the specific growth rate of the culture. The data obtained during 
growth of the transformed hybridoma in a bioreactor is consistant with the trends 
observed when the cell-line was grown in 1 litre stirrer flasks (5.4.11.C). However, 
in the bioreactor the duration of the culture was extended and greater cell yields were 
obtained.
Figure 5.13 Antibodv (MAbl concentration and specific production r a t e s  
\dM.khldi\ in the CMGSE-PQXB 1/2 hvbridoma in a biorector.
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5.5 DISCUSSION.
During this study electroporation was found to be a simple, rapid, and reproducible 
means of effectively transforming the PQXBl/2 hybridoma stably with exogenous DNA. 
Transformation frequencies in the range 10^ to 10  ^ were regularly achieved, depending 
on the vector construction employed. These results are comparable to those obtained 
from similar studies; Potter and colleagues (1984) obtained transformation frequencies 
in the range of 10  ^ to 10  ^ with both M12 mouse B-cell lymphoma cells, and mouse 
cytotoxic T-lymphocytes; Liu et al. (1987) reported that they achieved transformation 
frequencies of between 10*^  and 10  ^ when they expressed chimeric IgGl in mouse 
SP2/0 lymphoid cells; and Hendricks and colleagues (1988) attained a transformation 
frequency of 10  ^ to 10  ^ when they transformed mouse J558L myeloma cells with 
recombinant tPA.
The effective use of electroporation for DNA-mediated transformation requires careful 
optimisation of the electric field strength, and pulse characteristics, for each cell-line. 
It was fortunate that in this study an effective protocol, developed for an analogous 
cell-line, was available. To facilitate the optimisation of the electroporation conditions 
for cell transformations a simple and rapid dye staining technique using erythrosin-B 
has been developed (Winterboume et al., 1988). The transient expression of the firefly 
luciferase gene has also been found to be a rapid and sensitive indicator of gene 
expression, which can be employed to determine the effects of altering electroporation 
field strength on the transformation efficiency (Andreason and Evans, 1989).
During initial attempts to transform the PQXBl/2 hybridoma to glutamine independence 
the SV40 early promoter was used to drive expression of the CHO GS-cDNA. The 
SV40 early promoter region is active in a wide variety of cel 1-types from many 
species, including mouse cells (Ondek et al., 1988; Southern and Berg, 1982; Weidle 
and Buckel, 1987). The SV40 early promoter is less active than some other 
promoters, such as the human cytomegalovirus (hCMV) promoter (Boshart et al., 1985) 
and the Rous sarcoma virus long terminal repeat (RSV LTR) promoter (Cornelia et al., 
1982). However, the use of these very strong promoters may result in the 
overexpression of proteins, causing genetic instability. Furthermore, it was envisaged
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that the use of the "weaker" SV40 early promoter would result in the selection of 
transformants in which the GS-gene had been inserted at a particularly advantageous 
location in the host cell genome for its subsequent efficient transcription.
No glutamine-independent PQXBl/2 transformants were obtained though when the SV40 
early promoter was used to drive the expression of the exogenous GS-gene. This was
thought to be a consequence of the expression in these cells of insufficient levels of
GS to allow glutamine independent growth. Evidence for this speculation was obtained 
from the experimental data:-
1. In analogous transformations, the xanthine guanosine phosphoribosyl transferase 
(gpt) selectable marker gene, under the control of the SV40 early promoter, had been 
successfully introduced into the hybridoma using the same electroporation conditions, 
and stable transformants selected for resistance to my cophenol ic acid in medium 
containing xanthine, hypoxanthine and thymidine (gpt-medium). This demonstrated the 
effectiveness of both the transformation protocol and the SV40 early promoter in this 
cell-line.
2. To enable GS transformants to be selected using gpt-selection, the GS-gene was 
co-transformed into the hybridoma together with the gpt-gene, and the recipient cells 
were selected using gpt-selective media. No GS-transformants, however, were obtained. 
Selectable marker genes have been reported to be effectively co-transformed by
electroporation into lymphoid cells (Toneguzzo et al., 1986). As the integration of
exogenous DNA into the chromosomal host DNA is a rare event - only 0.05% to
0.1% of cells which have taken up the DNA are thought to integrate it into part of 
the nucleus (Winnacker, 1987) - it is unlikely that the gpt-gene expression vector DNA 
would integrate at one site, and the GS-gene sequence at a different site, on the same, 
or another, chromosome. DNA going into cells is thought to ligate together to form 
structures termed "pekalosomes". The co-integration of two plasmids into the same 
chromosome site has been found in recombinant CHO cells transformed with both a 
DHFR expression vector, and either the genes for recombinant tPA or CD4 IgG 
(Warum et al., 1990).
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3. To ensure that the GS-gene was introduced into the chromosomal DNA of the 
PQXBl/2 hybridoma, an expression vector (pKSVlO.lGS.gpt) was constructed which 
contained the GS-gene and the gpt-gene coding sequences, both under the regulatory 
control of SV40 early promoter sequences. Initially the vector was transiently 
expressed in COS cells. This enabled the rapid production of analytical quantities of 
protein for subsequent molecular and biochemical characterisation, required to 
demonstrate that the two cloned genes present in the vector were correctly transcribed, 
and translated into active enzyme. Subsequently, PQXBl/2 cells were transformed 
with pKSVlO.lGS.gpt by electroporation. Transformants were obtained growing in gpt- 
media, demonstrating the effective expression of the gpt-gene, but not in G-DMEM, 
conversely showing possibly inadequate expression of the GS-gene. The gpt- 
transformants were also found to be unable to grow in glutamine-free gpt media.
To achieve glutamine independent transformants vector constructs (pCMGS and 
pCMGS.gpt) were required which contained the CHO-GS cDNA gene coding sequence 
under the regulatory control of the human cytomegalovirus (hCMV) promoter region. 
The hCMV promoter is regarded as a relatively strong viral promoter capable of 
directing high levels of gene expression, and has little cell-type or species preference 
(Boshart, 1985). It was estimated that a single copy of the integrated GS-gene was 
present in the chromosomal DNA of the transformed hybridoma(s), which is consistent
with previous studies on the integration of exogenous DNA into the host cell
chromosome (Hendricks et al., 1988; Warum et al., 1990). The GS-gene has been 
used to transform a number of cell-lines to glutamine independence, including CHO, 
SP2/0 hybrid cells, and NSO myelomas (Bebbington and Yarranton, 1989). These 
transformations were carried out to enable the GS-gene to be used as a dominant 
selectable marker, and amplification system, for the expression of heterologous genes,
including tPA, TIMP, and chimeric antibodies.
Differences between the abilities of the SV40 early promoter and the hCMV promoter 
to express GS in mammalian cells have been reported (Bebbington and Yarranton, 
1989). In contrast to this study though, cell-lines were successfully transformed to 
glutamine independence with GS under the regulatory control of the SV40 early 
promoter, but the transformation frequencies were lower than the corresponding results
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obtained using the hCMV promoter. The reason for the differences in the abilities of 
the SV40 early promoter and the hCMV promoter to express GS-cDNA appears to be 
partly due to differences in the nucleotide sequences occuring in the regulatory region.
The SV40 early promoter has been analysed and within the regulatory region of SV40 
a number of enhancer sequences have been found (Banerji et al., 1981; Benoist and 
Chambon, 1981). As mentioned earlier (chapter 1) enhancers are cfr-acting regulatory 
elements of DNA that stimulate transcription of adjacent genes by RNA polymerase H, 
in either orientation, and over distances up to several kilobase pairs. The SV40 
transcriptional enhancer is composed of separate 15 to 20 bp-long enhancer elements 
that cooperate with one another, to enhance transcription (Ondek et al., 1988). These 
enhancer elements have been found to display unique patterns of cell-specific enhancer 
activity (Ondek et al., 1987; Schirm et al., 1987).
The hCMV promoter region has been found to contain several different enhancer 
sequences (Boshart et al., 1985). Four groups of directly repeated sequences have been 
identified which are 17bp, 18bp, 19bp and 21bp in length. However, unlike the repeat 
sequences in the SV40 promoter region, the repeats in the hCMV promoter region 
are imperfect and are separated by nonrepetitive DNA sequences. The hCMV 18bp 
and the 21bp repeat sequences have been found to share homology with repeat 
sequences found in the SV40 early promoter. In the SV40 early promoter the latter 
2 Ibp repeat sequence are known to bind the transcription factor Spl (Gidoni et al., 
1984).
Boshart and co-workers (1985) have found that different subunits of the hCMV 
enhancer region can independently substitute the SV40 enhancer. This infers that the 
strong enhancer sequences of hCMV have arisen through amplification and subsequent 
diversification of a set of original enhancer sequences. The various imperfect repeat 
motifs found to be separated from each other by nonrepetitive DNA in the hCMV 
enhancer region may be conserved units of such amplication processes. This diversity 
of enhancer elements in the hGMV promoter could explain why the relatively long 
hCMV promoter region is stronger than the SV40 early promoter region.
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The effect of genetically modifying glutamine metabolism on the growth and the 
physiology of the PQXBl/2 hybridoma was investigated. The glutamine-independent 
transformed CMGSE-PQXB cell-line was grown in glutamine-ffee media (G-DMEM) in 
a 1 litre stirrer flask, and its growth characteristics compared to those of the 
untransformed PQXBl/2 hybridoma grown under the same conditions, but in G-DMEM 
supplemented with 2mM glutamine. The transformed cells grew to a higher cell 
density and the culture was found to continue over an extended time period in 
comparison to the untransformed cells (Figure 5.14). Also, the transformed cells were 
found to have a lower maximum specific growth rate (0.023h*') compared to the 
untransformed cells (0.042h ‘). When the transformed hybridoma was grown in a 14 
litre stirred tank bioreactor, in which the external enviroment could be more precisely 
controlled, a very high maximum cell density of 2 x 1(P was achieved, and the batch 
culture continued for 200 hours.
FIGURE 5.14 : A COMPARISON OF THE GROWTH OF PQXBl/2 
AND TRANSFORMED CMGSE-PQXB HYBRIDOMA 
CELL LINES.
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Increased cell yields have been reported for a number of cell-lines growing in 
glutamine-ffee media, including human diploid cells (Griffiths, 1973) McCoy cells, 
BHK-21 cells, and Vero cells (Butler et a/., 1983; Hassell and Butler, 1989; 
Nahapetian et al., 1986). Glutamine in the medium is known to be prone to chemical 
decomposition (Tritsch and Moore, 1962) and to be degraded by serum-derived enzymes 
(Wein and Goetz, 1973), both of which release free ammonia which is cytotoxic 
(Butler, 1985; Glacken, 1988; Reuveny et al., 1986). Its catabolism as an energy 
substrate also generates cytotoxic concentrations of ammonia. It is, therefore, plausible 
that the observed enhanced cell yields of the transformed PQXBl/2 hybridoma are a 
consequence of the reduction in ammonia accumulation in glutamine-ffee media. This 
theory is supported by studies by lio and co-workers (1984) who have reported 
obtaining greater than 50% increases in cell yields for a myeloma cell-line when 
ammonia concentrations in the culture medium were reduced by the use of an absorbent 
(Silica-aluminum ZCP-50). Differences in the efficiency of the metabolism of the 
alternative energy substrates in the media (eg. glucose, pyruvate, glutamic acid) may 
also be a contributory factor.
In the transformed cell cultures there was a higher percentage of overall glucose 
utilised (40%) compared to the untransformed hybridomas (30%). A reduced ratio of 
glucose consumed to lactate produced (1.0:1.2) was also observed in the transformed 
cell-lines in comparison to the "parent" hybridoma (1.0:1.5). This data suggests that 
a greater proportion of the glucose utilised enters Krebs cycle, and hence is more 
efficiently catabollsed. However, this may be misleading since lactate can also be the 
end product of glutamine metabolism, and will consequently not accumulate by this 
route in glutamine-ffee media (Podge and Rubin, 1975; Lanks, 1987; Reitzer et at., 
1987).
Throughout the batch cultures of the CMGSE-PQXB hybridoma, in either the stirrer 
flasks or in the bioreactor, neither glutamine or ammonia were detected in the culture 
medium, indicating that in the transformed cell-line any glutamine synthesised remains 
in the cell where it is catabolised, and that any ammonia produced during the culture 
is rapidly utilised by the cell. The utilisation of ammonia is consistent with earlier 
data obtained for the PQXBl/2 hybridoma, which outlined a "tri-phasic" nutrient profile
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characterising growth and antibody production (chapter 3). During this sequence there 
were phases of anunonia production and utilisation. This pattern was also observed 
during batch culture of the untransformed hybridoma in 1 litre stirrer flasks in medium 
initially containing 2mM glutamine, there was a characteristic trend of glutamine 
depletion, paralleled by ammonia accumulation, the levels of ammonia rising from 1.2 
to 3mM.
Antibody production in the CMGSE-PQXB hybridoma was found to be non-growth 
associated, which is consistent with data for the untransformed PQXBl/2 cell-line, 
although' the transformed cell-line was found to secrete lower antibody titres (1 lug/ml) 
than the untransformed line (2lug/ml). From the data it appears that in the 
transformant, despite elevated levels of GS, synthesis of glutamine is sufficient for cell 
survival and proliferation, but inadequate to support the greater demand for synthesis 
of high yields of antibody. Crawford and Cohen (1985) found that not only was 
glutamine essential for lymphocyte differentiation in vitro, but also that immunoglobulin 
synthesis and secretion was considerably enhanced in the presence of glutamine. 
However, this hypothesis does not correlate with antibody production being non-growth 
dissociated.
1
in preliminary experiments
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CHAPTER 6.
CONCLUDING REMARKS.
The overall objective of this study was to investigate the effects of genetically 
modifying glutamine metabolism on the physiology of a hybridoma cell-line. To 
achieve this a number of specific aims were pursued;
1. The characteristics defining cell growth, metabolism, and product synthesis in the 
PQXBl/2 hybridoma during batch culture were established (section 3.4). A three-phase 
culture physiology was identified, in which there were defined periods of growth, 
antibody synthesis, and glutamine and ammonia production and utilisation. During this 
type of culture it was ascertained that; (i) the cell growth kinetics were analogous to 
the classical microbial kinetics outlined by Monod (1942), (ii) glutamine and glucose 
were both used as substrates, and their uptake parallelled by the accumulation of 
ammonia and lactate in the culture medium, (iii) antibody production was non-growth 
associated, and (iv), ammonia was assimilated.
The energy charge (EC) status of the cell was found to reflect the cell’s physiological 
status. From the data, evidence was obtained which suggests that EC is involved in 
the regulation of antibody synthesis, with antibody production occurring when the EC 
was within a particular "domain". Further studies are required to elucidate the 
mechanisms involved, for example, perhaps it is related to ribosomal efficiency during 
antibody synthesis.
2. Glutamine was found, during the above investigations, to be a key substrate for 
growth of the PQXBl/2 hybridoma. The carbon of glutamine is known to be a major 
energy substrate in cultured mammalian cells (Ardawi and Newsholm, 1982; Zielke, 
et al., 1978), and the amide nitrogen of glutamine provides the source of nitrogen in 
a plethora of biosynthetic reactions (reviewed by Meister, 1974), thereby, indicating the 
central role of glutamine in cell metabolism. The PQXBl/2 hybridoma was found to
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be incapable of adaptation to growth in the absence of glutamine, and glutamic acid 
was unable to substitute for glutamine as a substrate in this cell-line. This suggests 
that the cell has a low glutamic acid uptake rate, and/or expresses inadequate levels 
of GS to convert sufficient glutamic acid to glutamine to support cell growth. 
Variations in the abilities of different cell-lines, including CHO cells, HeLa cells, and 
human diploid cells (section 4.5), to adapt to growth in glutamine-free media have been 
reported in the literature (Ardawi and Newsholme, 1984; Griffiths, 1973; Hassell and 
Butler, 1989).
3. Glutamine can be synthesised within the cell by glutamine synthetase from glutamic 
acid and ammonia (Meister, 1974). During growth of the PQXBl/2 hybridoma in 
stirred batch culture, active GS was found to be expressed appar ently when the 
intracellular levels of glutamine were depleted (section 3.4.2). However, the levels of 
activity of the GS enzyme were found to be inadequate to support cell growth in the 
absence of exogenous glutamine (section 4.4). Variant hybridomas with amplified levels 
of the GS gene were obtained (section 4.4.1), but these cells still required low levels 
of glutamine (0.5mM) in the medium to support growth. Several cell-lines have been 
reported to grow in glutamine-free media following amplification of the endogenous GS- 
gene copy number, including CHO cells (Sanders and Wilson, 1984), mouse 3T6 cells 
(Young and Ringold, 1983), and mouse 3T3 cells (Bhandari et al., 1988). From 
analysis of the data collated during the present adaptation experiments, it was 
concluded that the hybridoma was unable to express sufficient endogenous GS to enable 
the synthesis of adequate amounts of endogenous glutamine to permit growth in the 
absence of glutamine supplementation.
4. To develop PQXBl/2 cells capable of growth in glutamine-ffee media, the cell was 
manipulated by increasing the levels of GS using recombinant DNA technology. To 
enable this, a method of transforming cell-lines to glutamine independence was 
established (section 5.4). This comprised transforming the cell-line by electroporation, 
with a vector containing an active GS-gene, growing the transformed cells on a medium 
initially containing glutamine, and subsequently diluting the glutamine out with fresh 
medium to a medium in which glutamine is lacking. It was found that transformation 
of hybridomas with vectors containing GS cDNA under the regulatory control of a 
SV40 early promoter failed to produce glutamine-independent clones (section 5.4.4 and
2 0 1
5.4.8). However, analagous transformations using vectors in which GS cDNA was 
expressed using the hCMV promoter, achieved glutamine-independent cell-lines (section
5.4.9). Evidence from the transformation data indicates that the SV40 early promoter 
expressed insufficient active GS enzyme for the transformed cells to grow without 
glutamine. Further analysis of clones transformed with GS cDNA under the control 
of the SV40 early promoter is needed to ascertain the reason for this.
5. The effect of transforming the hybridoma with GS on glutamine metabolism, and 
cellular physiology, were compared to observations made in the untransformed 
hybridoma (section 5.4.11). It was found that a number of the growth characteristics 
of the transformed cell were improved. A higher cell yield was achieved, and the 
culture was maintained over an extended time-period. This was thought to be a 
consequence of manipulating the cells’ metabolism to minimise the accumulation of 
ammonia, which is a cytotoxic endproduct of glutamine catabolism (section 5.5).
The transformed cell-line apparently utilized more glucose via Krebs cycle, since less 
lactate was produced per mole of glucose consumed, thereby, enabling greater yields 
of ATP to be achieved (see supplementary Figures A and B). However, the 
hybridoma secreted lower levels of antibody, which may be a consequence of the 
medium composition being optimal for cell growth, but not for antibody synthesis 
(discussed earlier during section 5.5).
In further studies it would be interesting to ascertain whether or not GS expression is 
triggered by a depletion in the levels of intracellular glutamine, as suggested by this 
study. It would also be of interest to determine the fate of the glutamine synthesised 
by the transformed cell, by growing the cells in the presence of radiolabelled 
precursors. In addition, the possibility of optimising the glutamine-free medium 
formulation to enable production of greater levels of antibody requires investigating.
During this study a programme was initiated to modify the metabolism of animal cells, 
and one genotypic change has been made to a major biochemical pathway. The 
resulting cell-line exhibits a number of favourable growth characteristics, thereby, 
making it a good "host" cell-line for further genetic manipulations. One such strategy
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could be to manipulate the pathway through which glutamic acid is metabolised (Figure 
A).
Glutamic acid may be catabolised either via glutamate ddiydrogenase (GDH) to alpha- 
ketoglutarate, and subsequent Krebs cycle conversions, or by either alanine or aspartate 
transaminases. If all the glutamic acid is processed via GDH the terminal products 
may be either; pyruvate, lactate, or acetyl-CoA, and the ATP yields would be 9, 12 
and 15 moles of ATP per mole of glutamic acid catabolised, respectively. Higher 
ATP yields cannot be obtained since acetyl-CoA is not oxidized in Krebs cycle by 
mammalian cells (Lanks, 1987; Zielke et al., 1978). However, if all the glutamic acid 
is processed via either alanine or aspartate transaminases, alanine and aspartate 
respectively are the end products, and only 9 moles of ATP are formed per mole of 
glutamic acid utilized. Increasing the levels of GDH in the cell, therefore, will direct 
glutamic acid catabolism via the o/pAa-ketoglutarate - pyruvate route, and thus should 
maximise the levels of ATP available to the cell.
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APPENDIX 1.
TISSUE CULTURE MEDIA FORMULATIONS (GIBCO T.TFE TECHNOLOGIES INC.^ 
RPMI Media Series 1603,1629,1630,1634,1640
The RPMI media series , developed at Roswell Park Memorial institute, were designed specifically for growing human and 
m ouse leukaemia cells. ___
RPMP 1603 
C a t No. 
041-1915
RPMP 1629 
C a t No. 
041-1845
RPMP 1630 
C a t No. 
041-1855
RPMP 1634 
C a t No. 
041-1885
--------
RPMP 1640 
C a t No. 
041-1875
Inorganic Salts mg/L mg/L mg/L mg/L mg/L
CaCL 100.00
Ca(NO,), • 4H ,0  \ 200.00 100.00 100.00 100.00
FeSO. • 7H ,0 1.00
KCI 400.00 400.00 400.00 400.00 400.00
MgSO; • 7H ,0 200.00 200.00 100.00 100.00 100.00
MnSO, • H ,0 1.00
NaCI 6000.00 6460.00 6000.00 6000.00 6000.00
NaHCO, 1500.00 • 2200.00 2000.00
NaH,PO. • 2H .0 260.00 i 580.00 ,
NajHPO, ■ 7H,0 152.00/, 2835.00 2835.00 1512.00;
Other Com ponents
Eacto-peptone 600.00
Glucose 2500.00 3000.00 2500.00 2000.00 2000.00
Glutathione (reduced) 0.50 10.00 10.00 1.00
Phenol red 5.00 10.00 5.00 5.00 5.00
Amino Acids
L-Alanine 13.40
L-Arginine HCl 200.00 42.10 200.00 100.00 200.00
L-Asparagine 50.00 45.00 30.00 30.00 50.00
L-Aspartic acid 19.90 30.00 30.00 20.00
L-Cysteine HCl a 31.50
L-Cystine 50.00 100.00 100.00 50.00
L-Gtutamic acid 15.00 . 22.10 80.00 80.00 20.00
L-Qlutamine 500.00 219.20 300.00 300.00 300.00
Glycine 15.00 7.50 15.00 15.00 10.00
L-Histidine HCl • H ,0 20.00 20.90 a 35.00 35.00 15.00
L-Hydroxyproline 19.70 20.00
L-lsoleucine (Alio free) 80.00 39.30 50.00 50.00 50.00
L-Leucine (Methionine free) 80.00 39.30 50.00 50.00 50.00
L-Lysine HCl 25.00 36.50 60.00 75.00 «10.00
L-Methionine 30.00 14.90 15.00 15.00 15.00
L-Phenylalanine 20.00 15.50 30.00 30.00 15.00
L-Proiine (Hydroxy L-Proline free) 10.00 17.30 30.00 30.00 20.00
L-Serine 100.00 26.30 50.00 50.00 30.00
L-Threonine (Alio free) 35.00 17.90 50.00 50.00 20.00
L-Tryptophan “ 20.00 3.10 10.00 10.00 5.00
L-Tyrosine 20.00 18.10 30.00 30.00 20.00
L-Valine 10.00 17.60 40.00 40.00 20.00
Vitamins
Ascorbic acid 0.50
Biotin 0.05 0.20 0.20 0.10 0.20
D-Ca pantothenate 0.25 0.20 3.00 0.25 0.25
Choline Cl 2.00 5.00 3.00 3.00 3.00
Folic acid 0.01 10.00 2.00 1.00 1.00
Folinic acid 0.01
i-lnositol 5.00 36.00 5.00 15.00 35.00
Niacin 0.01
Nicotinamide 0.20 0.50 2.50 2.50 1.000
Nicotinic acid 0.50
Para-aminobenzoic acid 0.50 1.00 0.50 1.000
PyridoxaJ HCl 0.50
Pyridoxine HCl 1.00 0.50 2.00 2.00 1.000
Riboflavin 0.10 0.20 0.50 0.25 0.200
Thiamine HCl 0.25 0.20 5.00 0.25 I.OO'Aj
Vitamin B„ 0.05 2.00 0.05 0.10 o.oorv
1  ^ -  Medium used during this study.
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Eagle’s Media and Modified Eagle’s Media
3ME. B au i Medwm (EaçM)
H t  Eagt*. a  PSEBM 8M 82 (1955) MEM IfKl ModWWd e*3M M«oium
Component
BMP
Ammo Ackl
(50x1 
Cat. No. 
043-1050
BMP
SotuPon 
(100x1 
Cat. No. 
043-10*1
BMP
Sotutnn 
(lOOx) 
Cat. No. 
043-1040
BMP
Eana’s
Liquid 
C at No. 
041-1010
BMP 
Han**- 
U qud 
C at No. 
041-1370
0ui6«eeo'i'
MEM
Liquid
CaLNo.
041-11*5
Outpaced** 
MEM 
Liquid 
C at No. 
*41-19*5
lacova*
ModAad
DuiPaeco':
Medium
Cat No.
041.1510
Oulpeccd'i
MEM
(10x1
CaLNo.
042-3501
Inorganic Salts 
CaCl, (anhyd.) 
CaCl, • 2H ,0
m g/L m g/L m g/L m g/L
200.00
m g/L
140.00
mg/L
200.00
mg/L
200.00
mg/L
165.00
m g/L
2640.00
Fe(NO,), : 9H ,0  
KCI 400.00 400.00
0.10
400.00
0.10
400.00 330.00
1.00
4000.00
KNO,
KH,PO, 60.00
0.076
MgCI, • 6HjO 
M gSO, (anhyd.)
100.00
97.67
M gSO. - 7H ,0  
NaCI 8500.00
200.00
6800.00
100.00
8000.00
200.00
6400.00
200.00
6400.00 4505.00
2000.00
64000.00
NaHCO, 
NaHjPO, ■ H ,0
2200.00
140.00c
350.00 3700.00
125.00a
3700.00
125.00a
3024.00
125.00 1250.00
Na,HPO. ■ 7H ,0  
N a,SeO , • 5H ,0
90.00
0.0173
O ther C om ponents
G lucose
H epes
1000.00 1000.00 1000.00 4500.00 4500.00
5958.00
45000.00
Phenol red
Potassium  penicillin G 4
10.00 10.00 15.00 15.00 15.00 170.00
Sodium pyruvate 
Sodium succinate
110.00 110.00
Streptomycin sulphate 
Succinic acid
Amino A cids
L-Alanine
L-Arginine
25.00 356.00
L-Arginine ; HCl 
L-A sparagine
1050.00 2100.00 21.00 21.00 84.00 84.00 34.00
25.00
840.00
600.00
L-Aspartic acid 
L-Cystine 500.00 1200.00 12.00. 12.00 48.00 48.00
30.00 530.00
480.00
L-Cystine • 2HCI 
L-Glutamic acid
91.24
75.00 590.00
L-Glutamine
Glycine
292.00 292.00 580.00
30.00
580.00
30.00
584.00
30.00 300.00
L-Histidine
L-Histidine HCl • H ,0
400.00 800.00 8.00 . 8.00
42.00 4ZOO 42.00 420.00
L-lsoleucine
L-Leucine
1300.00
1300.00
2600.00
2600.00
26.00
26.00
26.00
26.00
105.00
105.00
105.00
105.00
105.00
105.00
1050.00
1050.00
L-Lysine 
L-Lysine HCl 1812.00 3625.00
29.20 29.20
146.00 146.00 146.00 1460.00
L-Methionine
L-Phenyialanine
375.00
825.00
750.00
1650.00
7.50
16.50
7.50
16.50
30.00
66.00
30.00
56.00
30.00
56.00
300.00
660.00
L-Proline
L-Serine 42.00 42.00
40.00
4ZOO
460.00
420.00
L-Threonine
L-Tryptophan
1200.00
200.00
2400.00
400.00
24.00
4.00
24.00
4.00
95.00
16.00
95.00
16.00
95.00
16.00
950.00
160.00
L-Tyrosine
L-Tyrosine
900.00 1800.00 18.00 18.00 7Z00 72.00
104.20
720.00
(Disodium salt) 
L-Valine 1175.00 2350.00 23.50 23.50 94.00 94.00 94.00 940.00
Vitamins
Siotin
D-Ca pantothenate
100.00
100.00
1.00
1.00
1.00
1.00 4.00 4.00
0.013
4.00 40.00
Choline bitartrate 
Choline chloride 100.00 1.00 1.00 4.00 4.00 4.00 40.00
Folic acid 
i-lnositol
100.00
180.00
1.00
1.80
1.00
1.80
4.00
7.20
4.00
7.20
4.00
7 2 0
40.00
72.00
Nicotinamide 
Pyridoxal HCl
100.00
100.00
1.00
1.00
1.00
1.00
4.00
4.00
4.00
4.00
4.00
4.00
40.00
40.00
Riboflavin 
Thiamine HCl
10.00
100.00
0.10
1.00
0.10
1.00
0.40
4.00
0.40
4.00
0.40 
. 4.00
4.00
40.00
Vitamin S.. 0.013
|y =  Medium used during this study.
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APPENDIX 2.
Nucleotide Cal and predicted amino acid sequence for the CHO GS gene, 
together with the published peptide sequences fc') and peptide designations 
tdl of the bovine brain GS. (from Havward et aL. 1986)
1 1 0  2 0  3 0  110 5 0  6 0  7 0
a :  --CCCAGCCGAGAATGGGAOTAGAGCCGACTGCTTGATTCCCACACCAATCTCCTCGCCGCTCTCACTTCG  ' » > » » > > » » » » » »  »>> « «  <<< « < «  «<
80 g o  100 .110 120 130 m o
a :  CCTCGTTCTCGTGGCTCGTGGCCCTGTCCACCCCGTCCATCATCCCttsacafltACCGCi'CAGAGCACCTTCCAÛG  
«  «<<<<«>»> » » »  <<<<<< «  «
150 160 170 1 8 0  190 200  210  220
a :  ATGGCC A C C T C A G C AA G rrC C C AC TTG A A CA A A A A C A TC A A G C A A A TO TA C TTG TG C C TO C C CC A G G C TG A G A A A  
b ;  " i r ~ A  T S Â S S H L N K N I K Q H Ï  L C L P Q G E K  
c ;  AcA, T ,  S ,  A,  S ,  S ,  H, L B K g  I  K Z v  Y m  a  L P Q C d  K
d :  C8 X-D • CB X I - B
1 5 10  1 5 *  20
230 2 l|0 2 5 0  260  ' 2 7 0  280 290
a ;  GTCCAAGCCATOTATATCTGCQTTGATGOTACTGGAGAACGACTGCGCTCCAAAACCCGCACCCTGGACTGTGAG 
b t V Q A H Y I W V D O ' T O E G L  R C i C T R T L D C E  
o l V Q A H Y I H l  D G T G E O L R C K T R T L X s X  
d :  Cfl V I I
25  3 0  3 5  40  4 5
30 0  3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  360 3 7 0
a :  CCCAAGTGTGTAGAAGAGTTACCTOAGTGGAATrrTGATGOCTCTAGTACCTTTCAGTCTGAGGGCTCCAACACT 
b t  P K C  V E E L  P E W  M F D G  S S T F Q  S  E * G  S H S
o t P K k p a ' a t n l z r
50  5 5  60 6 5  70
3 8 0  3 9 0  4 0 0  4 1 0  4 2 0  4 3 0  « 4 0
a ;  GACATGTATCTCAGCCCTGTTGCCATGTTTCGOGACCCCTTCCGCAGAGATCCCAACAAGCTGGTGTTCTGTGAA 
b ;  D M  Y L  S P V A H F R D P F R R D P H K L V F . C . E
o ;  H Y L v P a A  H F  R D P F k R D P  H X L V F C E  
d :  CB X I I - C  CB V I - C
75  M  85  90 95
4 5 0  4 6 0  470 4 8 0  4 9 0  5 0 0  5 1 0  5 2 0
a ;  GTTTTCAAGTACAACCGGAAGCCTGCAGAGACCAATTTAAGGCACTCGTGTAAACGGATAATGGACATGGTGAGC 
b : V F K Y H  R K P A E T N L R H S C K R  I H D M V S  
o î V F X Y N k r P A E T N L X X t C  H B H  V S
d :  CB XIV CB X I I - C
10 0  1 0 5  1 1 0  1 1 5  1 2 0
5 3 0  5 4 0  5 5 0  5 6 0  5 7 0  5 8 0  5 9 0
a ;  AACCAGCACCCCTGOTTTGOAATOOAACAGGAGTATACTCTGATGGGAACAGATGGGCACCCTTTTGGTTGGCCT 
b : N Q H P W F G H E Q E Y T L H  O T D O H P F G W P  
o t N Q X P X F O H E Q E Y T L H O T r G r P F G  X P  
d ;  CB X I I - A  CB V I - D
1 2 5  130 1 3 5  1 40  14 5
600 610 620 630 6 4 0  650 660 670
a :  TCCAATGGCTTTCCTOOGCCCCAAOGTCCGTATTACTGTGGTOTGGGCGCAGACAAAGCCTATGGCAGGGATATC
b : 3 M G F P 0 P Q 0 P Y Y C G V G A D K A Y G R D I
c r S H C F X O P Q a
150 1 5 5  1 6 0  1 6 5  1 7 0
6 8 0  690 700  7 1 0  720  '  730 7 4 0
a ;  GTGGAGGCTCACTACCGCGCCTGCTTGTATGCTGGGGTCAAGATTACAGGAACAAATGCTGAGGTCATGCCTGCC 
b : V E A H Y R A C L Y A O V K I T G T N A E V M P ‘ A 
c :  A C L Y A G I K  g O T  H X X V H P A
d ;  T V I I - G  -  CB V I - D  CB X I - J l
175 1 8 0  1 8 5  190 195
750 760  770  780  790 *'  800 "  810 820
a ;  CAGTGGGAATTCCAAATAGGACCCTGTGAAGGAATCCGCATGGGAGATCATCTCTGGGTGGCCCGTTTCATCTTG
b j Q U E F Q I G P C E G I R M G D H L W V A R F I L
c ; Q W . E F Q l G P C E G I d H
2 0 0  205 2 1 0  2 1 5  2 2 0
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8 3 0  8 4 0  • 8 5 0  6 6 0  8 ? 0  8 8 0  8 9 0
a :  CATCGAGTATGTGAAGACTTTGGGGTAATACCAACCTTTGACCCCAAGCCCATTCCTCOGAACTGGAATGGTCCA 
b t U R V C E D F G V I A T F D P K P I P G N W H G A  
2 2 5  2 3 0  2 3 5  2 4 0  2 4 5
9 0 0  9 1 0  9 2 0  9 3 0  9 4 0  9 5 0  9 6 0  9 7 0
a ;  GGCTGCCATACCAACTTTAGCACCAAGGCCATGCGGGAGGAGAATGGTCTGAAGCACATCGAGGAGGCCATCGAG 
b - . G C H T H F S T K A H R E E H G L K H I E E A I E  
o ;  H X E E N G L K y l E E A I E
d :  CB I I I - C
2 5 0  2 5 5  2 6 0  2 6 5  2 7 0
9 8 0  9 9 0  1 0 0 0  1 0 1 0  1 0 2 0  1 0 3 0  1 0 4 0
a :  AAACTAAGCAAGCGGCACCGGTACCACATTCGAGCCTACOATCCCAAGCGGGGCCTGGACAATGCCCGTOGTCTG 
b : K L S K R H R Y H I R A Y D P K G O L D N A R G L  
c t X L S t K s n l n y q  A Y B P K
d :  T I X - B - 2  T I X - B - 1
2 7 5  2 8 0  2 8 5  2 9 0  ' 2 9 5  "
1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0  1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0  
a ;  ACTGGGTTCCACGAAACGTCCAACATCAACGACtTTTCTGCTGGTGTCGCCAATCOCAGTGCCAGCATCCGCATT 
b z T G F H E T S N I f l D F S A G V A H R S A S I R I  
c ;  T S N I M y q  g - A S I R I
d :  ( - C B  I I I - C )  T I X - C - 1
3 0 0  3 0 5  3 1 0  3 1 5  3 2 0
1 1 3 0  1 1 4 0  1 1 5 0  1 1 6 0  1 1 7 0  1 1 8 0  1 1 9 0
a :  CCCCGGACTGTCGGCCAGGAGAAGAAAGGTTACTTTGAAGACCGCCGCCCCTCTGCCAATTGTCACCCCTTTGCA 
b ;  P R T V G Q  E K  K G Y F E D R R P S A N C D P F A
c :  P R
d :  T I X - E
3 2 5  3 3 0  3 3 5  3 4 0  3 4 5
1 2 0 0  1 2 1 0  1 2 2 0  1 2 3 0  1 2 4 0  1 2 5 0  1 2 6 0  1270
a :  GTGACAGAAGCCATCGTCCGCACATGCCTTCTCAATGAGACTGGCGACGAOCCCTTCCAATACAAAAACTAATTA 
b ;  V T E A I  V R T C L L H E T Q D E P F Q Y X N » » »
o :  T C L L N Z T G B Z P F Q Y K
d :  T V I - K
3 5 0  3 5 5  3 6 0  3 6 5  3 7 0  3 7 2
1 2 8 0  1 2 9 0  1 3 0 0  1 3 1 0  1 3 2 0  ^ ' ( « ^ 1 3 3 0  1 3 4 0
a :  GACTTTGAGTGATCTTGAGCCTTTCCTAGTTCATCCCACCCCGCCCCAGCTGTCTCATTGTAACTCAAAGGATGG
1 3 5 0  1 3 6 0  1 3 7 0  1 3 8 0  1 3 9 0  1 4 0 0  1 4 1 0  1 4 2 0
a :  AATATCAAGGTCTTTTTATTCCTCGTGCCCAGTTAATCTTCCTTTTATTGGTCAGAATAGAGGAGTCAAGTTCTT 
e :  AATATCAAGGTCTTTTTATTCCTCGTGCCCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA
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APPENDIX 3.
PLASMID RESTRICTION MAPS.
A. Plasmid pCMGS (CelltechL
pCMGS contains the major immediate early gene promoter, enhancer, and complete 5’- 
untranslated sequence from human cytomegalovirus (hCMV-MIE), inserted between the 
Nco 1 sites such that it directs expression of the CHO-GS coding sequence. The 
region of the plasmid used to prepare a GS-gene probe is shown.
PvuII
Ncol
Ncol
pCMGS
74 J 4
A Ncol 
Ncol
EcoRI
ECoRI
BamHI
GS Probe
208
B. Plasmid pKSVlO (Pharmacia).
pKSVlO is a shuttle vector for the transfer of cloned DNA from E.coli into 
mammalian cells. The plasmid contains a unique Bgl 2 site between the SV40 early 
promoter and the large SV40 T antigen. Downstream from the distal large T antigen 
splice site is the SV40 early polyadenylation signal. RNA is transcribed from the 
SV40 early promoter, spliced using the large T antigen splice signal and terminated 
at the SV40 early polyadenylation signal. The plasmid was used during this study to 
construct pKSVlO.lGS.gpt (Figure 5.2).
S a l  I * P o ly a d e n y la tio n  S i te
pKSV-10
■^7900 b p
p8R322
on
mRNA splice junctions
SV40 ori 
SV40 72-bp and 21 -bp repeats
Kpn
EcoR I
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c . Plasmid pKSVlO.lGS^gpt»
The construction of pKSVlO.lGS.gpt is illustrated in Figure 5.2 and details are given 
in the text (section 5.3). The plasmid was derived from pKSVlO and used to express 
the CHO GS cDNA from pSV2.GS, and the E.coli "gpt" gene in mammalian cells.
Bam H1
Bam H1
Kpn1
p K S V IO G SG PT  
- (11 .5K b)
Hind 3
Bam HI Bgl 2
KEY
P = promoter region 
pA = poly adénylation S. splice sites
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D. Plasmid pSV2GS
pSV2GS is derived from the pSV2 series of vectors (Mulligan and Berg, 1980). The 
vector contains the CHO-GS coding sequence (Nael to PvuII nucleotides), . inserted 
between the Hindin and Bgl H sites, such that its expression is directed by the SV40 
early promoter.
AMP
vu
ORI
5-5kb
EcoRI Hind
’y A
BamHI
Bglll
APPENDIX 4.
LISTINGS OF THE CUBIC SPLINE CURVE FITTING PROGRAMME (M.E.BUSHELLT
5MODEO
6*CAT
10DIMX(60),Y(60),DY(60),A(60),B(60),C(60),D(60),slope(300) 
20DIM R(60),R1(60),R2(60),T(60),T1(60),U(60),V(300),J(300) 
30CLOSE£0
40INPUT"NAME OF DATA FILE," FILE$
50D=OPENIN FILE$
60INPUT£D,N2 
70PRINT"ENTER X,Ys"
80FOR R= 1 TO N2 
90 INPUT £D,X(R),Y(R) 
lOOIF Y(R)=0 THENY(R)=0.0001 
110IFR=1 THEN 140 
120IFX(R)>X(R-1) THEN 140 
130PRINT"NOT ALLOWED": GOTO 90 
140 NEXT R 
150CLOSE£0 
160N1=1:S=100 
170PROCFIT 
172PROCMEAN
175 FOR 1=1 TO N2:DY(I)=mean/fit:NEXT
180M1=N1-1
190M2=N2+1
200R(M1)=0
210R(N1)=0
220R1(N2)=0
230R2(N2)=0
240R2(M2)=0
250U(M1)=0
260U(N1)=0
270U(N2)=0
280U(M2)=0
290P=0
300M1=N1+1
310M2=N2-1
320H=X(M1)-X(N1)
330F=(Y(M1)-Y(N1))/H 
340FOR 1= Ml TO M2 
350G=H
360H=X(I+1)-X(I)
370E=F
380F=(Y(I+1)-Y(I))/H
390A(I)=F-E
400T(I)=2*(G+H)/3
410Tl(I)=H/3
420R2(I)=DY(I-1)/G
430R(I)=DY(I+1)/H
440R1(I)=-DY(I)/G-DY(I)/H
450NEXT
460FOR 1= Ml TO M2
470B(I)=R(I)*R(I)+R1(I)*R1(I)+R2(I)*R2(I)
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480C(I)=R(I)*R1(1+1)+R1(I)*R2(1+1) 
490D(I)=R(I)*R2(I+2)
500NEXT
510F2=-S
520FOR 1= Ml TO M2 
530R1(I-1)=F*R(I-1)
540R2(I-2)=G*R(I-2)
550R(I)=l/(P*B(I)+T(I)-F*Rl(I-l)-G*R2(I-2)) 
560U(I)=A(I)-Rl(I-l)*U(I-l)-R2(I-2)*U(I-2) 
570F=P*C(I)+T1(I)-H*R1(I-l)
580G=H
590H=D(I)*P
600NEXT
610FOR I=M2 TO Ml STEP -1
620U(I)=R(I)*U(I)-Rl(I)*U(I+l)-R2(I)*U(I+2)
630NEXT
640E=0
650H=0
660FOR I=N1 TO M2 
670G=H
680H=(U(I+1)-U(I))/(X(I+l)-X(I)) 
690V(I)=(H-G)*DY(I)*DY(I)
700E=E+V(I)*(H-G)
710NEXT
720V(N2)=-H*DY(N2)*DY(N2)
730G=V(N2)
740E=E-G*H
750G=F2
760F2=E*P*P
770IF F2>=S OR F2<=G THEN 910 
780F=0
790H=(V(M1)-V(N1))/(X(Ml)-X(Nl))
800FOR 1= Ml TO M2 
810G=H
820H=(V(I+1)-V(I))/(X(I+l)-X(I))
830G=H-G-R1 (T-1)*R(I-1)-R2(I-2)*R(I-2)
840F=F+G*R(I)*G
850R(I)=G
860NEXT
870H=E-P*F
880IF H <= 0 THEN 910 
890P=P+(S-F2)/((SQR(S/E)+P)*H)
900GOTO 520 
910FOR I=N1 TO N2 
920A(I)=Y(I)-P*V(I)
930C(I)=U(I)
940NEXT
950FOR I=N1 TO M2 
960H=X(I+1)-X(I)
970D(I)=(C(I+1)-C(I))/(3*H) 
980B(I)=(A(I+1)-A(I))/H-(H*D(I)+C(I))*H 
990NEXT
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lOOOCLS
1010J=0
1020FOR I = 1 TO N2
1030FOR XX=X(I) TO X(I+l)-X(N2)/300 STEP X(N2)/300
1035J=J+1:IF J> 300 THEN 1060
1040H=XX-X(I)
1050 V(J)=(X(I)+H):J(J)=(((D(I)*H+C(I))*H+B(I))*H+A(I)) 
1060NEXT,
2010MODE1
2020VDU19,3,6,0,0,0 
2030 MOVE100,100 
2040PROCMAX 
2050YMAX=0
2060FORI=2 T0300:IFJ(I)>YMAX THEN 2300
2070 NEXT
2075PROCYMAX
2078PROCSLOPES
2080PROGaxes{XMAX,YMAX)
2160FORI=2TO J-1 
21700=2
2180PROCplot(V(I),J(I),C,I,YMAX)
2200IF slope(I)<0 THEN 2220
2210 PROCplot(V(I),slope(I),C-1,I,slopemax)
2220NEXT
2225PROCZMAX
2230GCOL0,l
2240VDU5
2250FORR=1TON2:MOVE(82+X(R)/XMAX*1087),(108+Y(R)*720/YMAX)
2260PRINT"*"
2270NEXT
2280PROCend
2290END
2300YMAX=INT(J(I)+l):GOTO2070 
2310DEF PROCaxes(XMAX,YMAX)
2320COLOUR1:PRINT"VALUES USING ";lab;"% PARTIAL CUBIC SPLINE" 
2330 PRINT"FILE ";FILE$
2340PRINT"INPUT P FOR PRINTOUT"
2350PRINT" N FOR DIFFERENT 0 OF POLY"
2360PRINT" M TO EXIT TO MENU"
23 70MOVE100,820:DRAW100,100:DRAW 1279,100 
2380VDU28,0,5,39,0 
2390VDU5:FORI=0TO10
2400X=100+110*I:MOVEX,100:DRAW X,90 
2410Y=100+70*I:MOVE 100,Y:DRAW 90,Y 
2420MOVE X-20,30:PRINT;I*XMAX/10 
2430MOVE 0,Y+10:PRINT;I*YMAX/10:NEXT I 
2440MOVE100,100 
2450 Y=0 
2460ENDPROC
2470 DEF PROCplot(X,Y,C,I,MAX)
2490 PLOT69,(100+X/XMAX*1087),(100+Y*720/MAX)
2500 ENDPROC
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2510DEFPROCend 
2520CLOSEE0 
2530INPUT X$
2540IF X$="P" THEN *GIMAGE EPC T H&170 V&170
2550IF X$="N" THEN ENDPROC
2560ENDPROC
2570DEFPROCMAX
2580 XMAX=INT(X(N2))
2590REPEAT
2600XMAX=XMAX+1
2610UNTIL XMAX/10=INT(XMAX/10)
2620ENDPROC
3000DEFPROCYMAX
3005YMAX=YMAX-1
3010REPEAT
3020YMAX=YMAX+1
3030UNTIL YMAX=INT(YMAX)
3040ENDPROC 
4000DEFPROCMEAN 
■‘4005 total=0 
4010FOR R=1 TO N2 
4020total=total+Y(R)
4030NEXT
4040mean=total/N2 
4050ENDPROC 
4999DEFPROCFIT 
5000INPUT "%FIT",X
5050Y=-240.602259+(X*12.097012)-(X*X*0.222751935)+(X*X*X*2.04077541 
X*7.53139105E-6)-(X*X*X*X*X*1.22210512E-8)-(X*X*X*X* E-3)-(X*X*X*
X*X*4.44614344E-10)+(X*X*X*X*X*X*X*6.87608965E-12)
5060fit=Y 
50701ab=X 
5080ENDPROC 
6000DEFPROCZMAX 
6050MOVE 1200,100 
6065DRAW 1200,820 
6070FOR I%= 1 TO 10
6080Z=100+70*I%:MOVE 1200,Z:DRAW 1190,Z 
6090MOVE 1030,Z+10;PRINT;I%*slopemax/10 
6100NEXT
7000DEFPROCSLOPES 
7005slopemax=0 
7010FOR 1% = 2 TO 300
7015 IF (V(I%)-V(I%-1))=0 THEN slope(I%)=0 
7017 IF (V(I%)-V(I%-1))=0 THEN 7050
7020slope(I%)=(J(I%)-J(I%-l))/(V(I%)-V(I%-l)):IF J(I%)=0 THEN 7050 
7030IF slope(I%)<0 THEN 7050
7040 IF slope(I%) > slopemax THEN slopemax=slope(1%)
7050NEXT
7052 slopemax=slopemax*1000 
7054 slopemax=INT(slopemax)
7056 slopemax=slopemax/1000 
7060ENDPROC
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APPENDIX S.
PROTOCOL FOR NMR MEAUSUREMENTS (K.BRINDLE & P.BRADDOCIO
Media samples (100ml) were collected during the course of a batch culture, in which 
PQXBl/2 hybridoma cells were grown in RPMI containing ImM '^N-NH^Cl (section 
3.4.3). Samples were freeze-dried at Surrey University and then sent for analysis by 
^N-NMR. The analysis was carried out as outlined below by Kevin Brindle and Peta 
Braddock (Biochemistry Department, Oxford University).
A. Extracting Media For NMR.
Freeze-dried media was resuspended in an equal volume of cold acetone, and left for 
15 minutes on ice. The protein precipitate was removed by centrifugation at 2000g 
at 4°C for 5 minutes. Residual acetone was evaporated off in a speedvac, and the 
media stirred with chelex 1(X) for 2 hours at room temperature to chelate any ions. 
The chelex was removed by filtering through a glass sinter, freeze-dried overnight, and 
resuspended in 3ml distilled deionized water. The pH was adjusted to 8, and samples
spun at 12000g for 5 minutes at room temperature to remove particles before running
in NMR.
B. Nuclear Mass Resonance (NMR) Spectrum Measurements.
’H NMR spectra of concentrated cell supernatants were obtained at 300 MHz on a 
Brucker AM 300 spectrometer. Samples were run without a deuterium lock and were 
unspun. The spectra were the sum of 64 scans collected into 2K data points, with 
a sweep width of 4 kHz, 90° pulse, and a 15 second relaxation delay. No exponential 
line-broadening was applied to the free induction prior to Fourier transformation. The 
transformed spectra were base-line corrected to enable determination of the areas of the 
signals. Chemical shifts were referenced to sodium 3-trimethylpropionate (TSP) at 0.0 
ppm, contained in a coaxial capillary suspended in the centre of the NMR tube. The
TSP also served as an intensity standard for quantification of the signals.
Heteronuclear ‘^ N-'H spin echo spectra were acquired using a pulse sequence. Spectra 
were the sum of 512 scans collected into 4K data points.
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APPENDIX 6.
FACTORS AFFECTING THE UPTAKE OF DNA BY ELECTROPORATED CELLS.
1. Electrical variables.
Waveform: The waveforms of electrical pulses used for electroporation are of two
types: "square wave" and "exponential decay". A square wave is generated by rapidly 
increasing the voltage to the desired amplitude, holding that voltage for a specified 
time, and rapidly reducing the voltage to zero. An exponential decay waveform is 
generated by the discharge of a capacitor. In this case the voltage rises very rapidly 
to a peak amplitude, and then declines, as an exponential function of both the 
resistance and the capacitance. In general, square wave generators are more expensive 
than capacitor discharge devices. Since there is no evidence that square wave pulses 
are more effective in electroporating cells, the capacitor discharge method is more 
commonly used.
Capadtance, resistance, and RC time constant: The characteristics of the
exponential decay waveform are determined by three variables (Figure 1):
a) Size of the capacitor (the amount of charge it will store at a given voltage, usually 
stated in microfarads [uF]),
b) Voltage to which the capacitor is charged, and
c) Resistance of the circuit through which the capacitor is discharged.
The exponential pulse delivered by the Gene Puiser apparatus is described by:
a) Vo, the initial voltage to which the capacitor is charged less any losses in the 
circuit, and
b) y , the resistance-capacitance (RC) time constant, which is defined as the time it 
takes for the voltage to decline to 1/e (about 37%) of the initial voltage, y depends 
on the size of the capacitor (C), and the resistance (R), through which it is discharged.
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Figure 1. Electrical circuit of capacitor discharge.
Charging
power
supply
DischargeCharge
CapadtorPS
Shocking chamber 
containing cell 
suspension and DNA
Resistance of the electroporation medium: The resistance of the electroporation
medium is dependent on its ionic strength, as the ionic strength increases, resistance 
of the medium decreases. A number of electroporation media have been used with 
different ionic strengths, including phosphate buffered sucrose, phosphate buffered saline 
(PBS), and HEPES buffered sucrose.
Cuvette geometry: Another variable affecting the resistance across the sample cuvette 
is the volume of electroporation medium in the cuvette. The resistance is proportional 
to; (a) the length of the path through the buffer, and (b) the cross-sectional area of 
the path.
Voltage and field strength: The voltage, or potential difference, between the
electrodes of the sample cuvette, has a major effect on the efficiency of electroporation 
and the survival of cells (Andreason and Evans, 1988; Potter et a/., 1988). The
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voltage effect is dependent on the voltage gradient, or field strength (E), expressed in 
volts per cm of interelectrode distance (Id), and can be determined by the relationship; 
E =  V/Id.
2. Other experimental variables.
Cells: The cell-type, the growth-rate, and the growth phase of the population are
important variables in electroporation experiments. There is some evidence that 
transfection efficiency is cell cycle dependent, for example, incubation of cells with 
colcemid before shocking enhances transfection efficiencies, suggesting that mitosis is 
a period of competency (Potter et al., 1984).
Electroporation medium: The electroporation medium affects the cells in a number
of ways; (a) the resistance of the medium influences the pulse time constants (as 
mentioned above), (b) the osmotic character of the buffer affects the turgidity (hence 
fragility) of the cells, (c) components of the medium, such as divalent cations, may 
affect the stability of cell membranes during the pulse, or (d), components of the 
medium may enter cells during electroporation causing adverse effects.
DNA: The form of the DNA may influence the efficiency of transfection. To obtain
cells with integrated, stably maintained DNA, linear DNA enables higher transformation 
frequencies than circular DNA because a higher recombinational activity is provided by 
the free ends (Forger et al.y 1982). To obtain cells with either transiently or stably 
maintained episomal sequences circular DNA should be used. The purity of the DNA 
also influences the transformation, as does the amount of DNA, It has been found 
that the transfection efficiency increases with DNA concentration in the range 2 to 
40ug per ml (Andreason and Evans, 1988). Carrier DNA may also contribute to 
increased transfection efficiency.
Temperature: The temperature of the pre- and post-pulse incubations has been found
to influence the transformation frequency (Winterboume et al., 1988). This appears 
to vary according to the cell-type.
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Figure B.
The floiv sheet of respiration, showing the 
origin of the pairs of hydrogen atoms re­
moved by dehydrogenases, with transfer of 
their electrons (2e“) to the electron-transport 
chain, which carries them to oxygen. Reduc­
tion of each atom of oxygen requires 2e“ + 
Energy set free during transport of a 
pair of electrons from NADH to oxygen is 
harnessed to cause the coupled synthesis of 
three molecules of ATP from ADP and phos­
phate in the process of oxidative phos­
phorylation. The electron-transport chain is 
shown here in abbreviated form.
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